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CHAPTER I
INTRODUCTION
Alpha adrenergic receptors have been reported to limit coronary
blood flow under conditions of augmented oxygen demands when
production of vasodilator metabolites might be expected to overwhelm
the influence of alpha mediated vasoconstriction.

Even when blood

flow is reduced, alpha receptors have been shown to limit flow to the
ischemic region.

The blood supply to the heart is closely tied to

myocardial metabolism.

When the balance is upset under conditions of

ischemia such as occur following a coronary artery occlusion, oxygen
demand outstrips the oxygen supply and an infarction may result.
Early investigations into prevention of myocardial infarction focused
on reducing the oxygen demand by blocking myocardial beta-1 receptors
which mediate increases in myocardial oxygen consumption when
stimulated.

Studies indicated that elevated levels of sympathetic

input in the presence of beta-blockade might alter the amount of blood
flow to the ischemic myocardium by limiting the flow into the region
via alpha-mediated vasoconstriction.
The first study in this dissertation proposed to examine the
effect of sympathetic nerve stimulation in the presence of betablockade on infarct size.

In this preparation, the infarct size was

assessed with tri-phenyltetrazolium chloride and normalized to the
area at risk.
The second study was done to determine what effect sympathetic
1

2
nerve stimulation had in the presence of beta-blockade on regional
myocardial blood flow following coronary artery occlusion.

The

hypothesis was that alpha-mediated vasoconstriction limited blood flow
to the ischemic zone by reducing the collateral blood flow to the
region or by restricting flow in the ischemic zone.
While alpha receptor vasoconstriction can be demonstrated under
conditions of beta-blockade and elevated sympathetic input to the
heart, the hypothesis that alpha receptors exhibit a tonic restraint
on coronary flow, while accepted by some investigators, has been
refuted as untenable by others.
examined in the third study.

There were several hypotheses

The first was to demonstrate whether

there was significant alpha-mediated tone under resting conditions
following circumflex coronary occlusion, second, whether this tone
limits flow to the ischemic zone and third, whether regional
denervation of the ischemic zone provides any beneficial effects by
removing the tonic alpha restraint.

The technique used for regional

denervation was developed in this laboratory and included cutting of
the ventrolateral cardiac nerve where it courses over the pulmonary
veins, and painting a thin strip of phenol around the perimeter of the
circumflex artery perfusion zone.

Topical application of phenol has

been shown to penetrate approximately 0.25 cm into the epicardium
causing coagulation necrosis and destruction of sympathetic nerves
which run in the upper 0.5 mm of the epicardium.
The last study was done to determine whether alpha mediated
vasoconstriction in the circumflex bed could be elicited by specific
cardiac thoracic nerves, and whether the vasoconstriction was predomi-

3

nantly alpha-1 or alpha-2 mediated.

Recent evidence suggests that

alpha-2 receptors although originally believed to be presynaptic in
origin are also located on post-synaptic effector organs.
It is hoped that the work presented in this dissertation will
provide additional information regarding the influence of sympathetic
nerves on coronary blood flow under pathophysiologic conditions of
coronary artery occlusion and myocardial ischemia as well as on blood
flow during physiologic conditions.

CHAPTER II
GENERAL LITERATURE REVIEW
Under normal physiologic conditions, the autonomic nervous
system is the major external influence on coronary vascular resistance.

The research presented in this dissertation is concerned

primarily with determining the extent of control of coronary blood
flow exerted by the sympathetic branch of the autonomic nervous
system, specifically in the pathophysiologic setting of myocardial
ischemia.

A.

SYMPATHETIC INNERVATION OF THE HEART
The sympathetic supply to the heart is via the first through the

fourth thoracic spinal sections (138).

The cell bodies of the

preganglionic fibers are located in the intermediolateral cell column.
The axons leave the spinal nerve and synapse in the paravertebral
ganglion via the white rami communicantes.

Unmyelinated post-gangli-

onic fibers leave via the gray rami communicantes to end on effector
cells within the heart.

A detailed description of the innervation of

the heart was provided by Woollard in 1926 (136).

Forty five days

after removal of the stellate ganglia, Woollard used methylene blue
staining to study the innervation of the heart.

The nerves supplying

the heart course along the coronary arteries, forming spirals around
the vessels.

The coronary circulation was described as receiving the

richest innervation of all arterial beds (137).

4

Woollard concluded

5

from his studies that the large coronary arteries are innervated by
both the parasympathetic and sympathetic systems, and that the smaller
arteries are innervated primarily by vagal fibers.

Penetration of the

myocardium by these nerves gave rise to a plexus of fibers underlying
the epicardium as well as the endocardium.

More recently, confirma-

tion of Woollard's studies has been provided by investigations
utilizing histo-fluorescence.

The coronary arteries have been found

to be densely innervated by adrenergic terminals (32), which are
located primarily in the adventitia of the vessel (33).
Subsequent studies have described the specific cardiac nerves to
the heart.

Nonidez gave detailed anatomical descriptions of the

cardiac nerves and their distribution to the heart (100).

He estab-

lished that many preganglionic fibers synapse in the middle cervical
ganglion, and that a number of preganglionic fibers synapse above the
level of the aortic arch.

In addition, Nonidez determined that

parasympathetic fibers supply the structures above the coronary
sulcus.

In his description of the cardiac sympathetic nerves, he

described the superior cardiac sympathetic nerve which carries
sympathetic post-ganglionic fibers.

This nerve carried fibers which

end as pressoreceptors on the arch of the aorta.

Nonidez did not

consider this nerve to be a true cardiac sympathetic nerve, as it did
not distribute below the aortic arch.

The major left cardiac nerve

was the middle cardiosympathetic nerve which reaches the left ventricular base and joins nerve branches of the coronary arteries to
form a nerve plexus on the posterolateral surface of the left ventricle.
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The nomenclature devised by Mizeres in his studies is still used
today (92).

The three major left side cardiac nerves were the

innominate (ICN) cardiac nerve, the ventromedial cervical cardiac
nerve (VMCCN) and the ventrolateral cervical cardiac nerve (VLCCN).
These latter two nerves are analogous to the superior cardiosympathetic nerve and the middle cardiosympathetic nerves of Nonidez,
respectively.

Mizeres' studies came to some slightly different

conclusions from those of Nonidez.

Mizeres, in describing the course

of the ICN, concluded that the ICN was not a cardiac nerve since it
did not reach the left ventricular wall.

Furthermore, the VMCCN was

found to be composed of both branches of the autonomic nervous system,
having both vagal and sympathetic fibers.

Although Nonidez did not

consider the superior cardiosympathetic nerve (VMCCN) a true cardiac
nerve, as did Mizeres, both investigators were in accord that the
VMCCN sent branches to the aorta.
as the largest of the nerves.

The VLCCN was described by Mizeres

It also had many interconnections with

the vagus, and carried sympathetic postganglionic fibers as well as a
few afferent fibers.

Mizeres postulated that there may be ganglia in

the ventral limb of the ansa subclavia.
In a later study in 1958, Mizeres determined that stimulation of
the left cardiac nerves had more of an influence on the force of
contraction of the heart, rather than any noticeable effects on
cardio-acceleration (93).

Randall expanded these original observa-

tions of Mizeres in a number of studies investigating the functional
importance of cardiac sympathetic nerves (106,107).
will be described in more detail later.

These studies

7

B.

ADRENERGIC INFLUENCES ON CORONARY BLOOD FLOW
One of the earliest recorded mentions of coronary vasomotor

activity was described by Newell-Martin in 1880, when he noted a vasomotor response of the coronary arteries (99).

Newell-Martin had

undertaken the study to determine what happens to coronary pressure
throughout the cardiac cycle.

The debate at that time involved

whether flow occurred solely during diastole due to obstruction of the
Sinus of Valsalva by the aortic leaflets during systole.

During the

course of this study, he noted that in one of the pressure tracings,
the coronary artery pressure was greater than carotid artery pressure
(76 mm Hg, and 64 mm Hg, respectively).

Rather incidently, Newell-

Martin remarked that often, it was difficult to cannulate a coronary
branch, since it appeared to be considerably smaller upon insertion of
the cannula than it had at first appeared.

After a few minutes, it

would dilate to twice the size it was when constricted.

This visual

observation on coronary vasomotor tone might at the time have seemed
merely anecdotal.

However, several years later, Porter provided the

first evidence that coronary arteries respond to external stimuli
(105).

By stimulating the cervical vagus, Porter was able to decrease

the flow through the cut end of a coronary artery from 13 to 8 drops
per 15 seconds.

The rate of flow was found to return to control

levels following cessation of the stimulation period.

Thus, it was

demonstrated by Porter that coronary arteries can constrict in
response to neural stimulation, and also that the cervical parasympathetic trunk contained sympathetic fibers.
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From the beginning of the century, numerous investigations addressed the topic of adrenergic influences on coronary blood flow.
Wiggers contended that vasodilation was the main response of coronaries, although he observed that when the heart was not beating,
coronary blood flow decreased in response to adrenalin (134).

Studies

undertaken by Barbour suggested that 'vasospasm' may be due to release
of adrenalin and the consequent vasoconstriction of the arteries (6).
Brodie and Cullis determined that the coronary vessels were supplied
with both vasoconstrictor and vasodilator fibers (15).

They deter-

mined that although the primary effect was constriction which could be
elicited by a low dose of adrenalin, a large dose of adrenalin
overwhelmed the constrictor effect causing a vasodilation.

This

apparently satisfactory explanation for the paradoxical actions of
adrenalin was not enough to prevent a plethora of investigations
concerning adrenergic influences on coronary blood flow.
A cursory examination of the literature on this subject reveals
that there are a number of studies with conflicting results.

Coronary

arteries have been reported to constrict (6,7,121,125) dilate (26,135), constrict and dilate (2,3,10,12,50,56,73,95), or do nothing
(31), in response to adrenergic stimuli.

In some instances an initial

constriction preceding a dramatic vasodilation may have been recorded
by an investigator but was not remarked upon (135).
A plausible explanation for these differences can be attributed
to the variety of preparations used.

Studies have been done on

isolated hearts (57,67), isolated vessels (2,7,9,26,73,95), nonworking
hearts (55), arrested hearts (52), anesthetized animals (58,121,128),

9
and conscious animal preparations (83,104).

Furthermore, even in the

vessel strip preparation, opposing responses can be obtained depending
on the size of the vessel examined (2,95,139).
The ground work for clarification of the results from these
studies was laid by Cannon and Rosenblueth in a series of experiments
done in the early 1930's (20).

Cannon was among the first investiga-

tors to describe the effects of 'sympathin' as separate from 'adrenin'.

He postulated that sympathin was the chemical mediator of

sympathetic nerve stimulation and that when released it combined with
a substance in the effector organ to produce either sympathin E or
sympathin I.
might vary.

Depending on which organ was stimulated the response
Thus sympathin released from the heart was excitatory,

but that released from the coronary arteries was inhibitory due to the
variable concentration of the sympathin I or E substances in each
tissue.
It was Ahlquist however, who demonstrated that the same chemical
mediator could exert different effects depending on where it was
released (1).

Ahlquist determined that there were two types of

adrenergic receptors which mediated the effects of sympathin which he
believed to be identical to adrenin.

These receptors could not be

categorized as purely inhibitory or excitatory as Cannon had believed.
To prove his hypothesis, Ahlquist selected a series of sympathomimetic
amines for which the order of potency on the following functions was
determined: vasoconstriction, excitation of the uterus and ureters,
contraction of the nictitating membrane, dilation of the pupil, and
inhibition of the gut.

The order of potency was, from most active to
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least active: !-epinephrine> dl-epinephrine> arterenol >methyl
arterenol >methyl epinephrine > N- isopropyl arterenol.

However, the

order of potency for the same amines was different, (N-isopropyl
arterenol > 1-epinephrine > methyl epinephrine > dl-epinephrine >
methyl arterenol > arterenol, from most to least active), on the
following functions: vasodilation, inhibition of the gut, and myocardial stimulation.

One type of receptor was associated with most of

the excitatory functions and at

le~st

one inhibitory function of the

intestine (the alpha receptor), and the other receptor which he
arbitrarily designated the beta receptor was associated with most of
the inhibitory functions and one important excitatory function
(myocardium).

Thus, N-isopropyl arterenol was more potent on actions

associated with beta receptors, whereas arterenol was more potent on
those actions determined to be mediated by alpha receptors.
Identification of the chemical mediator released by sympathetic
nerves was accomplished by von Euler, who localized norepinephrine to
nerve terminals and the sediment of axons in the mid 1950's (132).

By

the mid 1950's, the action of sympathetic nerves was known to be via
release of norepinephrine which stimulated both alpha and beta
receptors, thus eliciting different end organ responses depending on
the concentration of receptor present.
In 1967, Lands determined that beta receptors could be divided
into two subtypes, beta-1 and beta-2 (74,75).

His basis for this

subdivision came from experiments he had performed on the actions of
several sympathomimetic amines including isoproterenol, epinephrine
and norepinephrine on different physiological functions.

The effects
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of these different agents were assessed on fatty acid mobilization
from rat adipose tissue, cardiac stimulation, bronchodilation, and
vasodilation.

A similarity was found for the relative potencies of

each of the drugs on lipolysis/cardiac stimulation and on bronchodilation/vasodilation.

There was a low correlation between the action

of norepinephrine, for instance on cardiac stimulation and bronchodilation, but the correlation between its potency on lipolysis and
cardiac stimulation was high.

Lands designated the receptors located

on the heart and adipose tissue, and small intestine as beta-1, and
those found on the uterus, diaphragm, bronchioles and vasculature as
beta-2.

Following the development of specific beta-agonists and

antagonists in the 1960's, the location and function of beta-1 and
beta-2 receptors in the cardiovascular system was clarified by
different investigations.
Klocke found that isoproterenol in a potassium arrested heart
caused a drop in perfusion pressure of a constant flow system which
was blocked by nethalide (beta-blocker) (71).

Several investigations

determined that coronary beta receptors were of the beta-2 type
(14,52,55,86).

Gross and Feigl published a study in which they con-

cluded that the coronary vascular receptor is of the beta-2 type.

In

the potassium arrested heart they found that practolol (a beta-1
antagonist) blocked the dilation evoked by isoproterenol only at very
high concentrations (lo-3M), whereas propranolol blocked the dilation
at lo-7 M.

Salbutamol, although a selective beta-2 agonist, produced

a dilation only one eighth as potent as that induced by the nonselec tive beta-agonist isoproterenol (52).

Their findings concurred
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with an earlier study by Broadley, in which salbutamol was also used
to evoke direct vasodilation (14).
However, in a different study, Hamilton and Feigl determined
that beta-2 receptors on the arteries are not of functional importance
(SS).

In the beating non-working heart, they blocked beta-1 receptors

with practolol, and alpha receptors with dibozane, then stimulated the
left stellate ganglion at 10 Hz.

They found that the vasodilation

which could be attributed to beta-2 receptors under these conditions
was very slight.

Stimulation of beta-2 receptors by isoproterenol in

the presence of
beta-1 blockade did evoke a significant vasodilation.

Thus, they

concluded that although beta-2 receptors can cause significant
vasodilation in the coronary bed when stimulated by exogenous catecholamines, they are not of physiologic importance since neural
stimulation has more of an effect on alpha and beta-1 myocardial
receptors.

Domenech and MacLellan found similarly that beta-2

activation caused a large dilation in the subepicardium and effected a
redistribution of blood flow to the subepicardium from the subendocardium (34).

This preparation involved beta-1 blockade with practo-

lol, and stimulation of beta-2 receptors with salbutamol, and isoproterenol, hence the confounding influence of alpha receptor stimulation
by neurally released catecholamines was circumvented in this study.
Beta-1 receptors have also been proposed to cause direct as well
as indirect vasodilation of coronary vessels.

Vatner et al. demon-

strated in the conscious animal, that in the presence of beta-1
blockade, isoproterenol (beta-l,beta-2 agonist) and pirbuterol (a
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beta-2 agonist) no longer caused vasodilation due to beta-1 receptors
(129), which seemed to confirm the results from an earlier study (8).
In the study by Baron et al., canine coronary and skeletal muscle
vessel strips were blocked by phenoxybenzamine (alpha blocker), and
isoproterenol caused a vasodilation which was blocked by propranolol
as well as by practolol a beta-1 blocker.

However, isoproterenol

adminstration following beta-1 blockade with practolol did not block
the vasodilation of skeletal muscle arterioles, which have predominantly beta-2 receptors (8).
The concept of metabolic control of coronary blood flow was
introduced more than 70 years ago when Brodie and Cullis observed that
an increase in cardiac activity led to an increase in cardiac metabolism and the release of carbonic acid.

They tested the effect of

this metabolic substrate by putting it directly on coronary arteries
and observed that it caused dilation (15).
Shipley and Gregg noted that left stellate ganglion stimulation
caused parallel increases in coronary blood flow and cardiac work
(116).

This came about because an increase in work led to an increase

in metabolism and vigor of contraction.
tions for their findings.

They proposed two explana-

First they postulated that there was a

local production and release of metabolites and second, that stimulation of the stellate ganglia produced a local, relative anoxia caused
by a disproportionate increase in the rate of oxygen utilization and
existing coronary blood flow.

Subsequent studies (38,41,49) confirmed

these observations that there was a link between myocardial oxygen
consumption and coronary blood flow.

Eckstein used a preparation in
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which he could control cardiac output, and in which the coronary
arteries were perfused at a constant pressure (38).

A nerve branch

from the left stellate ganglion was stimulated at 50 Hz.

In this

study, during stimulation of the cardiac nerve, cardiac work increased
by 13%, whereas myocardial oxygen consumption increased 100% from
control and coronary blood flow increased 37% from control.

His

interpretation of these results was that since the increase in
myocardial oxygen consumption was much greater than the increase in
cardiac work, when cardiac sympathetic nerves were stimulated, they
release an adrenin-like substance which "renders the heart anoxic and
inefficient".

Feinberg and Katz concurred with Shipley and Gregg that

catecholamines augment coronary blood flow and cardiac work (41).
However, in their study, they found a decrease in the A-V 02 difference and an increase in coronary sinus 02 content.

This apparent

vasodilation, in addition to metabolic vasodilation contradicted
evidence gathered by other investigators from that time.

Intracor-

onary injection of epinephrine and norepinephrine elicited a reduction
in coronary sinus blood oxygen tension concomitant with an increase in
blood flow in the fibrillating heart in a study by Berne (10).

His

explanation for this was that myocardial oxygen consumption increased
more than coronary blood flow.
The limitation in the blood flow increase during adrenergic
stimulation was also noted in a study by Hashimoto (57).

In an

isolated Langendorff heart which was cross-perfused from a donor
animal, he found that epinephrine and norepinephrine increase myocardial oxygen consumption more than isoproterenol.

However, isoproter-
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enol caused greater changes in blood flow that either epinephrine or
norepinephrine.

Utilizing two early adrenergic blockers, he separated

the alpha and beta actions of these drugs.

Administration of the beta

blocker dichloroisoproterenol (DCI) with the subsequent stimulation by
norepinephrine and epinephrine, elicited decreases in coronary blood
flow although there were no longer increases in myocardial oxygen
consumption.

The decrease in blood flow was reversed by alpha

blockade with dibenzylene.

With isoproterenol there was a propor-

tionate increase in blood flow and MV02, but with epinephrine and
norepinephrine, MV02 increased more than coronary blood flow.
Dibenzylene prior to administration of norepinephrine and epinephrine,
eliminated the mismatch in flow and oxygen consumption previously seen
with both catecholamines.
Although there is a link between myocardial oxygen consumption
and coronary blood flow, blood flow did not increase as much as
expected during sympathetic stimulation in the above studies, since
the reduction in coronary sinus oxygen tension indicates an increased
extraction of oxygen due possibly to alpha receptor limitation of
flow.

This might explain the conclusions of Eckstein that the heart

became inefficient during sympathetic stimulation since the matching
between cardiac work and increase in blood flow was not so close
during sympathetic stimulation as it was at rest (38).

In retrospect,

it seems obvious that alpha receptor stimulation contributed to the
mismatch in coronary blood flow and oxygen consumption.

In Eckstein's

study, coronary sinus oxygen content decreased from 8.5 to 3.5 vol%,
during an increase in blood flow, indicating a limitation in flow
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during metabolic vasodilation.

The differences in the preparation

used by Feinberg and Katz can explain their contradictory findings
that oxygen consumption decreased while blood flow increased (41).

In

their study, the drugs were given intravenously, the hearts were not
neurally decentralized, nor were blood pressure or heart rate controlled.

The effects of baroreceptor reflexes on the heart superim-

posed on systemic injection of sympathomimetic agents caused a wide
variation in the control response to the drugs.

They reported that

epinephrine elicited a pressor response in 4 out of 10 of the dogs,
and of the remaining 6, 5 had blood pressures which returned toward
control.

Moreover, heart rate was elevated in six of the animals, and

depressed in four of the animals.

Berne, on the other hand, admini-

stered norepinephrine intracoronary, to a fibrillating heart, thus
avoiding the confusing contribution of baroreceptors reflexes, and
metabolic increases in blood flow (10).
The increased work of the contractile elements leads to a net
production of cellular metabolites.

The identity of the elusive

metabolite produced by the heart was proposed by Berne in 1964 to be
adenosine (11).

Adenosine fulfills many criteria for metabolically-

mediated vasodilation, it is present in the normal heart, it readily
crosses the cell membrane, and is rapidly metabolized in the blood and
surrounding tissues (13).

When Lands designated the receptor medi-

ating cardiac stimulation as beta-1 in 1967, the link between neural
stimulation and coronary blood flow was made.

Since that study, the

identification and localization of beta receptors discussed above led
to the general consensus that beta-1 mediated increases in myocardial
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metabolism were the primary neural influence on coronary blood flow,
and that beta-2 receptors, although located on the coronary vasculature, play a distant second in eliciting vasodilation.

c.

NEURAL INFLUENCES DURING MYOCARDIAL ISCHEMIA
The coronary circulation is subject to a number of influences

both extrinsic and intrinsic.

The primary determinant of coronary

blood flow is the metabolism of the heart.

In addition, the autonomic

nervous system modulates coronary blood flow.

Under circumstances in

which sympathetic nervous system (SNS) activity is elevated such as in
exercise, beta-1 mediated metabolic vasodilation augments coronary
blood flow with the favorable consequence of increased delivery of
oxygen to the myocardium.

However, myocardial ischemia illustrates a

case in which the increase in SNS activity can become deleterious.
Following a coronary artery occlusion there is an increase in the
level of plasma catecholamines (66,109,110).

In addition, there is an

increase in sympathetic nervous system activity (85,124).

The

resulting stimulation of both alpha and beta receptors leads to an
oxygen supply-demand imbalance since oxygen delivery is limited due to
the combination of arterial obstruction and vasoconstriction.
Simultaneously, the need for oxygen is increased in the non-ischemic
myocardium due to the stimulation of beta-1 receptors.

Consequently,

standard treatment involved administration of beta-receptor blockers
such as propranolol or timolol.

These pharmacologic agents were

thought to provide protection due to blockade of beta-1 mediated
increases in oxygen consumption (87,133).

Functional studies sup-
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ported these conclusions.

Although stimulation of beta receptors

augments myocardial contractility under normal conditions, under
conditions of ischemia, function has been shown to deteriorate.
Davidson et al. demonstrated in the contracting Langendorff rat heart,
that isoproterenol increased left ventricular pressure (LVP) from 103
to 166 mm Hg, and LVdP/dt from 1840 to 6000 mm Hg/sec under control
conditions.

Following the reduction in flow to the heart from 9.5 to

2.4 ml/min, LVP was only 25 mm Hg, and LVdP/dt 683, mm Hg/sec.
Infusion of isoproterenol further reduced LVP to 23 mm Hg, and LVdP/dt
to 601 mm Hg/sec.

Although the change from control ischemic condi-

tions was not significant it can be seen that the usual inotropic
actions of isoproterenol are inconsequential, if not detrimental to
the ischemic myocardium (29).

These findings were extended to the

conscious animal preparation by Vatner et al. (130).

Vatner found

that the amount of paradoxical motion (123) in the ischemic zone, was
reduced by the injection of propranolol.

They also described a

redistribution of blood flow to the ischemic zone.

Gallagher et al.

reported that during coronary artery occlusion, heart rate increased

113% from resting levels during isoproterenol injection.

At the same

time the percent change in wall thickening (%b WT) and segmental
shortening, decreased from resting levels, whereas during control, %b
WT had increased to 40% during isoproterenol from 34% at rest.

During

a mild stenosis, at rest %b WT was 28% but during isoproterenol, it
decreased to -.3%, indicating paradoxical motion had developed (43).
Matsuzaki et al. demonstrated that administration of atenolol improved
regional left ventricular function in a severely ischemic region
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during exercise compared to exercise without atenolol.

Regional

myocardial blood flow during exercise and coronary artery occlusion in
the ischemic region was also improved due to an increase in the
endo/epi ratio (89).
Most of the early studies which investigated the effects of beta
blockade on infarct size reduction used propranolol.

Pretreatment

with 5 mg/kg of propranolol injected intraarterially caused a reduction in the amount of necrotic posterior papillary muscle in a study
by Rasmussen et al.

The necrotic area was reduced from 76 ± 5% in the

control animals to 43 ± 5% in the animals pretreated with propranolol
ten minutes before occlusion.

Delayed treatment with propranolol, at

three hours after occlusion, also reduced the total amount of necrotic
tissue to 62 ± 4% (108).
There are some disagreements in the literature as to the
beneficial effects of beta blockade on infarct size.

Burmeister used

three different blocking agents atenolol, nadolol and propranolol.
The drugs were given 5 minutes prior to coronary artery occlusion.
The left anterior descending artery was occluded for 1 hour and then
allowed to reperfuse.

At 24 hours the hearts were excised, sliced and

put in nitroblue tetrazolium.

The infarct size as a percent of the

left ventricle was assessed, and Burmeister found that all three drugs
reduced infarct size compared to control (19).

Reduction in infarct

size was demonstrated in other laboratories with various beta adrenergic blockers (63,117,131).

However, there were also studies which

contradicted these positive results.

Lange showed that pindolol and

metoprolol did not reduce infarct size, although both beta blockers
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were given after occlusion (76).
effect of propranolol (103).

Peter also did not show a protective

In a recent study by Geary et al.,

propranolol did not reduce the infarct size in baboons.

Geary

attributed his negative findings to the fact that baboons do not have
the extensive preformed collateral system of dogs (44).

However,

other studies have investigated the effects of beta-blockade on blood
flow and have found that although beta blockers may reduce infarct
size, the mechanism does not appear to be blood flow mediated (72,76,103).

It is generally believed that the beneficial effects are

probably due to a reduction in myocardial oxygen consumption. (87,133).

Most of the early studies did not assess infarct size as

accurately as the methods available in recent studies.

In humans, the

only way of assessing the severity of infarction was by determinations
of serial CPK levels, and S-T segment elevation, methods which are
notoriously prone to error.

In addition, in experimental studies, the

variations in the type of anesthetic used, duration of occlusion, time
of treatment, background level of catecholamines and possible involvement of cardiac reflexes in all probability add to the disparity in
results.

Many of these studies have been applied to the human

condition in which the elevation of sympathetic input is natural
during exercise, or anger.

The first study of this dissertation

proposed to address the effect of elevated levels of sympathetic input
in the presence of beta-blockade on infarct size.

D.

ALPHA RECEPTOR INFLUENCES ON CORONARY BLOOD FLOW
Numerous studies throughout the 1950's and 1960's indicated that
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alpha receptors indeed had a vasoconstrictor influence.

Berne

described an initial decrease in blood flow during administration of
norepinephrine followed by an increase in blood flow of longer
duration, at the time ascribing the increase in blood flow to an
increase in myocardial metabolism (10).

Although he considered

catecholamines to be primarily vasoconstrictors, the net effect was
vasodilation (12).

It was generally believed that although the

primary action of neural norepinephrine was to cause vasoconstriction,
this was almost immediately overwhelmed by stimulation of beta
receptors.
Feigl provided indirect evidence of alpha receptor mediated
vasoconstriction.

In chloralose anesthetized dogs pretreated with

propranolol, blood flow measured with an electromagnetic flow probe,
decreased 18% from control levels during stimulation of the left
stellate ganglion.

This vasoconstriction was blocked by phenoxybenz-

amine (39).
In 1967, Pitt et al. demonstrated that in conscious dogs, alpha
and beta receptors have a role in modulation of coronary blood flow.
In beta-blocked animals (with propranolol), intravenous injections of
catecholamines caused vasoconstriction which could be eliminated by
blockade of alpha receptors with dibenzylene.

Beta-receptor mediated

vasodilation could be elicited in the presence of alpha receptor
blockade and occurred prior to any alterations in metabolic or
hemodynamic indices (104).
Zuberbuhler and Bohr also demonstrated a role for alpha receptors in control of coronary blood flow.

They found that isolated
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strips of large coronary arteries underwent an initial contraction
followed by relaxation in response to norepinephrine and epinephrine
which suggested that large vessels might have equal populations of
alpha and beta receptors.

In contrast, the strips taken from smaller

coronary vessels almost always relaxed when exposed to catecholamines,
and the relaxation was reversed by the beta blocker nethalide.

This

was interpreted as demonstration of an exclusively beta receptor
population in the smaller resistance vessels (139).

Other investiga-

tions have demonstrated a differential population of adrenergic
receptors (2,95).
Malindzak using a whole animal preparation and cardiac sympathetic nerve stimulation in addition to injections of catecholamines,
showed that large vessels have more of a tendency to contract in
response to catecholamines, as will smaller vessels although the
constrictor response of smaller 'resistive' vessels is generally
masked by the compensatory metabolic responses of the myocardium to
sympathetic stimulation (84).
Additional evidence in support of alpha vasoconstriction came
from a study by McRaven et al.

They found that injections of norepi-

nephrine or isoproterenol caused a drop in perfusion pressure in the
circumflex artery which was perfused at a constant flow.

The drop in

pressure was reversed following blockade of beta receptors with
practolol (a beta-1 blocker).

Nerve stimulation (lOV, 4msec, variable

frequency) after practolol administration resulted in vasoconstriction
which was reversed by administering phentolamine.

They concluded that

alpha receptors could directly constrict coronary arteries when
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stimulated by neurally released catecholamines, but that this effect
is minimal and that vasodilator effects both direct and indirect
played a more important role, with vascular receptors having a more
important influence than myocardial receptors (91).
Vatner et al. demonstrated the ability of alpha receptors to
cause a potent vasoconstriction (128).

Ultrasonic dimension gauges

were implanted on the circumflex artery to measure the change in
coronary diameter.
agonist, 50

Following administration of methoxamine (an alpha

g/kg/min) there was a transient increase in coronary

diameter followed by a decrease in diameter (9 ± 2%) even though
arterial pressure was elevated by 65 ± 5%.

The calculated resistance

for large arteries and total resistance used to estimate small artery
resistance, increased by 108 ± 29 and 92 ± 14% respectively, indicating that alpha vasoconstriction was transmural and involved not only
the large epicardial arteries but also the smaller resistance vessels.
In another study by Macho and Vatner, prazosin was found to
reduce mean arterial pressure by 15 ± 4% in conscious dogs and to
decrease coronary vascular resistance significantly.

Although

prazosin caused significant reductions in various inotropic indices
(LV dP/dt, left ventricular end-diastolic diameter etc.) it did not
increase coronary blood flow significantly.

Hence they concluded that

prazosin decreased resistance significantly mainly by reductions in
afterload and preload thereby reducing oxygen consumption, but did not
exert its effects on resistance by increasing blood flow (83).

Vatner

had shown previously that stimulation of alpha receptors with methoxamine could produce powerful vasoconstriction in the presence of
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increased perfusion pressure, however in that earlier preparation, the
animals' reflexes were intact, and no ganglionic blockade was administered (128).
None of these studies declared that alpha receptors had a major
influence on blood flow under resting conditions.

While demonstrating

that alpha-receptors cause constriction, these studies did not
actually provide evidence from a physiological standpoint of the
importance of alpha receptors.

In the aforementioned examples, alpha-

receptor influences were demonstrated only in beta blocked preparations, or vessel strips in which vasomotor tone was independent of
metabolic influences.
It wasn't until the mid-1970's that there was evidence that
alpha receptors may modulate coronary blood flow even with concomitant
activation of beta receptors.

In a study by Feigl, blood oxygen

tension in the coronary sinus was measured, along with circumflex
artery blood flow (40).

During stimulation of the left stellate

ganglion for 90 seconds the heart rate, blood pressure and coronary
blood flow increased from control, while coronary sinus oxygen tension
(CS02) decreased from 19 mm Hg to 15 mm Hg.

Following administration

of propranolol, stimulation of the left stellate no longer produced
the marked increases in inotropic and chronotropic indices, but
coronary sinus oxygen tension was further reduced from 17 to 11 mm Hg.
This indicated that alpha receptors were 'unmasked' since increases in
metabolism were blunted by propranolol, and the decrease in CS02
tension was interpreted as evidence of alpha receptor vasoconstriction.

Following alpha blockade with dibozane, CSOz and coronary

25

vascular resistance no longer changed in response to left stellate
stimulation.

This study provided insight into the involvement of

alpha receptors in modulating blood flow.

cso 2 ,

By measuring changes in

instead of only looking at changes in blood flow, it was

determined that even with metabolic increases in flow, alpha-receptors
limited flow enough to cause an increased oxygen extraction and
decreased coronary sinus oxygen tension.

Although these changes had

been noted in previous studies (10,38), Feigl demonstrated conclusively that alpha-receptors are responsible for the seemingly paradoxical changes in flow and oxygen tension.
Mohrman and Feigl demonstrated in the closed-chest chloralose
anesthetized dog that alpha receptors restrict the beta-1 mediated
increase in blood flow by 30% (94).

Sympathetic activation was

elicited by either intracoronary injections of norepinephrine or
carotid sinus hypotension.

Measurements of 02 extraction and coronary

venous 02 content were used as determinants of the ability of the
heart to extract oxygen.

When alpha blockade with dibozane was

initiated, less oxygen was extracted and the coronary venous 02
content increased, indicating that there had previously been a
limitation of blood flow by alpha receptor stimulation.
Other investigations have shown that alpha receptors can limit
blood flow increases following physiologic augmentation of sympathetic
activity during exercise (60,98).

Murray and Vatner found in dogs

that were exercised freely, that alpha receptors limited the increase
in coronary blood flow during exercise.

Heyndrickx, under similar

conditions, found that alpha receptors can upset the 02 consumption/02
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supply ratio.

During control conditions, exercise decreased the ratio

from 1.43 ± 0.05 at rest to 1.27 ± 0.03 during exercise.

Following

alpha blockade, the ratio went from 1.31 ± 0.05 at rest to 1.33 ± 0.02
during exercise.

They concluded from this that oxygen delivery is

better matched to myocardial oxygen consumption during alpha blockade
by blunting the effects of alpha vasoconstriction on oxygen delivery.
Contrary to the findings of Heyndrickx, in which the match
between oxygen supply and demand diverged during sympathetic stimulation, Buchweitz and Weiss stimulated the ansa subclavia and found that
endocardial and epicardial oxygen extraction and blood flow increased
proportionately (16).

Buchweitz and Weiss found in open chest

anesthetized dogs, that stimulation of the ansa subclavia did not
alter the 02 supply/02 consumption ratio.

They concluded from their

study that any coronary vasoconstriction which might occur with high
levels of sympathetic input to the heart does not reduce the ability
of coronary blood flow to meet the increased metabolic demand for 02
and that these needs were adequately met by the vasodilation produced
by the increased metabolic state of the heart.

In their study, the

hearts were electrically fibrillated, excised, and quickly frozen
during control and stimulation of the stellate.

In addition, pento-

barbital anesthesia was employed, which may have blunted adrenergic
sensitivity to nerve stimulation.
Recently, alpha-receptors have been found to contribute to the
regulation of blood flow during flow limited conditions such as
stenosis or occlusion.

Buffington and Feigl examined the contribution

of alpha receptors to ischemia during partial occlusion of the
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circumflex artery (18).

Blood flow into the left coronary artery was

measured, and following a 70% area reduction, intracoronary norepinephrine resulted in increased oxygen extraction, decreased coronary
sinus oxygen content, and increased coronary vascular resistance.
Following alpha blockade with phenoxybenzamine, the increase in
myocardial oxygen consumption was prevented.

They concluded that

while alpha receptors may limit the increase in blood flow during
coronary stenosis, it was not severe enough to cause net lactate
production by the myocardium.

These results concur with those of

Gewirtz et al. who found that during a severe stenosis, alpha receptors may compete with but probably do not overcome metabolic vasodilation (46).
In the presence of a coronary occlusion, 'coronary steal' has
been described as the effect of shunting of blood from an one area of
the myocardium to another area of reduced vascular resistance via
collateral vessels.

When a substance is given which causes vasodila-

tion of one region of the myocardium, while another region remains
collateral dependent and maximally vasodilated, the vasodilation in
the non-collateral dependent region causes an increase in blood flow
velocity, and a decrease in perfusion pressure at the origin of
collateral vessels.

This results in an effective shunting of blood to

the non-collateral dependent regions (101).
Chiariello et al. described a 'reverse coronary steal' due to
alpha receptor activation in the normal zone.

In that study the left

anterior descending artery (LAD) was ligated and methoxamine was given
17-30 minutes after occluding the artery.

The stimulation of alpha
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receptors in the normal zone caused a reduction in flow to the normal
zone from 90.6 ± 4.3 to 77.7 ± 3.2 ml/min/100 gm and increased the
collateral flow to the ischemic zone from 21.4 ± 3.5 to 41.0 ± 4.2
ml/min/100 gm (21).

Giudicelli et al. reported similar findings.

In

their study, branches of the LAD were ligated in a chloralose anesthetized dog.

During stimulation of the left stellate ganglion (LSGS),

regional flow increased to the normal area by 35% but not to the
ischemic area.

When atenolol was given, LSGS decreased flow to the

normal zone by 24% but increased flow to the ischemic region by 64%.
These effects were abolished by the administration of phenoxybenzamine
(47).

Buck et al. demonstrated that the unmasking of alpha receptors

by beta-2 blockade with propranolol and pindolol caused a redistribution of blood flow to the subepicardium distal to a severe stenosis
due to the predominance of alpha receptors in the larger more epicardially located blood vessels (17).
The role of alpha receptors appears to be elusive under certain
circumstances.

Gorman and Sparks reported a progressive vasoconstric-

tion distal to a partial occlusion (48).
were paced at 180 beats per minute.

In this preparation, hearts

Myocardial blood flow was

determined at 30 and 180 minutes after occlusion.

Vasodilator reserve

was demonstrated with adenosine and norepinephrine.

Since norepineph-

rine increased flow in the ischemic region, the vasoconstriction which
evolved with time probably was not due to norepinephrine.

It is

interesting that in this preparation, the injection of phentolamine or
phenoxybenzamine increased flow in the ischemic zone, but propranolol
in addition to phenoxybenzamine decreased flow.

Thus, norepinephrine

29
increased flow via beta-adrenergic stimulation but was not responsible
for the vasoconstriction.

The authors could not satisfactorily

explain the phenomenon as due to alpha receptor vasoconstriction, but
postulated that it may have been due to the decreased release of
vasodilator metabolites, the increased release of an unknown vasoconstrictor substance, or increased cell-swelling due to the ischemia.
A recent study by Grover and Weiss confirms the results of
Gorman and Sparks, regarding the ability of the ischemic bed to
vasodilate.

They showed that with a 50% reduction of IAD flow, the

oxygen supply/demand ratio of the occluded region was reduced compared
to control.

However, the reduced oxygen supply/demand ratio did not

change when heart rate was increased up to 50% above the resting
level.

Thus, the authors concluded that a flow reserve must exist

(53).

It is possible that blood flow to the ischemic region is further
compromised by alpha-mediated vasoconstriction in the ischemic zone.
A recent report from our laboratory indicated that following coronary
artery occlusion, simultaneous blockade of both alpha and beta
receptors during sympathetic stimulation of the heart limited myocardial damage to a significantly greater extent than blockade of
beta-receptors alone (42).
Investigations concerning alpha-mediated vasoconstriction are
not limited to experimental studies but have been researched in the
clinical setting too.

Variant angina has been well-documented, and is

believed by some to be alpha mediated.

Levene reported in 1976, that

a 41 year old women with angina demonstrated vasospasm during coronary
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arteriography which coincided with episodes of angina.

Relief of

symptoms by administration of i.v. phentolamine, and phenoxybenzamine
improved her exercise tolerance (81).

The usual treatment for angina

does not seem to work for variant angina.

Kirshenbaum reported that

while calcium channel blockers appear to alleviate the symptoms,
nitrates help only in large doses, and propranolol is ineffective
therapy, and may even aggravate the condition (70).

These findings

were substantiated by Maze et al., who concluded further that although
alpha-blockers are effective in the treatment of vasospasm, in
practice they are given only if nitrates and calcium channel blockers
are ineffective (90).

Other studies have added information on the

role of alpha receptors during coronary artery disease (68,69,96,97).
Kern et al. determined that beta-blockade with propranolol can
potentiate vasospasm in some patients with CAD, possibly by unopposed
alpha-tone (68).

In another study, 18 patients with coronary artery

disease underwent the cold pressor test, with paced heart rates of 95
beats per minute.

During the cold pressor test, coronary vascular

resistance (calculated as mean arterial pressure over blood flow
measured with thermodilution) increased by 15%.

Five minutes after

100 mg of the alpha-1 blocker trimazosin, the cold pressor test
increased coronary vascular resistance by only 6% (69).

The ability

to increase coronary vascular resistance with the cold pressor test is
not limited to patients with coronary artery disease, as normal
patients who do not develop spasm, will have increases in coronary
vascular resistance in the presence of beta-blockade (68).

This

confirms an earlier report by Mudge (97), in which it was reported
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that patients with coronary artery disease have limited vasodilatory
mechanisms, and inappropriate increases in coronary vascular resistance during cold pressor testing.

E.

ALPHA-2 RECEPTOR MEDIATED CORONARY VASOCONSTRICTION
Over the past ten years, the possible involvement of alpha-2

receptors in coronary blood flow has been examined.

Studies by Starke

and Langer proposed that alpha receptors can inhibit the release of
norepinephrine by a negative feedback mechanism (77,78,118).

Langer

originally proposed that alpha receptors be separated into prejunctional and postjunctional receptors calling the former alpha-2
receptors and the latter alpha-1 receptors (77).

Eventually it was

determined that pharmacological differentiation of the receptors would
be more appropriate, since alpha-2 receptor activity could be demonstrated on the effector organ also (78).

A physiologic basis for

prejunctional modulation of norepinephrine release was provided by
Lokhandwala (82).

Since those studies were done, alpha-2 receptors

have been reported to contribute to coronary artery vasoconstriction
(64).

It has also been proposed that post-junctional alpha-2 recep-

tors as well as pre-junctional alpha receptors influence coronary
blood flow (24,30,58,59,61,62,119).
Heusch and Deussen concluded that there was a continuous
unmasking of sympathetic vasoconstriction with increasing severity of
stenosis, which is mediated by post-junctional alpha-2 receptors (58).
Holtz et al. also reported that norepinephrine induced vasoconstriction was attenuated predominantly by alpha-2 blockade not by alpha-1
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blockade (62).

This effect was examined during cardiac sympathetic

nerve stimulation (10 Hz) by Saeed et !ti.... (113).

They found that

during stimulation, coronary sinus oxygen saturation was decreased,
and responded similarly under beta-blockade with nadolol.

With alpha-

2 blockade the decrease in CS02 was attenuated, but not with alpha-1
blockade.

It was not explained why the results were similar during

beta-blockade, when all evidence points toward a greater role for
alpha-receptors when unmasked by beta-blockade.

It appears from

recent investigations, that it is more likely that both alpha-1 and
alpha-2 receptors mediate coronary vasoconstriction.

Decker and

Schwartz reported that the post-junctional receptors in the guinea pig
heart are of the alpha-1 and alpha-2 type (30).

Stevens and Moulds

reported similar findings in isolated human blood vessels (119).
Reusch and Deussen further categorized the alpha-receptors,
alpha -1 being located on large arteries, and alpha-2 on smaller
arteries (59).

This was based on the response to nerve stimulation of

changes in internal diameter of a large vessel, and late diastolic
resistance which reflects the contribution of smaller arteries.
Stimulation of the left stellate ganglion (LSS) in these studies was
for 90 seconds with measurements made at 1 minute.

It was interesting

that in this study, LSS in the presence of propranolol caused a
significant elevation of arterial pressure which was blocked by
prazosin, but not by rauwolscine.

This latter finding, although not

discussed in detail, is in accord with a study by Randall in which LSS
in the presence of beta-blockade increased mean arterial pressure
(106).

The increase which is not beta-mediated appears to be alpha-1
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receptor mediated (58,118).

However, the dearth of investigations on

myocardial alpha receptors does not allow a clear explanation for
these findings.
The role of alpha receptors has been thoroughly demonstrated
over a wide range of physiologic states, from their importance in
modulation of resting blood flow in the conscious animal, to their
involvement in limitation of blood flow during exercise, and finally
their role in limitation of blood flow under pathophysiologic circumstances such as partial or severe stenosis.

The second study of this

dissertation proposes to determine whether alpha receptors decrease
flow to the ischemic bed following complete coronary artery occlusion
in the presence of beta-blockade.

F.

EFFECTS OF CARDIAC DENERVATION ON CORONARY BLOOD FLOW AND
ISCHEMIC INJURY
In the previous discussion, the concept of sympathetic modula-

tion of blood flow under a variety of conditions was reviewed.

The

question then arises as to what effect denervation would have on the
heart and on coronary blood flow.

A classical method for establishing

the importance of a chemical mediator or hormone is to determine what
physiologic events occur in its absence.

Denervation of the heart was

employed early to trace the pathways of nerves to the heart (136).
However cardiac denervation was soon used not only to further experimental knowledge of cardiac innervation.

Leriche proposed that

cardiac denervation provided protection against ischemia and infarction in the clinical setting (80).

Contemporaries of his debated
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whether this would provide protection or simply eliminate a warning
signal of angina and impending myocardial infarction.
Following Leriche's report on the beneficial effects of cardiac
denervation in the treatment of intractable angina, other investigators devised their own methods of cardiac denervation (25,28), and the
reports of the protective influences of cardiac denervation during
cardiac disease began to accumulate.

The method of denervation

suggested a wide range of sympathectomy from simple removal of the
stellate ganglia to removal of the superior, middle and caudal
cervical ganglia, in addition to stellate ganglionectomy.

The reports

of the different clinical settings in which denervation was useful
were as numerous as the different methods employed to denervate the
heart.
One widely used technique developed by Cooper et !!.l..... involved
mediastinal neural ablation (25).

However a later study by Peiss et

al. determined that this technique was not totally effective in
eliminating neural input to the heart (102).

Peiss et al. found

evidence for reinnervation after one year following excision and reimplantation.

Neither mediastinal neural ablation nor bilateral

stellate ganglionectomy proved to be totally effective in eliminating
the sympathetic nerves to the heart since some of the nerves travel
via the vago-sympathetic trunk.

Cox et al. in 1936 found that

bilateral stellate ganglionectomy in dogs resulted in protection
against sudden coronary occlusion (27).

Moreover, denervation was

proposed to protect against malignant arrhythmias (37,114) and against
myocardial infarction due to coronary artery occlusion (65).

The
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manner in which cardiac denervation was purported to exert its
beneficial influences on cardiac viability was not determined in these
studies.

Indeed, the effects of cardiac denervation on the function

of the normal heart was not ascertained until a number of studies
undertaken by Donald et al. (35).

Donald and Shepard determined that

the response to exercise in dogs which had undergone cardiac denervation was similar in terms of capacity for work.

Although the ability

to increase cardiac work during exercise was similar, the heart rate
increased more slowly in the denervated animals.

Furthermore, Guyton

et al. proposed that in cardiac denervated animals the functional
responses to various forms of stress were similar to responses of
innervated animals due to the influence of circulating catecholamines
and the supersensitivity to norepinephrine of denervated hearts (54).
The beneficial influence of denervation has been challenged in a
recent study by Lavallee et al. (79).

Lavallee et al. showed that in

conscious animals there is no protective influence of denervation on
the development of a myocardial infarction in the conscious dog.

The

reason for the differences between this recent study and earlier ones
was believed to be due to the use of conscious vs anesthetized
animals.
The mechanism of denervation protective influence on myocardial
infarction has been proposed to be due to alterations in myocardial
blood flow following a coronary artery occlusion.

Barber et al. and

DuPont et al. both showed a reduction in myocardial regional blood
flow following denervation as compared to control (4,36).

However

DuPont et al. found that denervation caused an increase in blood flow
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to border zones following coronary occlusion, although the flow to the
core of the ischemic region was not increased (36).

Both studies

attributed the reduction in blood flow in the denervated regions to a
reduction in myocardial metabolism, although neither study addressed
the question of oxygen consumption and metabolism directly.

Some

years earlier, Gregg et al. had hypothesized that removal of cardiac
nerves resulted in an overall reduction in myocardial metabolism (51).
In recent years a number of investigators have employed denervation to determine whether there is a tonic restraint of coronary blood
flow by a resting level of sympathetic input to the coronary arteries
(22,61).
Demonstration of alpha-receptor limitation of flow under resting
conditions or a 'tonic restraint' of flow has been addressed by
numerous investigators.

Resting coronary blood flow was considered to

be under local influence and of course sympathetic influences would
only be noticeable when levels of sympathetic input were high.

But

consideration of resting sympathetic discharge of approximately 3 Hz,
would appear to indicate that the coronary bed, under resting conditions may have a small amount of sympathetic input.

Katz and Jochim

did show that removal of the stellate ganglia and vagi increased
resting blood flow (67).

About 35 years later, Schwartz and Stone

also reported that left stellectomy not only increased the blood flow
distribution to the endocardium, it also increased reactive hyperemia
from 476 ± 71% to 622 ± 86% of control flow.

Although propranolol

could reduce the reactive hyperemic response, phentolamine following
sympathectomy could not.

However phentolamine prior to sympathectomy
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did increase reactive hyperemia by 23% from the control response
(115).
Following regional sympathetic denervation with 6-Hydroxy dopamine, Holtz et al. found that the blood flow measured with microspheres, in the innervated region was 66 ± 14 ml/min/lOOgm compared to
resting blood flow in the denervated region of 108 ± 16 ml/min/100

gm.

Administration of propranolol did not alter the blood flow

distribution, however phentolamine abolished the regional differences
by increasing the flow in the control region to levels equivalent to
the sympathectomized region.

They concluded that there is a substan-

tial level of alpha vasoconstrictor tone on coronary blood flow (61).
Vatner et al. also proposed that alpha receptors exert a tonic
control over coronary blood flow.

Stimulation of the carotid sinus

nerve in the conscious dog resulted in a decrease in aortic pressure
of 28% and a decrease in coronary blood flow of 7%, resulting in a
decreased resistance of 22% from control.
did not prevent the dilation.

Propranolol and dopamine

Phenoxybenza.mine caused a reduction in

resistance to levels comparable to those elicited during carotid nerve
stimulation with beta-blockade.

There was no change in the resistance

during CSNS with phenoxybenzamine.

Guanethidine (ganglionic blocker)

also abolished the dilation, indicating that stimulation of the
carotid sinus nerve resulted in removal of sympathetic tone.

This

withdrawal of alpha-tone resulted in a vasodilation which could be
stopped by phenoxybenzamine or guanethidine (126).

In a similar set

of experiments, they found that alpha tone could be elicited by an
efferent pathway involving the mechanical reflex of pulmonary stretch
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receptors.

With an intracoronary injection of nicotine, the conse-

quent stimulation of chemoreceptors and increase in ventilation,
induced a reflex dilation of coronary arteries via a withdrawal of
sympathetics.

The dilation was abolished by alpha receptor blockade

or carotid sinus nerve section.

This dilation occured in spite of

reductions in metabolism (127).
An investigation by Chilian et al. does not support the idea of
a resting level of alpha vasoconstriction of coronary arteries.

In

this study regional denervation was achieved by topical application of
phenol.

Resting blood flow in the sympathectomized region was not

significantly different from blood flow in the normal zone or control
region.

Their results were not altered by beta-adrenergic blockade or

combined alpha and beta blockade.

The flows in the innervated region

were 0.87 ± .08 and 0.85 ± 0.07 ml/min/gm (22).
The effects of denervation have applications in tracing anatomic
pathways to the heart, in the clinical setting of transplantation, and
for treatment of angina.

In addition, a number of studies in the past

several years have investigated the possibility that ischemia itself
causes a regional denervation; and that the ischemic muscle is
'stunned' and unresponsive to nerve stimulation.
Martins et al. studied the effects of coronary artery occlusion
of cardiac function in both the ischemic and non-ischemic zones and
the response to left stellate stimulation and exogenous noradrenalin.
Dogs were anesthetized with alpha-chloralose, and either the 1AD or
circumflex artery isolated.

LSS during occlusion produced segmental

expansion whereas noradrenaline produced segmental shortening in the
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ischemic area.

They explained this impaired response of the ischemic

myocardium as due to the impaired response to sympathetic nerve
stimulation.

They did not offer a reason as to why impaired neuro-

transmission in the ischemic zone should cause an actual decline in
regional ventricular function.

It was, however not a significant

reduction of expansion during LSS.

LSS produced a change in length of

O.l ± 0.3 mm, and exogenous noradrenaline of 0.5 ± 0.1 which was
significantly different from the change in length during occlusion.
No mechanism of denervation was advanced in this study (88).
It is thought that sympathetic efferent nerves course in the
upper 0.25 -0.50 mm of the epicardium, since topical application of
phenol which destroys the upper 0.25 mm of epicardium, interrupts
sympathetically mediated changes in ventricular contraction.
et al.

Barber

(1982) demonstrated that not only does a transmural myocardial

infarction interrupt sympathetic neurotransmission in the ischemic
bed, it also impairs neurotransmission in the nonischemic regions (5).
It has been demonstrated previously that sympathetic fibers run with
coronary arteries and traverse the myocardium in a base to apex
fashion (45).

By injecting a rapidly hardening latex solution into a

branch of the IAD, the authors were able to produce a transmural
infarction by eliminating the contribution of collateral blood supply
to the occluded region.
tetrazolium chloride.

The infarction was assessed using triphenylTo determine the responsiveness to sympathetic

nerve stimulation, the effective refractory period (ERP) was measured
during right (RSS) and left (LSS) stellate stimulation.

Also, in

chronically infarcted dogs, regional norepinephrine content was
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measured in the ischemic and normal regions.

In zones apical to the

infarction, ERP did not change during RSS and left stellate stimulation, while sites basal to the infarction remained responsive to both
stellate stimulation and exogenous noradrenaline.

The denervation was

not homogenous however in the areas apical to the occluded region, as
half of the sites remained responsive to stellate stimulation.

The

other sites which were not affected by stellate stimulation were
responsive to noradrenaline.

It should be noted that the possibility

of chemical denervation in areas surrounding the infarcted region due
to the release of alcohol during the hardening process may have
affected the results.

It was not well-defined in this study how

distally located the sites for the effective refractory period
measurements were.

It appears as though the basal location was

spatially well-removed, however, the apical sites were closer to the
region of infarction.

The consequences may be that the closer the

location to the infarction, the greater the possibility that the
region was actually denervated by the latex, and not due to interruption of sympathetic neurotransmission.
A more recent study on the subject of ischemia induced denervation was done by Ciuffo et al.

Myocardial segmental shortening was

measured before and after an occlusion of twenty five minutes.

Before

the occlusion, the shortening was 12% and increased with LSS to 20%
and with injected norepinephrine to 20% in the zone which was to
become ischemic.

After the period of ischemia and reperfusion, the

shortening was only 4%.

In response to LSS, shortening decreased even

further to 2.4%, but did increase in response to noradrenaline (13%).
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The reduced responsiveness to neural stimulation persisted for two
hours after reperfusion (23).
The loss of myocardial function following ischemia and reperfusion has been documented by other investigators.

Heyndrickx

observed that even when blood flow had returned to control values
following ischemia, the function remained depressed for a longer time.
However, in that study, he did not think it likely that the loss of
function was due to impaired neurotransmission (60).

The mechanism of

the disruption of neurotransmission is not explained, and is particularly intriguing since ischemia generally develops in the endocardium
first and progresses toward the epicardium.

Moreover, in the canine

model the possibility of a transmural infarction is not as likely an
occurrence as in other species due to the greater amount of collateral
blood flow.

The third study included in this dissertation was done to

determine whether removal of tonic alpha-vasoconstrictor tone would
increase the blood flow the ischemic zone.

G.

CARDIAC SYMPATHETIC NEURAL MODUI.ATION OF CORONARY BLOOD FLOW
An early study on the functional importance of cardiac nerves to

coronary blood flow and myocardial performance was reported by
Szentivanyi (120).

In that study, the author claimed to have been

able to differentiate the fibers innervating the heart as being
vasodilator and vasoconstrictor on the basis of their stimulation
thresholds.

Although these studies have not been duplicated, the idea

that the large bundles of cardiac nerves could have differential
influences on the heart was investigated extensively by Randall et al.
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Using the technique of epicardial stripping or phenol application, the
heart was selectively denervated, and the projections of cardiac
nerves to the heart were delineated (106).

To summarize his findings,

the innominate caused an increased contractility in the right ventricle and left ventricular apex.

The ventromedial cardiac nerve

increased right ventricular conus contractility, and the VLCCN
increased contractility to the posterolateral left ventricle.

He also

found that the more distally the sympathetic trunk was stimulated, the
more localized were the areas affected by nerve stimulation (107).
Studies by Geis and Kaye determined that the right stellate ganglion
(RSG) and the left stellate ganglion (LSG) innervate the anterior and
posterior left ventricle.

The RSG was found to send projections to

the posterior base, and the LSG to project to the anterior left
ventricle via branches from the VLCCN (45).

These studies, although

providing insight into the innervation of the heart, did not specifically determine the effects of cardiac sympathetic nerve stimulation
on blood flow the heart.

Specific effects on the posterior left

ventricle were not described in these studies.
Rinkema et Jil.... eKamined the influences of left stellate stimulation and right stellate stimulation on regional myocardial blood flow
in the anesthetized dog.

They found that flow to the circumflex

region was increased more by LSS that flow to the anterior region.
However, it was determined that the LSG innervated all portions of the
left ventricular myocardium.

Following administration of propranolol,

Vasoconstriction during LSS was determined (111).

These findings were

in accord with results from Ross and Mulder, and Tato et al.

43

(112,122).

Takenada et al.

demonstrated that the anterior ansa

subclavia and the VLCN cause vasoconstriction especially with practolol or propranolol (121).
Thus, although the left stellate ganglion can be concluded to
affect regional left ventricular blood flow, separate cardiac nerve
stimulation effects on blood flow have not been investigated previously.

The exact location of sympathetic pathways to coronary vessels

is not established.

Changes in blood flow can be demonstrated with

sympathetic stimulation, and vasoconstrictor effects during betablockade can be used to isolate the effects of nerves going to
coronary arteries from their effects on myocardial function.

However,

the exact pathways and nerves have not been described and isolated.
Thus, the fourth study in this dissertation, examined which cardiac
nerves modulate circumflex coronary blood flow, and whether the
vasoconstriction elicited by these nerves is alpha-1 or alpha-2
mediated.
It is hoped that these studies will add to our present knowledge
of the role of the cardiac sympathetic nerves on myocardial blood flow
during ischemia.

A clearer definition of sympathetic influences on

the ischemic heart is important in light of the widespread clinical
use of adrenergic blockers in the treatment of coronary artery disease
and myocardial infarction.
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CHAPTER III
GENERAL METHODS

A.

SURGICAL PREPARATION
Mongrel dogs of either sex were premedicated with either

morphine sulfate (2.5 mg/kg, s.c.) or xylazine (2 mg/kg, s.c.)
approximately 15-20 minutes before being given alpha-chloralose
(50-100 mg/kg, i.v., Sigma Chem. Co. in solution with sodium borate,
ratio of 1:1.23, chloralose: borate).

Alpha-chloralose was chosen as

the general anesthetic, since it does not adversely affect hemodynamic
variables (2,11) and does not depress cardiovascular reflexes as does
pentobarbital anesthesia (6,12,44).

A polyethylene catheter (PE-260

tubing) was placed in the right femoral artery and connected to a
Statham P23dB pressure transducer for continuous monitoring of
arterial blood pressure.

The right femoral vein was catheterized with

PE-260 tubing for fluid and drug administration.

The trachea was

cannulated with a glass Y-tube which was connected to a Harvard
respirator.

Each dog was ventilated with room air at a positive

end-expiratory pressure of 5 cm of water.
isolated and severed.

Both cervical vagi were

Succinylcholine (20 mg, i.v.) was administered

as a muscle relaxant and the chest was opened in the 4th left intercostal space.

The corneal reflex and response to pinching of the toe

pad were checked every half hour when the effects of succinylcholine
had worn off, and additional anesthetic was administered when needed.
The heart was kept moist with sponge soaked in saline. In addition, a
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layer of plastic wrap was kept over the open chest to minimize
moisture and heat loss.

In studies in which the heart was paced, a

stainless steel bipolar electrode was sutured to the left atrial
appendage, and the heart paced at 150 pulses/min from a Frederick Haer
4i stimulator.
experiment.

Blood gases and pH were monitored throughout the

pC02 and pH were maintained within normal limits (pC02

30-40 mm Hg, pH 7.38-7.45), by adjusting the rate and/or volume of the
Harvard respirator, with infusions of 8.4% sodium bicarbonate (1
meq/ml) when necessary. p02 was monitored and kept within normal
limits (80-100 mm Hg) by adjusting the volume of inspired air on the
ventilator, with care taken that arterial pC02 levels were not
altered.

Core temperature, measured in the thoracic cavity by a YSI

temperature probe, was kept between 37-39° C by means of a heating pad
beneath the dog, and an infrared heating lamp above the dog when
necessary.

B.

STIMUIATION PROTOCOL
Both the right and left ansae subclaviae of the stellate ganglia

were isolated.

Both the anterior and posterior limbs of the ansae

subclaviae, were stimulated (7-10 Hz, 5 msec, 5-7 V) using bipolar
stainless steel electrodes.

Characteristic changes in the lead II

electrocardiogram consequent to stimulation confirmed that both limbs
of the right and left stellate ganglia had been isolated.

These

changes included an increase in the heart rate and increased negativity of the T-wave as described by Yanowitz upon stimulation of the
right stellate ganglion.

Yanowitz also described the increased
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positivity of the T·wave with left stellate ganglion stimulation (43).
The alteration of the polarity and peaking of the T-wave are due to
the altered repolarization pattern.

Geesbreght and Randall reported a

shortening of the P-R interval upon stimulation of the ansae subclaviae and a disappearance of the P-wave, with reappearance upon
cessation of the stimulation.

They attributed this movement of the

P-wave into the QRS interval to a shifting location of the pacemaker
(18).

Figure 3-1 is a sample trace of the Lead II EKG during both

right and left ansae subclaviae stimulation.
Square wave pulses were delivered by either a Grass SD9 stimulator or a Frederick Haer constant voltage output stimulator, and
monitored on a calibrated differential oscilloscope.

These stimula-

tion parameters have been used frequently in other studies involving
stimulation of sympathetic nerves.

Although these levels were higher

than the frequency of tonic sympathetic discharge (1-3 Hz) described
by Folkow, they were lower than what Folkow considered to be maximal
physiologic levels (20 Hz) for stimulation of sympathetic nerves
(16).

In comparison to more recent studies, these levels were lower

than those used in a recent study by Reusch and Deussen (20 Hz) (20),
and they are of similar magnitude to those used in studies involving
cardiac sympathetic nerve stimulation (10-20 Hz, 5 msec, 4-6 V,
Randall et al. 1968)(30), (10 Hz, 5 msec, 3-5 V, (31) or stimulation
of the first five thoracic ventral roots (10 Hz, 10 msec, 8V, Norris
~

al.)(28).

Hemodynamic responses were recorded on an 8 channel

Beckman Recorder model 612 (Frequency response: 10 div@ 10 mm, DC to
80 Hz; ± 1 db) at 25 mm/sec before, during and after the stimulation
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FIGURE 3-1
SAMPLE TRACING OF LEAD II EKG BEFORE, DURING AND AFTER
STIMUI.ATION OF THE LEFT AND RIGHT STELLA.TE ANSAE SUBCI.AVIA
The upper pair of tracings shows a recording of the Lead II EKG
(2Smm/sec) during stimulation of the left stellate ansae subclavia
(LSS, 8Hz, Smsec, 7V). The arrows indicate where ansae subclavia
stimulation occurred. A represents the control EKG trace, ~ is the
tracing during LSS, and f is the EKG following LSS. The time scale is
in seconds. Note the marked increase in positivity of the T-wave
during LSS, and the disappearance of the P-wave during LSS. The P-wave
gradually reappeared from the QRS complex following stimulation.
The middle pair of tracings shows the Lead II EKG during stimulation of the right stellate ganglion. The arrow shows the beginning
of the stimulation period. A.~,g, denote similar times as in Panel
One. Right stellate stimulation was stopped immediately prior to the
bottom trace. Note that prior to RSS, the T-wave was positive, and
that during RSS and following RSS, the T-wave was inverted, and that
the P-R interval remained constant.
The bottom pair of tracings shows the Lead II EKG during stimulation of the LSS following administration of timolol (0.2 mg/kg,
i.v.). LSS was started at the arrow, and stopped immediately prior to
the tracing of the bottom panel. Note that none of the changes which
occurred in Panel One are present in this recording.
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protocol.
In each study, the ansae subclaviae of both the right and left
stellate ganglia were tied with 2-0 silk and cut distal to the strands of
silk.

The cut distal ends were placed across the stainless steel

bipolarelectrode for subsequent stimulations.

Section of the right and

left ansae subclaviae and the cervical vagi, effected neural decentralization of the heart.

This was performed to prevent reflexes from arising

following coronary artery occlusion, and to insure against afferent
stimulation of the cardiac nerves.

During the stimulations, the polarity

of the bipolar electrode was kept the same with the negative electrode
toward the heart thus avoiding the possibility of anodal nerve block.

C.

ISOI.ATION OF THE CIRCUMFLEX ARTERY
The pericardium was incised and sutured to the walls of the chest

to form a pericardial cradle.

Approximately 5 mm of the circumflex

artery was isolated distal to the first marginal branch in studies l, 2,
and 3.

In the first study, the circumflex was ligated for 6 hours.

In

studies 2 and 3, the circumflex artery was occluded for a maximum of 7-8
minutes, after which the occlusion was released and the artery allowed to
reperfuse for 35-40 minutes.

This period of occlusion was chosen to

minimize the development of ischemic damage and allows multiple assessments of blood flow during the course of several different experimental
manipulations.

It has been dernonstrated that with periods of occlusion

of up to ten minutes followed by a twenty minute period of reperfusion
there is negligible ultrastructural damage (5), biochemical or metabolic
alterations (32).

In addition, Barber et al. have shown that a period of
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occlusion of five minutes does not alter baseline blood flow when
followed by a period of reperfusion of thirty minutes (4).

Janes et al.

reported that repeated periods of lAD occlusion of 5 minutes duration
followed by a 10 minute reperfusion do not alter the responsiveness of
the anterior wall to stellate ganglion stimulation as assessed by segment
length and intramyocardial pressure (21).

In study 4, approximately 5 mm

of the circumflex artery was isolated as close as possible to its origin
to allow perfusion of the majority of the circumflex bed.

In the fourth

study, the circumflex artery was occluded briefly while a catheter was
inserted and tied in place.

Normally the period of occlusion lasted no

longer than 1-1.5 minutes before perfusion with blood from the carotid
artery was begun.

Dissection and isolation of the circumflex artery with

2-0 silk may cause interruption of the nervous supply to the posterior
wall.

Dolezel et al. reported that implantation of a methacrylate ring

around the left coronary artery resulted in a significant decrease in the
adrenergic innervation as assessed by Falck's histochemical technique
(13).

They hypothesized that scarring of the area of implantation

consequent to the surgery resulted in compression of the pericoronary
nerves and the ultimate degeneration of the adrenergic nerves supplying
the area distal to the implantation.

However, Knight et al. reported

that even with the extensive isolation of the circumflex artery necessary
for implantation of ultrasonic flow probes on the circumflex artery, the
increase in posterior wall thickening during stimulation of the ansae
subclaviae in the group with the flow probe (71 ± 14%) was not significantly different from the increase in posterior wall thickening of the
control group (67 ± 9%).

In addition posterior wall norepinephrine
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levels in the flow probe group (629 ± 4 pg/mg) were not significantly
different from the levels in the control group (589 ± 88 pg/mg) (24).
Thus it may be that although isolation of a coronary artery partially
interrupts adrenergic transmission to the region in question, norepinephrine levels do not decline significantly following instrumentation.
Whether isolation of the artery interrupts nerves controlling vasomotor
activity has yet to be investigated.
Lidocaine (40 mg,i.v.,bolus) was given prior to the initial
coronary artery occlusion and during the course of the experiment as an
additional bolus dose if there was an increased incidence of ventricular
arrhythmias.

D.

ADRENERGIC BLOCKING AGENTS
Table 3-1 provides a summary of the autonomic agonists and antago-

nists used throughout the studies.

Timolol, a non-selective beta--

blocker, was chosen instead of propranolol for several reasons.

As

described by Scriabine et al. it is 5-10 times more potent than propranolol, and exerts fewer agonist properties (35).
central effects than propranolol (38).

Timolol also has fewer

At concentrations required to

block beta-receptors, timolol does not exhibit membrane stabilizing
effects as does propranolol at an equipotent dose (29,36).

Blockade by

timolol (0.2 mg/kg, i.v.) was considered to be adequate when stimulation
of the left ansae subclavia produced no changes in the Lead II electrocardiogram (See Figure 3-1) or heart rate.

The blocking dose of timolol

was based on its beta-1 properties, since as was mentioned in the
literature review, the beta-2 receptors do not exert an important
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TABLE 3-1
AUTONOMIC AGONISTS AND ANTAGONISTS USED
SITE OF ACTION

DOSE USED

Timolol

beta-1,beta-2 receptors

0.2 mg/kg,LD,
0.08 mg/kg/hr ,MD

Prazosin

alpha-1 receptors

0.5 mg/kg

Rauwolscine

alpha-2 receptors

0.3 mg/kg

SYMPATHETIC AGENT
Adrenergic Blockers:

Adrenergic Stimulants:
Norepinephrine*

alpha-1&2, beta-1 and
beta-2 receptors

Phenylephrine

alpha-1 receptors

5

BHT-920

alpha-2 receptors

0.1 mg/kg

g/kg

PARASYMPATHETIC AGENT
Parasympathetic Stimulant:
Acetylcholine**

nicotinic and muscarinic receptors

Parasympathetic Blockade:
Atropine

muscarinic receptors

*Left stellate stimulation (8Hz, 5msec, 5-7V)
**Vagal stimulation (20Hz, 5msec, SV)

0.2 mg/kg
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influence on cardiac function or coronary blood flow in the dog.
Maintenance doses of timolol (0.08 mg/kg/hr, i.v.) were given to insure
blockade of beta-receptors throughout the experiment.

This dose of

timolol has been used in other studies (19) and is approximately 1/10 of
the usual dose of propranolol administeredin experimental studies (20,23,
40).

Alpha-1 blockade was achieved with prazosin hydrochloride (0.5

mg/kg, i.v.); a dose which is sufficient to attenuate the average 45-50
mm Hg rise in arterial pressure elicited by a 5 g/kg dose of phenylephrine (27,41).

Prazosin has been demonstrated in a number of studies

to exert non-significant effects on alpha-2 receptors (10,42).

Phenyl-

ephrine was chosen to test the efficacy of alpha-1 blockade since it is
considered to exert its agonist effects preferentially on post-junctional
alpha-1 receptors.

Rauwolscine (0.3 mg/kg, i.v.) is considered to be a

reasonably pure alpha-2 blocking agent, since at this dose it does not
block the effects of alpha-1 adrenergic agonists (26). This dose has been
shown to block the increase in diastolic pressure effected by a O.lmg/kg
dose of BHT-920 (37).

BHT-920 is a selective alpha-2 stimulator which is

pharmacologically similar to clonidine (25,39).

Atropine (0.2 mg/kg,

i.v.) was given in Study 4 to eliminate the influence of the parasympathetic nerves upon stimulation of the thoracic cardiac nerves (31).
Adequate blockade by atropine was tested with stimulation of the left
thoracic vagus (20 Hz, 5 msec, 5V).

E.

REGIONAL BLOOD FLOW DETERMINATION
In studies involving determinations of regional myocardial blood

flow, radioactive labeled microspheres (14.5 ± 0.6

m) were used (3M Co,
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New England Nuclear).

This size sphere was chosen since it causes less

axial streaming than larger sized spheres (7) and less arteriovenous
shunting than smaller spheres (1,7).

Fortuin et al. determined that with

arterial injection of microspheres of this size, less than 1% appeared in
the coronary sinus (17).

The microspheres were suspended in a 10%

dextran solution with 0.05% polyoxyethelene-20 sorbitan mono-oleate
(Tween 80) to dispel, the inherent aggregation of microspheres (33).

The

vials containing the spheres were sonicated for at least 20 minutes prior
to microsphere injection, and vigorously agitated in a vortex mixer
immediately prior to use.
ical organ technique.

Blood flow was calculated using the theoret-

For 30 seconds before microsphere injection, a

reference blood sample was withdrawn from the femoral artery at a rate of
5-7 ml/min, and reference blood withdrawal continued for at least 90
seconds following microsphere injection.

This period of withdrawal

insured that all of the spheres were trapped in the animal's blood
vessels or in the syringe.

Also, it has been shown that 98% of the

spheres are collected within the first 60 seconds (15).

The withdrawal

rate of the pwnp was calibrated at the end of each experiment to determine the exact rate of withdrawal.

Microspheres were injected into the

left atriwn via a catheter over a period of 30-40 seconds and were
flushed with 10 ml of warm saline.

The electrocardiogram was monitored

during the injection period, with care taken to stop injection during
periods of arrhythmia.

Careful handling of the left atrial catheter

minimized the incidence of injection arrhythmias, as did slow injection
of the microspheres.

At the end of the experiment, each heart was

electrically fibrillated, excised, and a segment of 5-French infant
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feeding tubing was inserted into the circumflex artery distal to the site
of occlusion.

Microfil was injected into the circumflex catheter to

delineate the perfusion area of the CX.

Microfil, a liquid compound used

to fill and opacify the vascular spaces of post-mortem tissues, was used
in Studies 2 and 3 to define the perfusion area of the circumflex bed
since it does not get filtered out of the vessels and become absorbed by
neighboring vessels and tissue.

Also, the stain does not dissipate when

placed in 10% formalin for fixing, as Evans blue dye does.

The hearts

were fixed for 24-48 hours, after which samples of the myocardium were
cut from both the stained and unstained regions, weighed, and placed in
plastic tubes.

Figure 3-2 illustrates how the ischemic area was deline-

ated, and the method by which the heart was sliced from apex to base.

A

sample slice shows how the endocardial and epicardial samples were cut
from the left ventricle.

The reference blood withdrawal samples were

also put into plastic tubes, and the syringes containing the blood
samples were rinsed with saline, and the rinse put into the respective
labeled counting tubes.

Heart and reference organ samples were counted

by a TM Analytic gamma counter (model 1185) utilizing a three inch Na!
crystal sensitive to gamma emissions.

The data from the gamma counter

were sent directly to an APPLE computer and stored on floppy disc, for
later analysis.

Blood flow values were obtained by the use of a computer

program which calculated blood flow in ml/min/gm using the original data
stored on disc from the gamma counter.

Blood flows were calculated using

standard equations with the appropriate corrections for background and
interference coefficients.

The equation used to calculate blood flow

was: MBF- (Ct/TW) x (RBW/Cb), where MBF - myocardial blood flow in ml/min
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FIGURE 3-2
ILLUSTRATION OF THE METHODS USED TO OBTAIN MYOCARDIAL
SAMPLES FOR REGIONAL BLOOD FLOW DETERMINATIONS
Illustration of the manner in which samples were taken for calculation of regional myocardial blood flow. AO-aorta, I.A-left atrium, PApulmonary artery, RV-right ventricle, LAD-left anterior descending
coronary artery, CIRC-circumflex coronary artery, LV-left ventricle. A
sample slice in the mid wall of the left ventricle is shown in the left
hand figure. The right hand figure shows how samples were cut from the
left ventricle. The stippled area is the area into which Microfil had
been injected, and delineates the circumflex (ischemic) region. NZnormal zone, IZ-ischemic zone (collateral dependent zone). Sample
numbers are used to define which region each sample was cut from. Sample
numbers 1 and 3 are normal zone endocardium, sample numbers 2 and 4 are
normal zone epicardium, sample numbers 5,7, and 9 are ischemic zone
endocardium and so forth for each of the slices of left ventricle.

LA CATHETER
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per gm, Ct - tissue radioactivity in counts/min, TW - tissue sample
weight in grams, RBW - reference blood withdrawal rate in ml/min, and Cb
- total radioactivity in reference blood sample.

Buckberg et al. deter-

mined by statistical analysis that a minimum of 400 microspheres per
sample was necessary to obtain a statistical error of <10% in calculations of blood flows.

To obtain a larger number of microspheres per

sample would have necessitated the injection of such a large quantity of
microspheres, that hemodynamic variables might have been changed (7).

In

the present studies, approximately 4.5 million microspheres per blood
flow determination were injected into the left atrium.

Baer et al. re-

ported that left atrial injections of 15 m microspheres totaling 48 x
106 did not affect hemodynamic variables or alter regional myocardial
blood flow (3).

It was calculated that in order to achieve the minimum

number of microspheres per sample, tissue sizes of >500 mg or tissue
samples with blood flows greater than 20 ml/min would have at least 400
microspheres trapped in the micro-vasculature.
Certain basic principles as outlined by Buckberg were adhered to
with the injection of microspheres (8).

We used the femoral artery as

the blood withdrawal organ since this has been determined to provide a
more reproducible collection of microspheres than other arterial lines
such as the brachial artery.

Second, the left atrium was used for the

injection of microspheres to provide for adequate mixing of the spheres
prior to entering the left ventricle or the left ventricular outflow
tract.

Third, the time for withdrawal was more than adequate to collect

the majority of microspheres
described by others (7,15).

(>95~)

circulating in the blood stream, as
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F.

USE OF THE MICROSPHERE METHOD FOR CALCULATION OF BLOOD FLOW DURING
ISCHEMIA
Utilization of the microsphere technique to determine ischemic

blood flow is prone to error for several reasons.

As explained above,

samples containing at least 400 spheres will yield accurate blood flow
measurements.

However, in regions in which blood flow is compromised

enough to cause ischemia, the number of microspheres lodged in the tissue
might not have been sufficient.

Retrospective analysis of ischemic

tissues in which sample size was greater than 1 gram yielded average
blood flow values for the entire heart which were not different from the
blood flow values used in the actual analysis of data (see Appendix A).
Second, injections of microspheres should be done under stable hemodynamic conditions.

The potential influence of arrhythmias was compensated

for by injecting the microspheres over 30-40 seconds, since microspheres
represent mean blood flow over consecutive heart beats.

In blood flow

determinations following coronary artery occlusion, microspheres were
injected after five minutes of occlusion, during which time hemodynamic
parameters were fairly stable, with the exception of some occasional
arrhythmias, thus fulfilling the requirement of a steady state for
accurate measurement of blood flow.

Even shorter periods of occlusion

(<30 sec) have been used to measure blood flow immediately following
coronary occlusion (14), thus one can be reasonably certain that a steady
state was achieved by five minutes after occlusion.

Third, the use of

microspheres during ischernia might lead to errors in calculation of blood
flow as shown by Jugdutt et al. who have found that there is a real loss
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of microspheres from cardiac tissue that has become ischemic (22).
However the study done by Jugdutt used a period of ischemia of several
weeks in chronically instrumented dogs, and 7-10
used.

m microspheres were

Another reason for the errors in blood flow determination cited by

Jugdutt was that there was an 'apparent' loss of microspheres from
ischemic tissue due to formation of edema.

This should not have been as

important in an animal model in which the periods of occlusion lasted for
only 5 minutes, followed by reperfusion.

Basuk et al. reported that

periods of 10 minutes of occlusion followed by 20 minutes of reperfusion,
caused little ultrastructural damage, and only slight edema formation
(5).

Capurro et al. found that there was microsphere loss due to a

prolonged period of ischemia prior to fixing of the samples in formalin
(9).

In this study the hearts were excised within 20 minutes of the last

period of occlusion.

G.

DATA ANALYSIS
All data were expressed as mean ± SEM.

All studies involved the

use of some form of analysis of variance to test for differences between
groups, with a form of modified T-test to isolate the differences.

All

statistical tests were run on SAS (Statistical Analysis System)(34). The
particular tests used, and data analysis will be discussed under each
specific project.
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CHAPTER IV
EFFECTS OF CARDIAC SYMPATHETIC NERVE STIMUIATION
DURING ADRENERGIC BLOCKADE ON INFARCT SIZE IN ANESTHETIZED DOGS.
A. INTRODUCTION
Myocardial injury or infarction may occur as a result of either an
interruption of coronary blood flow or a severe disruption in the balance
between oxygen supply and demand.

Augmentation of sympathetic nervous

system activity following coronary occlusion is reflected by a rise in
plasma catecholamine levels (33,34), and has been demonstrated directly
by recordings of cardiac sympathetic nerve discharge (6,23).

Activation

of beta-1 receptors by cardiac sympathetic nerves or circulating
catecholamines produces an increase in coronary blood flow primarily via
an increase in myocardial oxygen consumption (MV02) and the resultant
production of vasodilator metabolites (4).

There is also evidence that

catecholamines may effect coronary vasodilation directly by stimulation
of beta-1 receptors (40) and beta-2 receptors (16) located on the
coronary arteries.

During myocardial ischemia, increases in MV02 might

become crucial in determining the amount of flow available to the
ischemic region.

Increases in MV02 producing vasodilation in normal

tissue, may result in a "steal" of blood from the vasodilated ischemic
region (10).

If the oxygen demands of the myocardial cells are increased

by catecholamine stimulation in the presence of limited perfusion, a
vicious cycle can result, in which the blood supply to the underperfused
area is compromised further due to the increasing work demands of the
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heart and vasodilation of normal areas.

In addition, recent

investigations have demonstrated the potentially important contribution
of alpha receptors in limiting coronary flow at low levels of blood
pressure (7) and in the presence of a coronary stenosis (8,13).

Hence,

alpha-mediated vasoconstriction may not necessarily be overridden by the
large metabolic demands associated with catecholamine stimulation (29)
and in fact, could be deleterious by further limiting blood flow to the
ischemic region.

Thus, activation of both beta and alpha receptors by

neurally released or circulating catecholamines might exacerbate the
amount of damage initially incurred in the ischemic area.
Since a certain amount of cellular necrosis is inevitable following
permanent coronary artery occlusion, there has been considerable interest
in limiting the size of the infarct to prevent any further loss of
functional myocardial tissue. It appears likely that factors which reduce
neurally mediated increases in myocardial oxygen demands, such as
beta-receptor blockade (27,42) can reverse the potentially damaging
effects of catecholamines in the ischemic myocardium.

Several

investigations have shown that propranolol and timolol, both non-selective beta-blocking agents, can limit the size of myocardial infarcts
(19,20,27,32,33,38).

Moreover, propranolol has been reported to maintain

perfusion of zones bordering on the infarct (32), but the extent of
protection may be largely dependent on collateral flow since propranolol
did not restrict infarct
collaterals (12).

si~e

in baboons, which have no preformed

Grong et al., reported that timolol did not increase

blood flow to the ischemic area (15), however, Vik Mo et al., showed that
timolol provided more protection against infarct development than
,

78

propranolol (41).

The mechanisms whereby beta-blocking agents decrease

ischemic damage have not been established conclusively.
Other investigations have implicated alpha receptors in the
development of a myocardial infarct.

Chiariello et al, showed that

treatment with labetolol (a combined alpha and beta-adrenergic blocking
agent) following coronary artery occlusion resulted in a smaller infarct
size in rats as compared to those rats receiving a beta blocker alone
(9).

They attributed this to a decrease in afterload on the heart

following blockade of peripheral vascular alpha receptors.

The advan-

tageous hemodynamic effects of combined alpha and beta-blockade were also
reported by Nelson et al., (31).
The purpose of the present study was to assess the influence of
elevated sympathetic input on the development of a myocardial infarct
following circumflex artery ligation in hearts during conditions of
controlled autonomic input.

Specifically, we tested the hypotheses that

1) the reported beneficial effects of beta-blockade on infarct size are
contingent upon a basal level of sympathetic nerve activity prior to and
during coronary artery occlusion; 2) a high level of sympathetic activity
following beta blockade in the neurally decentralized heart will result
in an greater infarct size; and 3) the contribution of alpha receptors to
the development of a myocardial infarct will be accentuated by blockade
of beta-receptors with augmented sympathetic stimulation to the heart.
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B.

METHODS
1. General Preparation
Forty-two mongrel dogs of either sex (14-30 kg) were premedicated

with morphine sulphate (2.5 mg/kg; subcutaneously) twenty minutes prior
to the intravenous administration of a solution containing alphachloralose (100 mg/kg).

A catheter was placed in the right femoral

artery and connected to a Statham P23 dB pressure transducer for continuous monitoring of arterial blood pressure.

The right femoral vein was

cannulated for fluid and drug administration.

The trachea was cannulated

with a glass Y-tube, which was connected to a Harvard respirator.

Each

dog was ventilated with room air at a positive end-expiratory pressure of
5 centimeters of water.

Both cervical vagi were isolated and severed.

Through a thoracotomy in the fourth left intercostal space, both the
right and left stellate ganglia were isolated and decentralized.

In

three groups of dogs, the anterior and posterior ansae subclavia from the
left stellate ganglia were placed across a bipolar electrode for subsequent stimulation.

In order to pace the heart a separate bipolar elec-

trode was attached to the left atrial appendage at a site remote from the
level of circumflex artery occlusion.

The circumflex coronary artery was

isolated distal to the first marginal branch with 2-0 silk for subsequent
occlusion.

2. Protocol
The dogs were divided into five groups.

In Groups 1, 2, 4 and 5,

the hearts were neurally decentralized as described above and electrically paced at 150 beats per minute.

In previous studies we had deter-
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mined this heart rate to be above the average heart rate of chloralose
anesthetized dogs. It was not possible to pace the hearts in Group 3,
since the heart rates increased to approximately 200 beats/minute
following left stellate stimulation, and the rates decreased to about 150
beats/minute over the course of two to three hours.

The first group

served as a control group (CTRL; n-5), receiving no beta-blocking agents
or neural stimulation.

In the second group (TIM; n-6), a blocking dose

(0.2 mg/kg) of the non-selective beta-adrenergic blocker timolol, was
administered intravenously as a bolus at least twenty minutes prior to
circumflex artery occlusion.

A maintenance dose of timolol (0.04

mg/kg,IV bolus) was given every hour to insure adequate beta-blockade.
This dose was found to be effective in blocking both inotropic and
chronotropic actions of left stellate stimulation (8 Hz, 5 msec, 5-7
volts).

Group 3 (LSS; n-7) served as a control for the group of dogs

receiving left stellate stimulation and timolol (Group 4).

In this group

the anterior and posterior ansae subclavia on the left side were
stimulated electrically within five minutes of coronary artery occlusion
and for the duration of the protocol (8 Hz, 5 msec, 5-7 volts) following
parameters used by Barber et al.(3).
administered in this group_

No adrenergic blocking agents were

The fourth group (LSS-TIM; n-5) also

received timolol prior to and during coronary occlusion.

In addition,

left stellate stimulation was begun immediately following CAO.

Approxi-

mately twenty minutes before coronary artery occlusion, dogs in Group 5
(LSS-TIM-PRAZ; n-6) received prazosin (O.Smg/kg, IV bolus), as well as
timolol.

The effectiveness of alpha receptor blockade was tested with

phenylephrine (5 g/kg,IV bolus) (25). This dose of phenylephrine raised
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the blood pressure an average of 64 mm Hg prior to blockade.

If blood

pressure did not increase more than 10 mm Hg following administration of
phenylephrine, blockade by prazosin was considered to be adequate.
stellate stimulation was also begun following CAO in this group.

Left
All

dogs.received 40 mg of lidocaine prior to circumflex artery ligation to
reduce the incidence of lethal arrhythmias early after coronary
occlusion.

In each dog, the occlusion was maintained for six hours.

3. Determination of the Area at Risk
The area at risk was determined in each dog in the following
manner.

After six hours of occlusion, the circumflex artery was

cannulated immediately distal to the ligature using 5-French infant
feeding tubing.

A polyvinyl catheter was placed in the left atrium for

injection of Evans blue dye (l.5% solution, lml/kg).

The dye was

injected rapidly into the left atrium and allowed to circulate until the
anterior free wall was stained a deep blue.

The circumflex artery distal

to the point of occlusion was perfused simultaneously with 50 ml of warm
0.9% NaCl using a modification of the methods described by Lange (23).
Both the dye and saline were injected by hand.

Immediately after

injection of the dye the heart was electrically fibrillated and the left
ventricle was vented with 18 gauge needles and excised.

Venting was done

to prevent the possible alteration of the area at risk due to acute
ventricular dilation and the consequent increased wall tension.

The

right ventricular free wall, both atria, valvular tissue and aortic and
pulmonary trunks were cut away leaving only left ventricle and septum
intact.

The left ventricle was sliced transversely from base to apex
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into 6-8 slices, each slice approximately 1 cm in thickness, and both
sides were photographed.

The area at risk was defined as the unstained

region of the myocardium (saline perfused), and total left ventricular
area was calculated as the sum of the unstained area and the stained area
following Evans blue injection.

Colored pins were placed on either the

basal or apical side for identification of which side was being viewed.

4. Determination of Infarct Size
Infarct size was assessed using triphenyl tetrazolium chloride
solution (TTC) to stain for dehydrogenase enzymes (11,21,22).

This

method provides immediate quantitation of the infarct size and shows
excellent correlation with the amount of necrosis determined
histologically (11).

The slices were rinsed in cold tap water and

incubated for ten minutes in TIC maintained at 37 degrees centigrade.
Each slice was again photographed to record infarct sizes.

After film

development the slices were projected onto a computer digitizing graphics
tablet and the areas of the myocardium, area at risk, and infarct were
measured by planimetry.

The infarct size was normalized by estimating it

as a percent of the area at risk.
Of the 42 dogs, 19 dogs fibrillated within the first 15-20 minutes
post-occlusion.
occlusion period.

13 of these dogs died before the end of the 6 hour
The six dogs which survived the occlusion period were

included in the analysis of data.

Of these dogs, two were in Group 2,

three were in Group 3, and one was in Group 4.

All dogs which fibril-

lated were electrically defibrillated and given an additional dose of 40
mg lidocaine and 20 ml of an

8.~~

sodium bicarbonate solution.
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5. Statistical Analysis
Data were first analyzed using standard one way analysis of
variance techniques. When the calculated F value was significant, differences between groups were determined using the Tukey test.

Statistical

significance was reached when the calculated value for p was less than
0.05.

All data are presented as mean± standard error of the mean (SEM).
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C. RESULTS
In Groups 1, 2, 4 and 5, (CTRL, TIM, LSS-TIM, and LSS-TIM-PRAZ,
respectively) heart rate was kept constant throughout the experiment at
150 beats per minute.

The heart rate in Group 3 (LSS) increased from a

control level of about 110 beats/min to 200 beats/min following left
stellate stimulation.

Since the heart rate reached such high levels and

did not decrease to below 150 beats/min for several hours, these dogs
could not be paced.

Thus, the heart rates in Group 3 were higher than

those in the other groups.
The mean arterial pressure for all dogs remained constant throughout the experiment except in dogs that fibrillated.

The blood pressure

in dogs that fibrillated dropped below 40 mm Hg for no more than ten
minutes.

If the dogs were not revived within that period of time, they

were not included in the data analysis.

However, all dogs which were

successfully defibrillated were included in estimates of group mean
arterial pressures.

Mean arterial pressure was calculated as the average

pressure over the six hour occlusion period.
(MAP) for the control group averaged 101.0

±

The mean arterial pressure
5.5 mm Hg.

treated group, the averaged MAP was 99.5 ± 9.1 mm Hg.

For the timolol
The group of dogs

receiving left stellate stimulation had an averaged MAP of 109.2 ± 4.0 mm
Hg.

Group 4 MAP was 126.3

±

9.5 and the MAP for Group 5 was 92.6 ± 5.1.

The difference between groups was statistically significant (F value=2.87, p<.05) using analysis of variance.

However, the Tukey test could not

distinguish statistical significance between the specific groups at the
.05 level.
Figure 4-1 shows both the area at risk and the infarct size as a
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FIGURE 4-1
INFARCT SIZE AND AREA AT RISK AS A PERCENT OF
LEFT VENTRICULAR AREA
Percent of the left ventricle at risk or infarcted. On the left
is the area at risk as a percent of left ventricular area. On the
right is the infarct size as a percent of the left ventricular area.
The data are expressed as mean values for each group ± SEM. *indicates
Group 4 (LSS-TIM) was significantly different from Group 1 (CTRL)
(p<0.05).
tindicates Group 4 (LSS-TIH) was significantly different
from Group 3 (LSS) (p<0.05). *indicates Group 4 (LSS-TIM) was significantly different from Group 5 (LSS-TIM-PRAZ) (p<0.05).
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percent of the left ventricular area.

The mean values for the area at

risk (left hand panel of Figure 1) of each group are: CTRL, 34.6 ±1.5;
TIM, 35.0 ± 4.0; LSS, 28.6 ± 3.0; LSS-TIM, 32.5 ± 4.3; and, LSS-TIM-PRAZ,
37.0 ± 4.3.

No significant difference was found between groups for the

area at risk as a percent of the left ventricular area.

Thus, coronary

artery occlusion at the same approximate anatomic level in each dog
resulted in no significant differences in the size of the perfusion bed
of the artery between groups.
Mean values for infarct size as a percent of the left ventricular
area are shown in the right hand panel of Figure 4-1 for each group are:
CTRL, 8.4 ± 2.2; TIM, 11.8 ± 1.1; LSS, 9.1 ± 2.8; LSS-TIM, 19.1 ± 2.4;
and, LSS-TIM-PRAZ, 8.8 ± 1.5.

Significant differences were found between

Group 4 (LSS-TIM) and CTRL, LSS, and LSS-TIM-PRAZ (p<0.05).
difference between LSS-TIM and TIM.

There was no
The data for

infarct size as a percent of the area at risk is shown in Figure 4-2.
The mean value for CTRL was 23.5 ± 5.3; for TIM, 34.2 ± 1.4, for LSS,
31.4 ± 7.8; LSS-TIM 59.3 ± 3.9; for LSS-TIM-PRAZ, 25.6 ± 5.3.
Significant differences were found between LSS-TIM and all other groups
(p<0.05).
Analysis of the incidence of fibrillation, revealed that there were
no significant differences in the numbers of dogs that fibrillated
between the groups.

Reevaluation of the data without the dogs that

fibrillated did not change the significance between the groups.

BB

FIGURE 4-2
INFARCT SIZE AS A PERCENT OF THE AREA AT RISK
The percent of the area at risk infarcted. Infarct size from
each of the groups is plotted as a percent of the area at risk. Data
are expressed as mean ± SEM.
*indicates Group 4 (LSS-TIM) was
significantly different from all other groups (p<0.05).
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D.

DISCUSSION
One of the major findings of the present study was that timolol

treatment did not result in a smaller infarct size as a function of the
left ventricle or as a function of the area at risk compared to control.
This appears to be contrary to the results of previous studies in which
beta blockade was reported to limit infarct size (19,20,27,32,33,38). The
apparent discrepancy may be due to a basic difference in the experimental
preparation.

In those previous studies, the effect of beta-blockade was

evaluated by comparing a group of animals that received the drug prior to
coronary occlusion, to a group that received only the vehicle, both
groups had intact cardiac innervation.

Our rationale for using neural

decentralization in the present study was that it would be an effective
means of controlling cardiac autonomic input.

In this way, we could

eliminate the variability that occurs in extrinsic sympathetic activity,
prevent the increase in reflex nerve activity secondary to coronary
occlusion (26), and/or deliver a measurable and fixed level of selected
sympathetic activation.
The increased activation of adrenergic receptors which might
exacerbate ischemic damage could be due to augmented sympathetic nerve
activity, increased local release (35), local reflexes originating within
the myocardium (2), or come from circulating catecholamines.

However,

the fact that there was no significant difference between the control
group and the group receiving timolol demonstrates that circulating
catecholamines did not influence significantly the course of infarction.
If circulating or locally released catecholamines had been a significant
determinant, then the size of the infarct in the group receiving timolol
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would be expected to be larger via alpha receptor stimulation than the
control set of animals.

Furthermore, if there were a generalized release

of catecholamines in response to coronary artery occlusion, much of this
increase would be in the form of epinephrine, which has a greater
affinity for vascular beta-2 receptors which were blocked by timolol
(1).

Coronary vascular beta-2 receptors are not considered to play an

important role in the control of coronary blood flow (17).
In addition the hearts were paced at 150 beats per minute to avoid
the consequences that a variable heart rate would have on the development
of ischemia.

One of the beneficial effects of beta blockade is thought

to be its ability to lower heart rate (42).

By maintaining heart rate

constant throughout the period of occlusion, the effects that a lower
heart rate may have had on decreasing MV02 were eliminated.
Another aspect of this study was that the infarct size as a
function of the area at risk in the control group was smaller than those
reported in other studies (30,36,37,43).
explanations for the observed differences.

There are several possible
First, as explained above, in

the present study all cardiac nerves were acutely sectioned, eliminating
both direct and reflexly mediated nerve-stimulated catecholamine release
and the concomitant increase in myocardial metabolism.

Second, the

specific anatomic location of the occlusion and the artery used in our
study were different than those employed by others (30,36,37,43). Third,
the occlusion in our study was maintained for six hours with no reperfusion.

Finally, the various methods of measuring both infarct size and

the area at risk of infarction, may contribute to the differences in
results between separate studies.

We chose to express the infarct size
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as a percent of the area at risk as a means of normalizing the data.

In

this way we hoped to eliminate the variability in measurements between
dogs that would occur if the left ventricle became the standard against
which infarct size would be assessed.
results of our study.

This method is supported by the

There was no significant difference found between

TIM and LSS-TIM for the infarct size as a percent of the left ventricular
area, whereas there was a difference between these two groups for the
infarct size as a percent of the AAR.

This can be accounted for by the

inherently greater variability between left ventricular area as opposed
to the circumflex artery perfusion bed.
We found it surprising that the group of dogs receiving only LSS
had a similar mean infarct size to the control group.

This suggests that

simultaneous activation of both alpha and beta receptors may act such
that their opposing influences on coronary vascular smooth muscle offset
one another.

When opposing beta-mediated vasodilatory effects are

removed, stimulation of alpha receptors proves deleterious to the
ischemic heart.
The results clearly demonstrate that efferent stimulation of the
left

~

subclavia with concomitant beta-blockade produced larger

infarcts than in the other groups.

It is possible that the higher mean

arterial pressure of this group of dogs had an adverse effect on the size
of the infarct.

An increase in arterial pressure represents an increase

in afterload to the heart and thus, increased MV02.

Recent evidence

suggests, though, that acute increases in arterial pressure do not affect
the outcome of coronary artery occlusion, being neither beneficial nor
detrimental to infarct development (5).

It is our supposition that alpha
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receptors are responsible for the large size of the infarcts in Group 4
(LSS-TIM).

This is further supported by the results from Group 5 (LSS-

TIM-PRAZ) in which alpha-1 receptor blockade was effected by prazosin
(25).

It is possible that alpha receptors are more important in myocar-

dial ischemia with augmented levels of sympathetic input, since there was
no significant difference between the control and timolol-treated
groups.

It might be argued that the levels of stimulation used were

unphysiologic and might have overwhelmed the beta blockade.

However, the

level of blockade was adequate to prevent inotropic and chronotropic
responses from occurring following left stellate stimulation.

Thus, it

is possible that the levels of cardiac sympathetic input normally present
in the anesthetized dog were effectively blocked by beta-receptor
blocking agents, and that these levels were not high enough to elicit
significant alpha-mediated coronary vasoconstriction.

However, with high

levels of sympathetic input, and beta-1 adrenergic receptors blocked,
alpha receptors may have a proportionally greater role in the
development of a myocardial infarct.

This may be the case in a conscious

animal with elevated sympathetic tone during stressful situations or in
exercising animals.

Recently, Matsuzaki et al., have shown that

myocardial function in a region of decreased flow is close to normal
values at rest but deteriorates with exercise, and that atenolol (a
selective beta-I-receptor blocker), although improving function in the
ischemic area, does not restore it to control levels (28).
As a result of the increase in infarct size following left stellate
stimulation with beta blockade (Group 4), two conclusions may be drawn.
Either alpha receptor activation increases the size of the infarct by
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limiting coronary blood flow to the ischemic area, or there is a localized non-beta receptor mediated increase in myocardial oxygen consumption.

Alpha receptor stimulation of platelet aggregation and the

resultant formation of thrombi is an alternative explanation for an
alpha-mediated increase in infarct size (17).

Although alpha receptors

might have limited blood flow to the normal area, via unopposed vasoconstriction, no conclusions can be made regarding the actual mechanism of
the increase in infarct size by alpha receptors in this study.

Further

investigations are needed to determine the involvement of alpha receptors
in the development of ischemia, and its effects on the transmural and
global distribution of blood flow.
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CHAPTER V
ADRENERGIC INFLUENCES ON CANINE MYOCARDIAL BLOOD FLOW
FOLLOWING CORONARY OCCLUSION
A. INTRODUCTION
Competition of alpha-receptors with beta receptors in the regulation of coronary blood flow has been investigated for the past ten
years.

The premise that alpha receptors restrict coronary blood flow

despite augmented oxygen needs is well-documented.

Alpha-receptor

vasoconstriction has been demonstrated in conscious animals (21,24,35,
43), anesthetized preparations (7,8,22,31), and isolated vessel strips
(45).

Alpha receptors have been postulated to exert not only a tonic

influence on resting coronary blood flow (24,42,43) but also to limit the
increase in blood flow consequent to exercise (23,33).

Clinical evidence

of intense vasospasm resulting in angina (28,34) and myocardial infarction (12,27) led other investigators to speculate on the contribution of
alpha receptors to vasospasm.

Alpha receptors have been implicated in

the restriction of blood flow during administration of propranolol (26),
and during the cold-pressor test, causing constriction severe enough to
lead to angina (32).
Whether alpha receptor stimulation modulates blood flow during
ischemia has not been demonstrated conclusively.

Even in the case of

ischemia, when dilation due to ischemic metabolites would be expected to
exert an overwhelming influence on blood flow, alpha receptors have been
reported to limit blood flow (7).

Other investigations have suggested
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that during ischemia, beta receptor blockade affords protection to the
myocardium by unmasking alpha receptors in the normal region which limit
flow to the normal zone, enough to cause a 'reverse coronary steal'
(11,19).

However, Buck et al. concluded in their study that beta-recep-

tor blockade provided protection to the ischemic myocardium by lowering
indices of oxygen demand, thus allowing the available blood supply to
meet the oxygen demands of the myocardium (6).

In a recent report from

our laboratory, we found that combined blockade of alpha and beta
receptors prior to coronary artery occlusion led to a decrease in the
amount of myocardium which infarcted following coronary artery occlusion.

In dogs in which beta receptor blockade was administered, infarct

sizes were larger in the presence of stellate stimulation as compared to
control (16).

Whether this was due to an effect on myocardial blood flow

remains to be determined.

We postulated that the process of myocardial

infarction reported in that study was exacerbated by limitation of blood
flow to the ischemic region via stimulation of alpha-1 receptors.

The

purpose of this investigation was to elucidate the role of alpha-1
receptors on modulation of blood flow during coronary artery occlusion,
with and without beta-blockade in the presence of elevated sympathetic
input.

In addition, we wished to determine whether prazosin would alter

blood flow to the ischemic region regardless of whether it was given
prior to or following coronary artery occlusion.
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B.

METHODS
1. General Preparation
Twenty three mongrel dogs of either sex were preanesthetized with

morphine sulfate (2.5 mg/kg, s.c.) or xylazine (2 mg/kg, s.c.), 20
minutes before administration of alpha-chloralose (50-100 mg/kg, i.v.).
A catheter was inserted via the right femoral artery into the thoracic
aorta and connected to a Statham P23 dB pressure transducer for continuous monitoring of arterial blood pressure.

A catheter was placed in the

right femoral vein for intravenous administration of fluid and drugs.
The left femoral artery was also cannulated for later blood withdrawal
during the injection of microspheres.

The trachea was cannulated with a

Y-tube, the ends of which were connected to a Harvard respirator.

The

animals were ventilated with room air at a positive pressure of 5 cm of
water.

Both cervical vagi were isolated and cut.

Succinylcholine was

given as a muscle relaxant prior to opening the chest in the fourth left
intercostal space.

The dorsal and ventral limbs of both the right and

left ansae subclaviae were isolated.

Changes in the heart rate, P-R

interval and T-wave configuration upon stimulation confirmed that both
limbs had been isolated (17,44).

The ansae were then cut distal to the

stellate ganglia, and the cut distal ends of the left ansae subclavia
were placed across a bipolar electrode.

The pericardium was incised and

sutured to the sides of the chest cavity to form a cradle.

The

circumflex artery was isolated distal to its first major branch, and a
piece of 2-0 silk was placed under the artery.

A catheter was inserted

into the left atrial appendage for injection of microspheres.

A loading

dose of timolol (0.2 mg,kg, i.v.) was given prior to starting the actual
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protocol, with maintenance doses of timolol administered throughout the
duration of the experiment (0.08 mg/kg/hr, i.v.).

Blockade of the

beta-receptors was considered to be adequate when stimulation of the
ansae subclavia no longer produced typical changes in either the
electrocardiogram or heart rate.

Blockade of alpha-1 receptors was

accomplished by administration of prazosin HCL (0.5 mg/kg, i.v.).

This

dose of prazosin blocks the increase in blood pressure caused by a 5
g/kg,i.v. dose of phenylephrine (average increase in blood pressure 45
mm Hg) (29).

The preparation was allowed to stabilize for at least 20

minutes before beginning the experimental procedures.
Blood gases were continuously monitored, and kept within normal
limits (pH 7.38-7.45, pC02 25-35 mm Hg, p02 80-110 mm Hg) by adjusting
the rate and depth of ventilation, with infusions of bicarbonate when
necessary to keep pH normal.

The core temperature, measured with a

thermometer in the thoracic cavity was kept between 37-39° C, by means of
a heating pad under the dog, and an infrared heating lamp above the dog.
Plastic wrap was kept over the open chest to keep heat and moisture loss
to a minimum.

2. Regional Blood Flow Determinations
In each group of animals, four blood flow determinations were made.
Four of the following available species of 15

m microspheres (3-M) were

used in random order: Ce-141, Cr-51, Nb-95, Sr-85 or Ru-103, and Sc-46.
The microspheres were suspended in 50 ml vials of 0.5% dextran solution
with 0.05% Tween 80.

The vials were sonicated for 20 minutes prior to

use, and agitated on a vortex mixer immediately before use.

Reference
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blood withdrawal from the left femoral artery was begun 30 seconds before
injection of the microspheres.

The microspheres were injected into the

left atrium over a 30 second period and flushed with 10 ml of warm (37°C)
saline.

Reference blood withdrawal was continued for 90 seconds after

completion of the microsphere injection.
withdrawal averaged 2.5 minutes.

The total time for blood

Following the experimental procedures,

the heart was excised, the circumflex artery ligated at the point of
isolation, and a short piece of adult pediatric feeding tubing (8-French)
inserted immediately distal to the ligature, and tied securely in place.
Microfil was injected into the circumflex via the catheter until the
epicardium of the posterior wall was visibly stained.
placed in formalin for 48 hours.
6-7 slices from apex to base.

The heart was then

After this, the heart was sliced into

Samples of the myocardium were taken from

the posterior wall (stained region), and from the anterior free wall (unstained region).

Each sample was cut into endocardial and epicardial

halves, weighed, and placed in labeled counting tubes.

Blood

withdrawal

samples from each of the procedures, and the heart samples were counted
in a TM Analytic Gamma Counter (model 1185), and the output from the
gamma counter processed directly by an APPLE II computer.

Flows were

calculated using standard equations with corrections for background
counts and interference coefficients.

The equation for blood flow

determination is: MBF - (Ct/TW) x (RllW/Cb) x 100, where MBF - myocardial
blood flow in ml/min/100 gm; Ct - tissue radioactivity in counts/min, TW
- tissue sample weight in grams, RllW - reference blood withdrawal rate in
ml/min, and Cb - total radioactivity in reference blood sample.
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3. Experimental Protocol
Three groups of animals were studied.
flow determinations were made.

In each group four blood

Figure 5-1 depicts in graph form the

experimental protocols used in each group.

a. Group l

(Prazosin;Post-CAO)

In Group 1 (n=5) the first flow determination was following
beta-blockade with timolol (initial dose 0.2 mg/kg, i.v.); maintenance
dose 0.08 mg/kg/hr, i.v.) and served as the control.

The circumflex

artery was then occluded for the remainder of the experiment.

The second

flow determination was made during circumflex artery occlusion, in the
presence of timolol.

Left stellate stimulation (LSS: 7-10 Hz, 5 msec, 7

V) was begun and the third set of microspheres were injected during LSS
with the circumflex occluded.
injection, LSS was stopped.

After completion of the third microsphere
Prazosin (0.5 mg/kg i.v.) was administered

prior to the last blood flow determination, LSS was begun, and the fourth
set of microspheres was injected during LSS, under conditions of alpha-1
blockade and coronary artery occlusion.

The preparation was allowed to

stabilize for at least 20 minutes between microsphere injections.

This

group will be denoted as the Prazosin;Post·CAO group since prazosin was
administered after occlusion of the circumflex.
In Group 1 (Prazosin;Post-CAO), the amount of prazosin delivered to
the ischemic myocardium depended on the amount of collateral blood flow
to the area, since prazosin was administered following coronary occlusion.

Thus, the efficacy of alpba-1 blockade was not necessarily

homogeneous throughout the circumflex region.

Hence, the next group of
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FIGURE 5-1
EXPERIMENTAL PROTOCOLS USED FOR GROUPS 1,2, AND 3
Abbreviations denote the following: CAO: circumflex artery
occlusion; LSS: stimulation of the left ansae subclavia (8 Hz);
TIMOLOL: beta-blockade with timolol; PRAZOSIN: alpha blockade; RMBF:
regional blood flow determination (microsphere injection).
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animals was necessary to determine blood flow distribution during
ischemia with prazosin given prior to occlusion to insure uniform
blockade of the occluded region.

b. Group Z (Prazosin;Pre-CAO)
In Group 2 (Prazosin;Pre-CAO, n-7), the occlusion periods lasted
for a total of 7-8 minutes, and were followed by a thirty minute period
of reperfusion.

Microspheres were injected five minutes into the

occlusion period, and the occlusion was released upon completion of the
microsphere injection.

The first flow determination was made following

beta-blockade with timolol and served as the control.

An atraumatic

clamp was placed on the circumflex artery distal to the first marginal
branch, and the second flow determination was made after 5 minutes of
CAO.

Upon completion of the injection, the occlusion was released and

the heart allowed to reperfuse for 30-35 minutes.

After this period, the

CX was again clamped, stimulation of the left ansae subclaviae was begun
and maintained throughout the third period of microsphere injection.

At

the end of the third microsphere injection, LSS was stopped, the arterial
clamp was removed, and the artery allowed to reperfuse for 30-35 minutes.

Prazosin (0.5 mg/kg, IV) was administered during the reperfusion

period, and challenged with phenylephrine (5

g/kg, i.v.).

At the end of

the reperfusion period, the circumflex was again occluded, LSS was begun,
and the fourth blood flow determination was made after 5 minutes of
occlusion and LSS.

Although total occlusion time was 7-8 minutes there

is evidence that this period of occlusion does not cause ultrastructural
damage (4) or alter baseline blood flow when followed by a 30 minute
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period of reperfusion (2).

This group will be called Prazosin;Pre-CAO

since prazosin was given before occlusion of the circumflex artery.

c. Group 1 (Ctrl-Prazosin)
A third set of animals was included in this study to determine
resting blood flow in the neurally decentralized preparation.

In Group

Three (n-7), the effects of prazosin on coronary blood flow during
ischemia were tested without prior beta-blockade and with no sympathetic
input.

In this group of animals, the same model of circumflex occlusion

was employed.

The total duration of occlusion lasted from 7-8 minutes,

with microsphere injections begun after five minutes of occlusion.

Upon

completion of the injection, the occlusion was released and the artery
reperfused for thirty minutes.
in this group.

Four blood flow determinations were made

The first microsphere injection served as a control, with

no adrenergic blockers or sympathetic stimulation.

The second injection

was following a five minute period of coronary artery occlusion, again
with no adrenergic blockers.

The occlusion was released upon completion

of the injection of microspheres, and allowed to reperfuse for thirty
minutes.

The third blood flow determination was made following a

blocking dose of prazosin (0.5 mg/kg, i.v.).

The last blood flow

determination was made during coronary artery occlusion, in the presence
of alpha-1 blockade.

This group will be referred to as the Ctrl-Prazosin

group to denote that prazosin was administered under control conditions,
with no LSS or beta-blockade.
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4. Data Analysis
Statistical tests were run on the regional myocardial blood flow
values, on blood flows normalized to control flow, on resistance values,
and on the endo/epi ratios.
the control blood flow.

Blood flows were normalized to percent of

Resistance was calculated as the quotient of

mean arterial blood pressure / endocardial or epicardial blood flow at
the time of injection.

Only left ventricular samples were analyzed.

Thus anterior wall and posterior wall blood flow refer exclusively to the
left ventricular blood flow.

In each heart all samples from similar

regions (i.e. all anterior endocardial samples) were averaged together to
obtain a single blood flow value for each intervention.
value was used in the analysis of data.

The averaged

In order to determine whether

prazosin would exert a different effect on blood flow depending on the
severity of the blood flow reduction following occlusion, blood flows in
the posterior wall were separated in the following manner.

In each dog,

posterior wall blood flows were divided into two groups for analysis,
Group A included those samples in which blood flow was between 20-50% of
control flow following coronary artery occlusion, and Group B included
those samples in which blood flow fell to less than 20% of control flow
following coronary artery occlusion.

Repeated measures analysis of

variance was used to test for differences between experimental protocols,
and Tukey's multiple range test was employed to isolate for differences.
Comparisons were made between all of the groups for both the endocardium
and epicardium.
<0.05.

Statistical significance was reached at a p value of
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C.

RESULTS
1. Group 1 (Prazosin;Post-CAO)
The anterior and posterior wall blood flow values for Group 1 are

listed in Table 5-1.

In the anterior wall there were no significant

differences in blood flow between any of the groups, in either the
endocardium or epicardium.

In Group A of the posterior wall, the three

blood flow determinations were all significantly lower in the endocardium
following coronary artery occlusion compared to control (p<0.0001).

In

the epicardium, the blood flow during coronary artery occlusion (46.66 ±
4.98) was significantly lower than control (99.29 ± 11.67) (p<.0001).
However, in the epicardium, flow increased during left stellate stimulation (LSS) and during LSS following administration of prazosin, so that
the last two determinations of blood flow following coronary artery
occlusion (CAO-LSS, CAO-LSS-PRAZ) were not statistically different from
control.

In Group B of the posterior wall, flows following CAO in both

the endocardium and epicardium were all significantly lower than control
(p<0.0001).

In neither Group A nor Group B, were there were any signifi-

cant differences between the interventions (CAO, CAO-LSS, CAO-LSS-PRAZ).
When the flows were normali2ed to the control flow value (Table 52), there were no significant differences between flows in the endocardium or epicardium of the anterior wall.

The blood flow was

significantly depressed in the endocardium and epicardium during CAO,
CAO-LSS and CAO-LSS-PRAZ of Posterior

~all

Groups A and B compared to

control (p<0.0001).
There were no significant differences between groups in either the
endocardial or epicardial calculated resistance in the anterior wall.
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TABLE 5-1
REGIONAL BLOOD FLOW VALUES (ML/MIN/100 GM) DURING
PERMANENT CORONARY OCCLUSION
GROUP 1 (PRAZ;POST-CAO)

ANTERIOR LV
EPICARDIUM

ENDOCARDIUM

MEAN
SEM

CONTROL

CAO

CAOLSS

CAOLSS
PRAZ

CONTROL

CAO

CAOLSS

CAOLSS
PRAZ

116.33
12.33

88.41
6. 72

93.48
7.83

95 .65
16 .44

103.40
7.74

89.36
6.38

99.98
4.10

91. 76
14.26

POSTERIOR LV (A)
ENDOCARDIUM

MEAN
SEM

CONTROL

CAO

114. 82
16.01

38.68
6.26

EPICARDIUM

CAOLSS
1

37 .10
14.18

CAOLSS
PRAZ
1

1

39. 61
16. 89

CONTROL

99.29
11.67

CAO

46. 66
4.98

1

CAOLSS

CAOLSS
PRAZ

56.35
11.48

57.95
17.78

POSTERIOR LV (B)
EPICARDIUM

ENDOCARDIUM
CONTROL

MEAN
SEM

110.15
12.93

CAO

CAOLSS
1

11. 85
2.69

CAO·
LSS
PRAZ

22. 49 1 Z6. 25 1
12.96 18.51

CONTROL

93.71
9.95

CAO

CAOLSS
1

40. 53
7.46

51. 60
12.16

CAOLSS
PRAZ
1

46. 98
16.01

1

(Data are represented as mean ± SEM. Control: blood flow during beta
blockade; CAO: flow during circumflex occlusion; CAO-LSS: flow during
circumflex occlusion in the presence of left ansae subclavia stimulation;
CAO-LSS-PRAZ: CAO-LSS following i.v_ prazosin. 1 indicates significant
difference from control, p<0.0001; n=S)
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TABLE 5-2
NORMALIZED BLOOD FLOW VALUES (%) DURING
PERMANENT CORONARY OCCLUSION
GROUP 1 (PRAZ;POST-CAO)

ANTERIOR LV
EPICARDIUM

ENDOCARDIUM
CONTROL

MEAN
SEM

100.00
0.00

CAO

CAOLSS

CAOLSS
PRAZ

86.09
8.39

82.99
9.69

82 .20
7 .27

CONTROL

100.00
0.00

CAO

CAOLSS

CAOLSS
PRAZ

93. 71 100.85
4.80
8.89

88.88
7.49

POSTERIOR LV (A)
ENDOCARDIUM
CONTROL

CAO

EPICARDIUM

CAOLSS

CAOLSS

CONTROL

CAO

CAOLSS

FRAZ

MEAN
SEM

31.47 2 28.30
1. 76
8.79

100.00
0.00

2

31. 20 2
7.67

100.00
0.00

CAOLSS
PRAZ

48 .15 2 53.68 2 54.69 2
3.00
8.26 12.33

POSTERIOR LV (B)
ENDOCARDIUM
CONTROL

CAO

CAOLSS

EPICARDIUM
CAOLSS

CONTROL

FRAZ

MEAN
SEM

100.00
0.00

2

10. 53
1.67

16.66 1 19.37 2
7.93 11.49

100.00
0.00

CAO

CAOLSS

CAOLSS
PRAZ

45. 212 54. 05 2 47.39 2
8.86
9.90 11. 28

(Data represent the mean± SEM of percent of control flow. See Table 5-1
2
for definition of group names.
indicates significant difference from
control, p<.0001, n=5)
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Only the anterior wall resistances were calculated since the perfusion
pressure of the posterior wall could not be assumed to be either aortic
pressure, or uniform throughout the circumflex bed.
Table 5-3 lists the endo/epi ratios for the Prazosin;Post-CAO and
Prazosin;Pre-CAO groups.

In Group 1 (Prazosin;Post-CAO), there were no

significant differences between the endo/epi ratios in the anterior wall.
In the posterior wall, the endo/epi ratio was significantly lowered
during left stellate stimulation (0.68 ± 0.19 mm Hg 100 gm/ml/min) as
compared to control (1.16 ± 0.13) (p<0.02).

There no other significant

differences between groups.
The results from Group 1 indicate that combined alpha and beta
blockade following permanent ligation of the circumflex artery does not
increase flow to either the normal zone or the ischemic zone compared to
the flow during left stellate stimulation without alpha blockade.

2. Group 2
Figure 5-2 depicts the regional myocardial blood flow (ml/min/100
gm) for Group 2 (Prazosin;Pre-CAO).

In the top left panel of the figure

are the anterior wall endocardial blood flows.

Administration of

prazosin significantly increased blood flow to 134.08 ± 22.21, from 81.18

± 5.76 during control (p<0.0001).

The middle and right hand panels of

the upper graph show the blood flows for Groups A and B of the posterior
wall.

Endocardial blood flows shown for both groups A and B were

significantly lower than control during CAO, CAO-LSS and CAO-LSS-prazosin
(p<0.0001).

There were no differences between treatment groups.

The bottom half of Figure 5-2 shows blood flow in the epicardium of

TABLE 5-3
ENDO/EPI RATIOS FOR PERMANENT AND REPETITIVE
CORONARY ARTERY OCCLUSIONS

GROUP 1
ctrl

x
SEM

1.13

0.08

ANTERIOR
cao
caolss

1.15
0.16

0,94
0.10

caolsspraz

ctrl

1.05

1.16
0.13

0.07

POSTERIOR(A)
cao
cao- caolss
lsspraz
0.78
0.14

0.68
0.19

3

0.79
0.21

ctrl

1.18
0.05

POSTERIOR(B)
cao
cao- caolss
lsspraz
0.403 0.273 0.243
0.12 0.07 0.05

GROUP 2

x
SEM

ctrl

ANTERIOR
cao
caolss

1.14
0.05

1.30
0.09

1.26
0.03

caolsspraz

ctrl

1.13
0.05

1.20
0.09

POSTERIOR(A)
cao
cao- caolss
lsspraz
0.92
0.20

0.96
0.25

1.44
0.55

ctrl

1.21
0.09

POSTERIOR(B)
cao
cao- caolss
lsspraz
4

0.44
0.07

0.46
0.03

4

0. 30
0.04

4

(Data are listed as mean + SEM. Group 1 (n-5), Group 2 (n-7). ~p<0.02 compared to
control, 4 p<0.0001 compared to control. See Table 5-1 for definition of
Abbreviations.)
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FIGURE 5-2
REGIONAL MYOCARDIAL BLOOD FLOW VALUES (ML/MIN/100 GM)
DURING REPETITIVE CORONARY ARTERY OCCLUSION
GROUP 2 (PRAZOSIN;PRE-CAO)
Mean ± SEM values for posterior and anterior wall blood flows in
the left ventricular endocardium and epicardium of Group 2.
Control:
blood flow during control conditions, during beta-blockade; CAO: flow
during occlusion of the circumflex; CAO-LSS: flow during occlusion of
the circumflex artery and simultaneous left ansa subclavia stimulation;
CAO-LSS-PRAZ: flow during conditions of CAO-LSS in the presence of
alpha blockade. *indicates significant difference from control
(p<0.0001, n=7).
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the anterior left ventricle (left panel) and the posterior left ventricle
(middle and right panels).

Prazosin did not significantly alter the flow

in the epicardium (as compared to control, CAO or CAO-LSS).

Flows

decreased significantly from control during each of the interventions in
the posterior wall (p<0.0001).

However, there were no significant

differences between any of the interventions.
Figure 5-3 shows blood flows normalized to the control blood flow
value.

The left hand panel of the top figure shows that blood flow

following prazosin (167.03 ± 18.94) was significantly increased from the
normalized control value (p<.0001).

The middle panel and right panel of

the upper figure, illustrate that blood flow was decreased significantly
during all three interventions compared to control (p<0.0001).
The lower panel of Figure 5-3 depicts epicardial blood flows in the
anterior and posterior wall.

Blood flow in the anterior wall increased

significantly following prazosin (168.55 ± 16.48) as compared to control
(100 ± 0) and left stellate stimulation (117.34 ± 8.91) (p<0.0001).
Flows following CAO were all significantly lower than control in both
groups of posterior wall blood flows (p<0.0001).
Figure 5-4 shows calculated resistance values for the anterior
wall.

In the endocardium, resistance decreased significantly from

control (1.36 ± 0.13) following prazosin administration (0.74 ± 0.13)
(p<0.0001).

Resistance subsequent to prazosin was also significantly

lower than calculated resistance during left stellate stimulation without
alpha-1 blockade (1.17 ± 0.11) (p<0.0001).

In the epicardium,

calculatedresistance was significantly lower following alpha-1 blockade
(0.80 ± 0.11) compared to control (1.40 ± 0.17), CAO (1.29 ± 0.16) and

FIGURE 5-3
NORMALIZED REGIONAL MYOCARDIAL BLOOD FLOW VALUES (%) DURING
REPETITIVE CORONARY ARTERY OCCLUSION
GROUP 2 (PRAZOSIN:PRE-CAO)
Mean± SEM values for blood flows normalized to control (n-7).
The upper half of the graph represents the anterior and posterior left
ventricular endocardial blood flows. *indicates a significant difference from control (p<0.0001).
The lower half of the graph represents
the anterior and posterior left ventricular epicardial blood flows.
indicates a significant difference from control (p<0.0001). *'indicates
a significant difference from CAO-LSS (p<.0001). See Figure 5-2 for
abbreviations and legend.
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FIGURE 5-4
VASCULAR RESISTANCE IN THE ANTERIOR LEFT VENTRICULAR WALL
DURING REPETITIVE CORONARY OCCLUSION
GROUP 2 (PRAZOSIN:PRE-CAO)
Mean ± SEM values for the calculated left ventricular
resistances, in the anterior endocardium and the epicardium (n-7).
indicates significant difference frorn control (p<0.0001). "'kindicates
significant difference from CAO (p<O_OOOl).
~indicates significant
difference from CAO-LSS (p<0.0001). See Figure 5-2 for legend and
abbreviations.
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CAO-LSS (1.45 ± 0.13) (p<0.0001).
There were no significant differences in the endo/epi ratios in
either the anterior wall or posterior wall Group A.

In Group B of the

posterior wall, the endo/epi ratios were significantly lower than control
in the three interventions following CAO (p<0.0001) (See Table 5-3).
Thus, alpha-1 blockade with prazosin increased blood flow to the
non-ischemic areas of the left ventricle, during left stellate stimulation.

However, blood flow to the ischemic myocardium was not altered

significantly by prazosin administration, even when given prior to
coronary artery occlusion.
The third group of animals (n-7) did not show any significant
changes in either blood flow or resistance in the posterior and anterior
wall following administration of prazosin.

Blood pressure did not change

significantly following adminstration of prazosin.

The absence of a drop

in blood pressure following administration of prazosin in this group was
most likely due to lower levels of background sympathetic activity in
these dogs as opposed to the other groups.

This group of dogs

demonstrates that alpha-1 blockade without prior beta-blockade and in the
absence of elevated sympathetic input does not increase flow or reduce
resistance significantly from values prior to administration of prazosin.

3. Blood Pressure
Blood pressures during microsphere injection for Groups 1 and 2 are
listed in Table 5-4.

In Group 1 administration of prazosin dropped blood

pressure significantly from Control, CAO, and CAO-LSS (p<0.05).

In Group

2 prazosin decreased blood pressure significantly from control and from

TABLE 5-4
BLOOD PRESSURES (MM HG) FOR PERMANENT (GROUPl) AND
REPETITIVE (GROUP 2) CORONARY ARTERY OCCLUSIONS ,

GROUP 1
CONTROL

CAO

CAO-LSS

CAO-LSS-PRAZ

108.32 ± 3.63

111.54 ± 4.70

107.42 ± 6.86

88.60 ± 5.43
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GROUP 2
CONTROL

CAO

CAO-LSS

CAO-LSS-PRAZ

108.43 ± 5.52

101.50 ± 5.07

106.14 ± 5.51

87.17 ± 5.13

13

(Data are listed as mean+ SEM. Group 1 (n-5), Group 2 (n-7). 1p<0.05
compared to control, 2p<0.05 compared to CAO, 3 p<0.05 compared to CAO-LSS.
Table 5-1 for Abbrev.)

See

124
blood pressure during CAO-LSS (p<0.05).
The results from this study suggest that, while alpha-1 receptors
exert a modulating influence on regional myocardial blood flow in normal
areas, their importance can only be demonstrated in the presence of betablockade and elevated levels of sympathetic nerve stimulation.

In

addition, there does not appear to a significant influence of alpha-1
receptors on blood flow in the ischemic zone following complete coronary
artery occlusion.
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D. DISCUSSION
Previous investigations demonstrated that alpha receptors restrict
increases in blood flow following coronary stenosis (7,8).

Other

investigations have demonstrated that under conditions in which betamediated metabolic vasodilation might be expected to overwhelm alpha
receptor-mediated vasoconstriction such as severe exercise, there is
still limitation of blood flow via alpha receptors (23,33).
Our goal was to examine whether sympathetic stimulation and alpha-1
blockade with prazosin would redistribute blood flow to the posterior
wall following circumflex artery occlusion.

Chiariello et al. reported

that alpha mediated vasoconstriction in the normal zone effected a
reverse 'coronary steal' into the occluded bed (11).

This finding was

supported by Giudicelli et al., who found that stimulation of the left
stellate in the presence of beta-blockade decreased blood flow to the
non-ischemic region concomitant with an increase in flow to the ischemic
region (19).

Contrary to those reports, the major finding of this study

was that prazosin did not increase blood flow to the posterior left
ventricle following circumflex coronary artery occlusion.

Although

prazosin induced vasodilation in the normal zone in Group 2 (in which it
was given prior to occlusion), evidently this was not sufficient to
precipitate 'steal' of blood from the ischemic area.

GROUP 1:
In this group (Praz:Post-CAO), there was no effect of alpha
blockade on blood flow to either the anterior or posterior wall.

The

lack of an increase in blood flow to the posterior wall of Group 1 may be
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ascribed to the post-occlusion, systemic administration of prazosin, with
a resultant non-uniform distribution to the collateral dependent
posterior wall.

It is also possible that alpha-1 receptors do not have

an important influence on blood flow following a complete coronary artery
occlusion.

Previous studies utilized combined alpha-1 and alpha-2

blockade to demonstrate alpha mediated vasoconstriction in their preparations.

Although the role of alpha-2 receptors was not addressed in the

present study, recent investigations have suggested that alpha-2 receptors, both pre- and post-junctional may influence coronary blood flow
(22,24).
Insofar as flow could be delivered to the posterior wall only via
collateral vessels, it is understandable that very little change in flow
would be elicited in the ischemic bed as a result of anterior wall blood
flow changes.

Schaper reported that not only does it take several hours

for nascent collateral vessels to open, the resistance of these collaterals is extremely high.

Even when functional capacity has been reached

after four weeks of occlusion, the resistance in collateral vessels is
still 12-40 times higher than coronary vessels (40).

In addition, the

amount of left ventricle at risk of infarction following occlusion of the
circumflex is larger (41) than the amount in previous studies (11,19)
utilizing the LAD region.

Schaper calculated that the relative number of

collateral vessels supplying an ischemic region decreases with an
increase in volume of the myocardium perfused (40).

Thus, while other

studies demonstrate reverse steal of blood into the ischemic region, it
is unlikely that such a phenomena would exert a noticeable effect on
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delivery of blood flow to, and salvage of the ischemic region in this
study.
It should not be overlooked that the posterior wall might have been
unable to respond to nerve stimulation and adrenergic blockade, or that
the nerves themselves might have been impaired following isolation of the
vessel, and occlusion of the circumflex artery (15).

Several laborato-

ries have described 'stunning' of the myocardium following coronary
artery occlusion.

Ciuffo et .ElJ... implanted ultrasonic dimension gauges in

the midwall of the LAD region to assess myocardial function following
periods of ischemia of up to two hours.

They demonstrated that following

a twenty-five minute period of occlusion and reperfusion, segmental
shortening increased significantly in the post-ischemic zone in response
to systemic injection of norepinephrine.

However, the post-ischemic

response to stimulation of the cardiac nerves was impaired, and the
authors concluded that nerve conduction had been disrupted during the
period of ischemia (13).

One problem with Ciuffo's study was that the

placement of the crystals in the midwall would not allow separation of
function of the potentially ischemic endocardium from the epicardium.
Another problem is that the LAD region does not respond as markedly to
stimulation of the left cardiac nerves as does the circumflex region.
Finally, regional blood flow assessed by microspheres did not show any
difference in the response to nerve stimulation or systemic norepinephrine.

A study by Barber et al. provided evidence for loss of catechol-

amines and nerve activity following the injection of latex into a branch
of the LAD (3).

In the study by Ciuffo et al., the period of occlusion

was 25 minutes, and the study by Barber et al.,

the infarction was
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transmural.

Neither of these conditions is applicable for the present

study since the period of occlusion was not long enough to cause
transmural infarction, and in any case sympathetic fibers are thought to
travel in the epicardiurn (18), which did not become severely ischemic in
this study.
The endo/epi ratios did not show any significant changes except in
Group 1.

During combined LSS and CAO, the endo/epi ratio dropped

significantly from control in the posterior wall, due probably to a small
amount of vasoconstriction in the endocardiurn superimposed on the
existing level of decreased flow.

What is interesting is that prazosin

did not alter the endo/epi ratio in favor of increased flow to the
epicardiurn.

As Schaper remarked, increasing collateral flow to an

ischemic region will result in decreased endo/epi ratios, with more flow
going to the epicardiurn (40).
the expense of the endocardium.

This allows salvage of the epicardiurn at
Reduction of tissue damage depends on

limiting the wavefront of necrosis (37), and salvaging the epicardiurn at
the expense of leaving a core of endocardiurn damaged.

GROUP 2:
In Group 2 (Praz:pre-CAO), prazosin did not increase blood flow to
the occluded region, even when given before coronary artery occlusion.
However, prazosin caused an increase in flow and a decrease in resistance
to the anterior wall compared to control.

If prazosin had acted merely

by removing vasoconstriction imposed by LSS and beta-blockade, then it is
interesting that it actually increased blood flow significantly from
control levels.

It is conceivable that the increase in flow mediated by
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prazosin was

~ot

via its adrenergic blocking actions, but via a non-

specific effect on the coronary vascular smooth muscle.

Although an

initial report by Constantine supported the idea that prazosin acted
directly on smooth muscle to cause vasodilation (14), subsequent studies
have shown that prazosin's actions are alpha-receptor mediated (9,20,43).
The most probable explanation is that prazosin blocked coronary vascular
alpha-I receptors and that the flow increase was due to removal of
alpha-vasoconstriction.
It is also possible in Group 2 (Praz:Pre-CAO) that prazosin's
actions were due primarily to a release of vasoconstrictor tone imposed
on anterior wall blood vessels by circulating catecholamines.

The

contribution of circulating catecholamines to increases in blood flow
during mild exercise were examined in a recent investigation by Chilian
et al., (10).

Using conscious dogs, with regional denervation of the

posterior wall, they found that alpha receptors limit augmentation of
blood flow during exercise in the dog.

This vasoconstriction appeared to

be mediated primarily by circulating catecholamines, not by neurally
released catecholamines.

Their findings may explain why, contrary to our

expectations, stimulation of the left stellate did not decrease flow
significantly from control in either Group 1 or Group 2.

Moreover, the

left-side cardiac nerves do not innervate the anterior wall as uniformly
as the posterior wall (36).

Rinkema et al. demonstrated that in the

presence of beta-blockade with propranolol, left stellate stimulation
produced a 28% reduction in regional myocardial blood flow to the
posterior LV, and only a 16% reduction in flow to the anterior wall (38).
These results agree with an earlier study by Ross and Mulder.

During LSS
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in the study by Ross and Mulder, the resistance in the circumflex artery
during beta blockade increased by 75% compared to a 19% increase in the
LAD artery (39).
Significant differences in resistance between Control, LSS,
Prazosin and CAO·LSS, in the anterior wall were evident in Group 2
(Praz;Pre-CAO)

although flow had not changed significantly, due to a

significant drop in blood pressure following the administration of
prazosin.

This result concurs with findings by Macho and Vatner in which

prazosin did not increase flow significantly but may have evinced more of
an effect hemodynamically (30).
The resting level of resistance in the heart may account for
differences in the endocardial and epicardial response to prazosin.
Although the resistance was decreased in comparison to control and LSS,
the endocardial resistance was not significantly lower than that during
coronary artery occlusion.

The obvious explanation is that the endocar-

dium was slightly more dilated than the epicardium, hence the response to
additional vasodilation with prazosin was not as great.
wall, there were no differences between interventions.

In the posterior
This may be due

to the fact that blood flows were reduced so much following CAO, that
slight differences were not demonstrable between the subsequent interventions.

SUMMARY OF GROUPS 1 AND 2
The differences in results between Group 1 (Praz;Post-CAO) and
Group 2 (Praz;Pre-CAO) regarding the anterior wall can be ascribed to
differences in the experimental preparations.

In Group 1, the period of

131
occlusion lasted for up to two hours, with no reperfusion.

In addition,

cardiac nerve stimulation was maintained for approximately 15 minute
intervals, as opposed to five minutes in Group 2.

The role of cardio-

cardiac reflexes in the response of the anterior wall to posterior wall
occlusion should not be ignored, as reflex arcs through the middle
cervical ganglion have been demonstrated in decentralized preparations

(1).

GROUP 3
In the third group of dogs, alpha-1 blockade did not exhibit a
noticeable effect on blood flow.

Without prior beta blockade, alpha

receptors were not unmasked and hence the effects of beta receptors were
predominant (5).

It was also shown that elevated levels of sympathetics

were needed to stimulate the alpha receptors.

It is possible that the

existing levels of circulating catecholamines were not adequate to result
in alpha-mediated vasoconstriction without prior beta blockade.

In conclusion, contrary to what has been reported in the
literature, we did not see an increase in blood flow to the ischemic
region following alpha blockade with prazosin regardless of whether it
was given before of after coronary occlusion.

However, one disadvantage

of using microspheres is that when blood flow is low, the resolution of
the technique is limited.

Flows of at least 20 ml/min/100 gm are

necessary to deposit the required number of microspheres for reliable,
reproduceable flow measurements.

Thus, small changes in flow might have

gone undetected because of the greater degree of variability and error in
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measuring flow at such low levels.

In addition, in comparison to control

values of blood flow, the low flows would very large variations to have
differences detected by analysis of variance and Tukey test statistical
analysis.

It is probable that alpha receptor blockade did not increase

infarct size in the previous study by removing alpha mediated
vasoconstriction in the ischemic zone.

Although blockade of alpha

receptors may alter the course of myocardial infarction, it is probably
due to a mechanism that is not related to changes in myocardial blood
flow.

The possible involvement of alpha receptors in cardiac metabolism

and function should be clarified in order to understand more clearly
their involvement in the process of infarction.
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CHAPTER VI
EFFECTS OF REGIONAL DENERVATION ON MYOCARDIAL
BLOOD FLOW DURING CORONARY ARTERY OCCLUSION

A.

INTRODUCTION
Although cardiac denervation had been utilized as an experimental

tool to investigate the innervation of the heart (30), the suggestion
that cardiac denervation could be used clinically to alleviate angina was
initially suggested by Leriche (19).

Subsequent investigations extended

the number of clinical settings in which denervation was proposed to be
beneficial to include protection against lethal arrhythmias (8,25) and
myocardial infarction (17).
not well-established.

The mechanism of these protective effects is

It was thought by some investigators that the

protection may be due to alteration of regional myocardial blood flow
during ischemia.

DuPont et al. showed better perfusion of the border

zones during coronary artery occlusion in animals with sympathectomized
hearts compared to non-cardiac sympathectomized animals (7).

However,

Barber et al. found that blood flow to the ischemic zone did not change
significantly following cardiac denervation (1).

Both Barber et al., and

DuPont et al. suggested that the beneficial effects may be due to a
lowering of oxygen consumption (1,7).
Previous investigations have demonstrated a role for alpha receptors in the modulation of coronary blood flow under resting conditions
and during exercise.

Alpha receptors have also been implicated in the
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control of blood flow under conditions of ischemia severe enough to cause
net lactate production (3).

Holtz et al. demonstrated that the tonic

level of sympathetic vasoconstriction mediated by alpha receptors was
removed by regional denervation with 6-hydroxy dopamine (16).
Our hypothesis was that removal of alpha receptor mediated vasoconstriction in the ischemic zone, would enhance delivery of blood flow
from the normal zone, via a 'reverse coronary steal'.

Different tech-

niques for denervation have been used, ganglionectomy (5), autotransplantation (29), chemical sympathectomy with 6-hydroxy dopamine (16), and
intrapericardial denervation (23).
cardiac denervation.

Most of these studies utilized total

The intrapericardial denervation technique,

autotransplantation and mediastinal neural ablation interrupt parasympathetic as well as sympathetic input.

The disadvantages of these tech-

niques are the inability to localize denervation and use the normally
innervated region as control.

Recently the use of topical phenol has

been used to facilitate the selective sympathetic denervation of the
heart (2).

This technique was originally utilized for mapping of

sympathetic distribution of the left ventricle (12,22).

We combined the

technique of isolation and severing of the ventrolateral cardiac nerve,
which innervates the posterior left ventricle with application of topical
phenol to denervate the posterior wall.
The second aim of this study was to determine whether sectioning of
the VLCN as well as application of phenol in a ring circumscribing the
posterior wall would eliminate sympathetic fibers which exert vasomotor
control.
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B. METHODS
1. General Preparation
Mongrel dogs of either sex were premedicated with morphine sulfate
(2.5 mg/kg, s.c.) or xylazine (2 mg/kg, s.c.) approximately 15-20 minutes
before being given alpha-chloralose (50-100 mg/kg, i.v.).

A polyethylene

catheter (PE-260 tubing) was placed in the right femoral artery and
connected to a Statham P23dB pressure transducer for continuous monitoring of arterial blood pressure.

The right femoral vein was catheterized

with PE-260 tubing for fluid and drug administration.

The trachea was

cannulated with a glass Y-tube which was connected to a Harvard respirator. Each dog was ventilated with room air at a positive end-expiratory
pressure of 5 cm of water.
ered.

Both cervical vagi were isolated and sev-

Succinylcholine (20 mg, i.v.) was administered as a muscle

relaxant.

The chest was opened in the 4th left intercostal space.

Both

the right and left ansae subclavia of the stellate ganglia were isolated
and stimulated (7-10 Hz, 5 msec, 5-7 V) using bipolar stainless steel
electrodes.

Square wave pulses were delivered by a Frederick Haer

stimulator and monitored on a calibrated oscilloscope. During stimulation, changes in the heart rate, and Lead II electrocardiogram, specifically the P-R interval and T-wave configuration confirmed that both the
anterior and posterior limbs of the right and left ansae subclavia had
been dissected out (11,31).

Cutting of the right and left ansae subcla-

via, along with section of the cervical vagus, completed neural decentralization of the heart to prevent any reflexes from arising following
coronary artery occlusion, and to insure against afferent stimulation of
the cardiac nerves.

The pericardium was incised and sutured to the walls
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of the chest to form a pericardia! cradle.

No more than .5 cm of the

circumflex artery (CX) was isolated distal to the first marginal branch.
Blood gases and pH were monitored throughout the experiment and maintained within normal limits (pH 7.38-7.45, p02 80-120 mm Hg, pC02 30-40
mm Hg, HC03 23-28 mm Hg) by adjusting the rate and/or volume of the
Harvard respirator, with infusions of sodium bicarbonate (20 mEq/ml),
when necessary, to maintain pH normal.

Core temperature, measured in the

thoracic cavity by a YSI probe, was kept between 37-39° C by means of a
heating pad beneath the dog, and an infrared heating lamp above the dog
when necessary.

Succinylcholine (20 mg, i.v.) and additional anesthetic

were administered as needed.

The heart was kept moist with sponge soaked

in saline, and plastic wrap was kept over the open chest to retain
moisture and heat.
Blockade by timolol (0.2 mg/kg, i.v.) was considered to be adequate
when stimulation of the left ansae subclavia produced no changes in heart
rate or the Lead II electrocardiogram.

Maintenance doses of timolol

(0.08 mg/kg/hr, i.v.) were given to insure blockade of beta-receptors
throughout the experiment.

Lidocaine was given if there was an increased

incidence of arrhythmias.

2. Regional Blood Flow Determination
Four of the following species of radioactive labeled microspheres
(15 m) were used in random order: Ce-141, Cr-51, Sr-85 or Ru-103, Sc-46,
Nb-95.

The spheres were suspended in a 5% dextran solution with 0.05%

Tween 80.

The vials containing the spheres were sonicated for at least

20 minutes prior to microsphere injection, and agitated in a vortex mixer
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immediately prior to use.

For 30 seconds before microsphere injection, a

reference blood sample was withdrawn from the femoral artery at a
constant rate, and reference blood withdrawal continued for at least 90
seconds following microsphere injection.

The withdrawal rate of the pump

was calibrated at the end of the experiment to determine the exact rate
of withdrawal.

Microspheres were injected into the left atrium via a

catheter over a period of 30-40 seconds and were flushed with 10 ml of
warm saline.

At the end of the experiment, the hearts were excised and

the circumflex artery injected distal to the site of occlusion with
Microfil to delineate the perfusion area of the circumflex artery.

The

hearts were fixed in formalin for 24-48 hours, after which samples of the
myocardium were cut from both the stained and unstained regions, weighed,
and placed in labeled plastic tubes.

The reference blood withdrawal

samples were also put into labeled plastic tubes, the syringes containing
the blood samples were rinsed with saline, and the rinse put into the
respective labeled counting tubes.

Heart and reference organ samples

were counted by a TM Analytic gamma counter (model 1185) and data were
processed by an APPLE computer.

Flows were calculated using standard

equations with corrections for interference coefficients and background
counts.

The equation used to calculate blood flows was: MBF- (Ct/TW) x

(RBW/Cb) x 100, where MBF - myocardial blood flow in ml/min per 100 gm,
Ct - tissue radioactivity in counts/min, TW - tissue sample weight in
grams, RBW - reference blood withdrawal rate in ml/min, and Cb - total
radioactivity in reference blood sample.
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3. Regional Denervation
Denervation of the posterior wall was accomplished by cutting the
ventrolateral cardiac nerve where it courses over the pulmonary veins,
and by stripping the adventitia of the pulmonary veins, cutting any small
nerves located in the vicinity of the ventrolateral cardiac nerve, using
a technique developed in this laboratory.

Regional denervation was

further insured by painting a thin ring of phenol around the perimeter of
the posterior wall distal to the site of circumflex isolation and
occlusion.

Use of the blunt end of a cotton swab ensured that phenol did

not spread into the anterior region.

Phenol was also applied to the

interventricular sulcus, along the fat of the atrioventricular groove,
and in the region of the original dissection of the ventrolateral cardiac
nerve.

Phenol has been shown to penetrate approximately .25 mm into the

epicardium thus destroying sympathetic fibers which travel superficially
before penetrating the myocardium to innervate deeper layers (2,22).

4. Experimental Protocol
a. Group 1 (Ctrl-Lss-PhnLss-CaoPhnLss):
The purpose of this group was to demonstrate that alpha-vasoconstriction in the posterior wall following beta blockade would be eliminated after regional denervation.
used in this study.

Figure 6-1 illustrates the protocols

In Group l (n-7), the first flow measurement was

made following beta-blockade with timolol, and served as control.
Stimulation of the left ansae subclavia

was begun (LSS:8 Hz, 5 msec, 5-7

V), and the second injection of microspheres was made during the period
of stimulation.

Following completion of the microsphere injection,
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FIGURE 6-1
PROTOCOLS USED IN GROUPS 1 AND 2
The abbreviations denote the following: Timolol: timolol was
administered before beginning the sequence of microsphere injections;
RMBF: regional myocardial blood flow determination; LSS: left ansae
subclavia stimulation. Phenol: posterior wall denervation with topical
phenol; CAO: circumflex artery occlusion.
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GROUP 1 (N=7)
TIMOLOL
ILSS
I
15"

ILSS

ILSS

15"

15"

I [

11

I
I
I
I
I
I

I PHENOL
.I

!CAO
I I
II
I

I

I

I

I

I

RMBF 1

RMBF 3

RMBF 2

RMBF 4

GROUP 2 (N=7)
ITIMOLOL
!CAO
I
15"

30"
1

30"

ICAO

ICAO

30"

ICAO

r

11

15"

I
I

ILSS

15"

ILSS

I

11

I

I

I
I
I

I
I

RMBF 1

15"

I
RMBF 2

IPHENOL

RMBF 3

RMBF 4

145
stimulation was terminated, and the posterior wall was denervated.

The

third flow measurement was then made during a second period of left ansae
subclavia stimulation (LSS-Phen).

After the third injection period was

completed, the stimulation was stopped, and the circumflex artery was
ligated at the point of isolation, distal to the first marginal branch.
After five minutes of coronary artery occlusion left stellate stimulation
was again initiated, and the fourth flow determination was made (CAO-LSSPhen).

b. Group 2 (CAO/CAO·LSS/CAO-Phn/CAO-LSS-Phn)
In Group 2 (n-8), it was our aim to demonstrate that alpha-mediated
vasoconstriction in the ischemic posterior wall would be eliminated
following application of phenol.
made in each dog.

Four blood flow determinations were

All animals received timolol (0.2 mg/kg) prior to

starting the regional blood flow determinations.
was done via the methods described above.

Regional denervation

The model for coronary artery

occlusion was a 7-8 minute occlusion with injection of the microspheres
after five minutes of CAO, followed by release of the occlusion and
reperfusion for thirty minutes.

The circumflex artery was occluded

distal to the first marginal branch using an atraumatic clamp.

Micro-

spheres were injected after five minutes of occlusion, and following
completion of the injection, the occlusion was released, so that total
occlusion time was between seven and eight minutes.
The four experimental conditions were: 1) a control blood flow
determination in which the circumflex artery was occluded for five
minutes (CAO), 2) during coronary artery occlusion and simultaneous
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stimulation of the left ansae subclavia (CAO-LSS) (LSS was begun immediately after the clamp was placed on the circumflex, and both the occlusion and the stimulation were stopped at the end of the injection
period), 3) During coronary artery occlusion following regional denervation with topical application of phenol (CAO-Phen),

and 4) During

coronary artery occlusion with stimulation of the left ansae subclavia
following the topical application of phenol (CAO-LSS-Phen).

5. Data Analysis
Flows were expressed in ml/min/100 gm.

Resistance was calculated

as the quotient of mean arterial pressure and regional blood flow
(MAP/MBF).

In Group 1 the percent change in flow from control was

calculated for each of the experimental protocols for both the endocardium and the epicardium.

In Group 2, blood flow during the first

coronary artery occlusion served as the control blood flow determination.
Percent changes in flow for the subsequent blood flow measurements in
Group 2 were expressed as change from the first flow determination.
Blood flows, resistance, percent change in blood flow, endo/epi ratios
and blood pressures during each of the experimental conditions were
analyzed separately.

Analysis of variance for repeated measures was used

to test for differences betveen interventions, and Tukey's test was
employed to isolate the differences within groups.
cance was reached at a p value of <0.05.

Statistical signifi-
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C.

RESULTS
1.

Group 1
a. Hemodynamic Data:

In the presence of beta blockade, blood pressure in Group 1 was
significantly elevated during LSS (160.3 ± 14.4) compared to control
(132.6 ± 9.06), LSS following phenol (LSS-Phen: 123.3 ± 10.2) and CAO-LSS
following phenol (CAO-LSS-Phen: 115.4 ± 8.73) (p<.001).

Heart rates

during each of the blood flow measurements were not significantly
different.
b. Blood Flow Data:
Table 6-1 lists the blood flow values for Group 1 (Ctrl/LSS/PhnLSS/CAO-Phn-LSS).

Blood flow during LSS was significantly elevated from

the other treatment groups in the anterior endocardium (p<.0001) and
anterior epicardium (p<.001).

In the posterior endocardium, blood flow

during LSS was significantly higher than Control, LSS-Phen, and CAO-LSSPhen (p<.0001).

Blood flow during LSS was significantly different from

control and CAO-LSS in the posterior epicardium (p<.0001).

Flow was not

significantly different during LSS and during LSS following phenol
application in the posterior epicardium.

Blood flow fell significantly

from Control and LSS following CAO in the posterior endocardium and
epicardium (p<.0001).
Percent changes in blood flow in Group l(Ctrl/LSS/Phn-LSS/CAO-PhnLSS) are shown in Figure 6-2.

Jn the anterior wall, the changes in flow

during LSS-Phen and CAO-LSS-Phen were significantly different from the
change in flow during LSS in the endocardium (top left panel p<.0001),
and in the epicardium (bottom left panel p<.002).

In the posterior
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TABLE 6-1
Regional blood flow values for Group 1 (n-7) in (ml/min/100 gm).
Data are listed as mean flow ± SEM. Flows are divided into anterior
and posterior wall blood flows, and for each region endocardial and
epicardial blood flows are listed. Blood flow values for each of the
interventions are listed. Control: blood flow during control conditions, with beta blockade; LSS: flow during left ansae subclavia
stimulation; Phenol-LSS: flow during LSS following posterior wall
denervation with topical phenol; CAO-Phenol-LSS: flow during LSS and
circumflex artery occlusion, following posterior wall denervation.
indicates a significant difference from control, "trindicates significant difference from LSS,
*indicates significant difference from LSSPhen and 'indicates significant difference from CAO-LSS-Phen
(p<.0001).

*

TABLE 6-1
REGIONAL MYOCARDIAL BLOOD FLOWS DURING PERMANENT
CORONARY OCCLUSION BEFORE AND AFTER REGIONAL DENERVATION (GROUP 1)
(ML/MIN 100 GM)
ANTERIOR WALL
ENDOCARDIUM
CONTROL

LSS

PHENOL-LSS

CAO-PHENOL-LSS

92.41 ± 7.33

118.18 ± 9.87**'

89.96 ± 8.81

79.43 ± 8.47

EPICARDIUH
71. 25 ± 4. 88

92.09 ± 8.7B**t

71.33 ± 6.37

63.58 ± 5.31

POSTERIOR WALL
ENDOCARDIUM
CONTROL

LSS

PHENOL-LSS

CAO-PHENOL-LSS

84.84 ± 6.38

118.35 ± 12.80**'

88.29 ± 8.10

14.88 ± 6. 18*

EPICARDIUM
62.75 ± 4.49
(

86.0l ± 7.4o*'

sig. diff. from control,
p<0.0001)

69.57 ± 5.43

sig.diff. from LSS,

20.45 ± 6.34*

sig.diff. from phenol-LSS,
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FIGURE 6-2
PERCENT CHANGE IN BLOOD FLOV FROM CONTROL DURING
PERMANENT OCCLUSION BEFORE AND AFTER REGIONAL DENERVATION
Percent change in blood flow from control for group 1 (n=7). Data
are shown as mean % ± SEM.
The top panel illustrates endocardial
flows for the anterior and posterior LV. The bottom of the graph are
the epicardial flows for the anterior and posterior LV. *indicates
significant difference from LSS (p<.0001), 1cindicates significant
difference from LSS-Phen (p<.0001). See Table 6-1 for a description of
the group labels.
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endocardium (top right panel), the percent change in flow during LSSPhen was significantly different from LSS (p<.0001).

In addition, the

percent change in flow during CAO-LSS-Phen was significantly different
from LSS and LSS-Phen (p<.0001).

In the posterior epicardium, the

percent change in flow during CAO-LSS-Phen was significantly lower than
LSS and LSS-Phen (p<.0001).

There were no differences between LSS, and

LSS-Phen in the posterior epicardium.
There were no significant differences in the endo/epi ratios of the
anterior wall in Group 1 (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS).

The endo/epi

ratio dropped significantly to 0.64 ± .10 in the posterior wall during
combined CAO-LSS following phenol application compared to values of 1.39

± .06, 1.42 ± .14 and 1.30 ± .08 during control, LSS and LSS following
phenol, respectively (p<.001).
groups.

There were no other differences between

There were no significant differences between groups in either

the anterior or posterior wall resistances.
In summary, in Group 1 (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS), LSS in the
presence of timolol increased blood pressure and blood flow to both the
anterior and posterior wall even in the presence of beta blockade.

These

increases in blood pressure and blood flow to both the anterior and
posterior left ventricle were eliminated by the regional denervation of
the posterior wall.

2. Group 2
a. Hemodynamic Data:
Blood pressure during CAO following phenol application (112.50 ±
6.27) and during combined CAO-LSS following phenol application (112.76 ±
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6.82) decreased significantly from CAO (132.88 ± 5.36) and CAO-LSS
(129.00 ± 6.83) (p<.0002).

There were no statistical differences between

blood pressure during CAO and combined CAO-LSS or between blood pressure
during either intervention following phenol application.

b. Blood Flow Data:
Blood flow values for Group 2 (CAO/CAO-LSS/CAO-Phn/CAO-LSS-Phn) are
listed in Table 6-2.

Rlood flow during CAO-Phen was significantly

decreased from CAO and CAO-LSS (p<.02) in the anterior endocardium.
There were no other significant differences between groups in the
anterior epicardium or in the posterior endocardium and epicardium.
Figure 6-3 depicts the data for Group 2 (CAO/CAO-LSS/CAO-Phn/CAOLSS-Phn).

The data are represented as percent change from initial blood

flow values during circumflex artery occlusion.

In the anterior endocar-

dium (top left panel), the change in blood flow during CAO-Phen was
significantly different from the change in blood flow during CAO-LSS and
CAO-LSS-Phen (p<.002).

CAO-LSS was also statistically different from the

change in flow during combined CAO-LSS-Phen (p<.002).

There were no

significant differences between groups in the anterior epicardium (bottom
left panel) or posterior endocardiUJ11 (top right panel).

In the posterior

epicardium (lower right panel), the percent change in blood flow during
CAO-LSS-Phen was significantly different from the percent change in blood
flow during CAO-Phen (p<.002).
There were no significant differences in the endo/epi ratios for
either the anterior or the posterior wall.

There were no significant

differences in calculated resistance for either the anterior or posterior

154

TABLE 6-2

Regional blood flow values (in ml/min/100 gm left ventricle) for
group 2 (n-7). Data are represented as mean± SEM.
CAO: blood flow
during circumflex artery occlusion; CAO-LSS: flow during CAO and left
ansae subclavia stimulation; CAO-Phenol: flow during CAO following
posterior wall denervation with topical phenol; CAO-LSS-Phenol: flow
during CAO and LSS following regional denervation with phenol.
indicates significant difference from blood flow during coronary artery
occlusion (CAO), tindicates significant difference from blood flow
during CAO-LSS (p<.0.02).

*

TABLE 6-2
REGIONAL MYOCARDIAL BLOOD FLOWS DURING REPETITIVE CORONARY ARTERY
OCCLUSION BEFORE AND AFTER REGIONAL DENERVATION
(GROUP 2)
ANTERIOR WALL
ENDOCARDIUM

CAO

CAO-LSS

CAO-PHENOL

CAO-LSS-PHENOL

97.84 ± 10.48

100.38 ± 9.81

81.29 ± 7.'Jo*'

91.72±8.87

EPICARDIUM
85.92 ± 10.14

91.48 ± 8.69

77 .38 ± 6 .54

87 .17 ± 9 .11

POSTERIOR WALL
ENDOCARDIUM
CAO

CAO-LSS

CAO-PHENOL

8.97 ± 2.87

9.28 ± 1.86

6. 89

± 1. 55

CAO-LSS-PHENOL
7.63 ± 1.82

EPICARDIUM
17.55 ± 4.54

17.45 ± 4.67

( *sig. diff. from control,

13.46 ± 2.68

16.20 ± 3.41

tsig. diff. from CAO-LSS, p<0.02)
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FIGURE 6-3
PERCENT CHANGE IN BLOOD FLOW FROM CONTROL CAO DURING REPETITIVE
CORONARY OCCLUSION BEFORE AND AFTER DENERVATION
GROUP 2 (CAO/CAO-LSS/CAO-PHEN/CAO-LSS-PHEN)
Percent change in blood flow from flow measured during coronary
artery occlusion alone. Data represent mean± SEM. (See Table 6-2 for
expl'!kation of group names). *indicates significant difference from
LSS, indicates significant difference from CAO-Phen (p<.002).
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endocardium or epicardiurn.The results from this second group indicate
that regional denervation of the posterior wall does not increase blood
flow to the ischemic area.
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D.

DISCUSSION
GROUP 1 (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS)
One of the aims of this study was to determine whether denervation

of the posterior left ventricle would increase blood flow to that region
by removing alpha vasoconstrictLon.

An interesting aspect of this study

was that blood flow to the anterior and posterior wall and systemic blood
pressure in Group 1 were signLfLcantly elevated from control during LSS
even after beta-adrenergic blockade with timolol.

This contradicts the

results of previous investigations in which sympathetic input during beta
blockade resulted in a decrease in blood flow (24).

Feigl observed that

during LSS following beta-blockade with propranolol, blood flow decreased
by 18% from control.

This decrease in blood flow was blocked by admini-

stration of phenoxybenzarnLne (9).

In a later study, Feigl demonstrated

that during a 90 second stimulation of the left stellate ganglion, blood
pressure and blood flow increased but coronary sinus oxygen tension
decreased from 19 to 15

Dllll Hg.

Following beta-receptor blockade with

propranolol, these changes were blunted and coronary sinus oxygen tension
fell from 17 to 11 mm Hg.

The administration of dibozane blocked the

sympathetically mediated increase in coronary vascular resistance and
decrease in coronary sinus oKygen tension (10).

Other studies have

demonstrated a similar response of coronary vascular resistance during
nervous stimulation following beta blockade (13).

In addition, coronary

artery vasoconstriction has been demonstrated during stimulation of alpha
receptors with methoxamine (27).
It should be emphasized that the duration of stimulation and the
time course of blood flov measurements in the present study differs from
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the studies cited above.

In Feigl's studies, stimulation of the left

stellate ganglion was of brief duration (90 seconds) (10), while in the
present study the left ansae subclavia were stimulated for five minutes.
Rinkema et al. injected microspheres immediately after beginning stellate
stimulation (24).

In addition, the stimulation of cardiac nerves is

different from the systemic injection of exogenous adrenergic agonists.
An investigation by Williams and Most reported that during brief stimulation of alpha receptors via a bolus dose of phenylephrine, vasoconstriction was elicited.

However, with prolonged stimulation of alpha

receptors, the constriction gradually disappeared, and flow returned to
baseline levels (28).

lt should be noted that the reduction in vessel

diameter reported by Vatner was maintained over a sustained injection of
methoxamine.

In that preparation, the heart was not decentralized, nor

had ganglionic blockade been administered (27).

Hence the possibility

exists that the vasoconstriction in Vatner's study was in part the result
of withdrawal of sympathetic tone in the face of sustained elevated
peripheral pressure.
Thus, alpha-mediated vasoconstriction may be of a transient nature,
whereas with longer periods of sympathetic stimulation, stimulation of
alpha receptors no longer evokes vasoconstriction.

There is evidence to

suggest that alpha receptors on the myocardium can contribute to metabolism (21).

Therefore the role of alpha-receptors on myocardial metabo-

lism and the indirect effects on blood flow need to be established.
The mechanism whereby blood pressure increased in Group 1 (Ctrl/LSS/PhnLSS/CAO-Phn-LSS) even
unclear.

thou~h

myoeardial beta-receptors were blocked in

It is possible in the present study that beta-blockade was
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incomplete.

However, changes in HR and the Lead II EKG were absent

during suprarnaximal left stellate ansae subclavia stimulation.

In

addition, we found that increasing the dose of timolol did not eliminate
the rise in arterial pressure during stimulation.
blood pressure was not mediated by beta receptors.

Thus, the increase ion
Alpha-1 receptors

have been localized to the myocardium (6,14), and Starke demonstrated
that phenylephrine which is fairly selective for alpha-1 receptors,
caused an increase in blood pressure which was not due to increased
norepinephrine release (26).

It is therefore possible that stimulation

of alpha receptors led to the increase in blood pressure.
We found in several animals, that the rise in arterial pressure was
eliminated only when the application of phenol was extended from the
point of the coronary sinus down the interventricular groove.
Randall et al. which

utili~ed

Studies by

the phenol denervation technique noted that

nearly all of the inotropic responses of the anterior wall were eliminated when a line of phenol vas extended along the A-V groove to the
coronary sinus.

However, they found that the rise in arterial pressure

elicited by LSS remained present even when phenol had been extended along
the base of the heart (22J.

In the present study, it seems as though a

few nerve fibers reach the anterior left ventricle via the interventricular sulcus.

The fact that flow was increased significantly in the

anterior wall during LSS and dropped following application of phenol to
the posterior wall suggests several possibilities.

First, the presence

of significant innervation of the anterior wall by the ventrolateral
cardiac nerve or other nerves.

Geis and Kaye found that fibers from the

left stellate ganglion reach the anterior left ventricle after entering
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the epicardial plexus along the A-V groove near the marginal artery.

The

origin of these fibers was believed to be in the ventrolateral cardiac
nerve (12).

Application of phenol decreased flow in Group 1 and dropped

the flow in Group 2 from control and LSS.

Thus phenol either interrupted

the fibers to the anterior and posterior wall, or it dropped function in
the posterior wall enough to affect the overall function of the heart and
drop blood pressure.

The second, more likely possibility is that since

resistance did not change significantly it appears that the changes in
flow were passive, and due merely to changes in blood pressure.

Finally,

it is also possible that LSS in some way can affect the capacitance of
the proximal aorta and alter the afterload of the heart via non betaadrenergic mechanisms or by alpha mediated increases in myocardial
contractility.
In Group 1 (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS) regional denervation
dropped blood flow to both the endocardium and epicardium of the anterior
and posterior wall.

Thus while regional denervation has been reported to

be beneficial to the heart during ischemia, it may not be due to release
of sympathetic tone as Holtz has suggested (16).

Rather, it is more

likely to be due to a drop in overall myocardial metabolism as was
originally suggested by Gregg et al.(15).

The results of this study

confirm previous findings of Chilian et al. (4) in which phenol did not
increase blood flow to the denervated region with intact sympathetics.
The discrepancy between the studies by Holtz et al. and Chilian et al. is
not easily reconciled, since the differences in results may be due
entirely to the mode of regional denervation employed in each study.

It

is reasonable to postulate that the changes in flow in the present study
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may have been due to the changes in pressure since an autoregulatory
response might not have been expected to occur within the time frame of
the blood flow measurement.

GROUP 2 (CAO/CAO-LSS/CAO-Phn/CAO-LSS-Phn)
In Group 2, LSS did not increase flow to the anterior wall compared
to control.

However, in that group of animals, occlusion of the blood

supply to the posterior wall was a confounding factor in interpreting
alterations in blood flow to the anterior wall.

Indeed, in another study

from this laboratory (Chapter V), LSS did not change flow significantly
from control although administration of prazosin did increase flow
significantly from control but not from flow during left stellate
stimulation.

It is possible that in the present study following occlu-

sion in the posterior wall, function was impaired enough to limit the
increase in blood pressure during LSS.

It is unlikely that the nerves to

the posterior wall were in some way impaired by the period of ischemia.
Phenol application to the posterior wall dropped blood pressure even
during stellate stimulation so that the nerves were in all probability
functioning during the previous bouts of ischemia, particularly the
nerves to the anterior wall which may have passed through the posterior
wall.

SUMMARY OF GROUPS 1 AND 2
In conclusion, this study did not find evidence in support of
sympathetically mediated vasoconstriction in an ischemic region which
could be eliminated by regional denervation.

We found no evidence to
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suggest that denervation of the ischemic zone would enhance blood flow to
that region by a 'reverse coronary steal' mechanism.

However, this study

did find that posterior left ventricular regional denervation did produce
a drop in blood pressure in Group 2 (CAO/CAO-LSS/CAO-Phn/CAO-LSS-Phn),
and a drop in blood flow to the anterior wall in Group 2 (CAO/CAOLSS/CAO-Phn/CAO-LSS-Phn) _

In Group l (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS), the

blood pressure and blood flow during left ansae subclavia stimulation in
the presence of beta blockade increased.

In this group, posterior wall

denervation eliminated the response to sympathetic stimulation.

However,

since there was no change in resistance, the increase in blood flow was
probably of a passive nature and reflected the rise in arterial pressure
during LSS.

The increase in blood pressure during LSS appears to non-

beta in origin, and might possibly be due to stimulation of myocardial
alpha receptors.

Furthermore, the drop in blood pressure following

application of phenol indicates several possibilities.

Either phenol

interrupted nervous transmission to the entire left ventricle by denervation of the posterior wall, or posterior wall application of phenol
caused an overall decrease in cardiac function and metabolism, thus
dropping blood pressure and blood flow.

16S
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CHAPTER VII
INFLUENCE OF THE CARDIAC NERVES ON
BLOOD FLOW TO THE CIRCUMFLEX BED

A.

INTRODUCTION
Since the early part of this century it has been well-documented

that coronary arteries can constrict in response to adrenergic agents
(31).

Brodie and Cullis postulated the existence of both vasoconstrictor

and vasodilator fibers to the coronary arteries (1).

Studies undertaken

by Randall et al. investigated the cardiac nerve distribution to the
heart and its functional importance (22), thus extending earlier anatomic
studies on the pathways of autonomic nerves to the heart (18,19).

The

studies by Randall et al. involved mapping the distribution of nerves to
the left and right ventricles and atria.

However, in those studies, and

others from the same Laboratory, the investigations concentrated primarily on the chronotropic and inotropic effects of sympathetic stimulation,
and did not address the specific innervation of coronary arteries (7).
In addition, due to technical limitations, innervation of the posterior
wall was not as well defined as the anterior wall.

Thus, it was not

known whether each of the major cardiac sympathetic nerves exerted
discrete control over specific coronary arteries as well as having
localized influence on ventricular function.

Other studies which have

investigated cardiac syn.pathetic effects on blood flow have stimulated
either the stellate ganglia (29) or thoracic roots (8) and not specific
cardiac nerves, to investigate the regional distribution of blood flow in
168
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response to nerve stimulation.
Although under normal conditions, local control of blood flow
predominates, it is also of interest to determine whether the cardiac
accelerator nerves supplying local left ventricular regions also carry
fibers to the coronary arteries, and which type of nerve fiber has
greater influence on coronary blood flow during myocardial ischemia.

By

blocking beta receptors, it is possible to determine direct innervation
of the circumflex artery due to vasoconstrictor effects.

Thus one aim of

this study was to determine the specific neural control of blood flow
through the circumflex artery.
The vasoconstrictor actions of nerve stimulation on coronary blood
flow are well established in both experimental (5) and clinical situations (13).

It is believed that the sympathetic nervous system exerts a

tonic level of vasoconstriction (11,27) and that even under conditions of
increased metabolic activity (19,20), alpha-receptors can limit increases
in blood flow.

Most previous studies did not differentiate between

alpha-1 and alpha-2 receptors (5,30).

However, results from some recent

studies suggests that not only do pre-junctional alpha receptors modulate
coronary vasoconstriction by exerting influences on norepinephrine
release (10), but that post·junctional alpha-2 receptors also modulate
coronary blood flow

(4.12,2~).

The second goal of this investigation was

to determine whether alpha vasoconstriction reported in previous studies
is mediated primarily by alpha-1 or alpha-2 receptors or whether both
receptor subtypes exert equivalent influences on restricting coronary
flow.
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B.

METHODS
1. General Preparation
Mongrel dogs of either sex were premedicated with morphine sulfate

(2.5 mg/kg, s.c.) or xyla2ine (2 mg/kg, s.c.) approximately 15-20 minutes
before being given alpha-chloralose (100 mg/kg, IV).

A polyethylene

catheter (PE-260 tubing) was placed in the right femoral artery and
connected to a Statham P23dB pressure transducer for continuous monitoring of arterial blood pressure.

The right femoral vein was cathe-

terized with PE-260 tubing for fluid and drug administration.

The

trachea was cannulated with a glass Y-tube which was connected to a
Harvard respirator.

Each dog was ventilated with room air at a positive

end-expiratory pressure of 5 cm of water.
isolated and severed.

Both cervical vagi were

The left carotid artery was cannulated with

surgical grade Tygon tubing.

This served as one limb of the extracor-

poreal shunt delivering blood to the circumflex artery, distal to the
site of occlusion.
muscle relaxant.
space.

SuccLnylcholine (20 mg, IV) was administered as a
The chest vas opened in the fourth left intercostal

Both the right and left ansae subclavia of the stellate ganglia

were isolated and stimulated (7-10 Hz, 5 msec, 5-7 V) using bipolar
stainless steel electrodes.

The three major left side cardiac sympathe-

tic nerves were isolated, (Ventrolateral, ventromedial, innominate) in
addition to the left anterior (.AAS) and posterior ansa subclavia (PAS).
Square wave pulses (8

H~.

5 rnsec, 5-7 V) were delivered by a Frederick

Haer Pulsar 4i constant voltage stimulator, and voltage and frequency of
the delivered pulse were monitored throughout the experiment on a
Tektronix T922R calibrated oscilloscope.

Changes in the heart rate, and
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Lead II electrocardiogram, specifically the P-R interval and T-wave
configuration during stimulation of the left and right stellate ganglia
confirmed that both the anterior and posterior limbs of the right and
left ansae subclavia had been dissected out (6,33).

The right and left

ansae subclavia were cut distal to the stellate ganglia, and both
cervical vagi were cut, thus completing neural decentralization of the
heart and insuring against afferent stimulation of the cardiac nerves.
The pericardium was incised and sutured to the walls of the chest to form
a pericardial cradle.
A catheter was placed in the left atrium for measurement of left
atrial pressure.

A Konigsberg high fidelity pressure transducer (P-22)

was inserted into the left ventricular chamber via a stab wound in the
apex, and tied securely in place with purse string sutures.

The Konigs-

berg transducer was cross-calibrated with the systolic pressure of the
thoracic aorta, and the diastolic pressure recorded from the left atrium.
The left ventricular pressure signal was differentiated and recorded
throughout the experiment.

End diastole was determined as the start of

the positive slope of the LV dP/dt signal (See Figure 7-1).

All measure-

ments in this series of experiments were recorded on an 8-channel Gould
recorder with a frequency response of 125 Hz ± 1 div; 10 div @ 10 mm.
Calculation of resistance was determined as the quotient of the pressure
gradient between the aorta and the left ventricle at end-diastole, and
coronary blood flow at end diastole.
The circumflex artery

~as

Lsolated close to its origin, ligated

with a piece of 2-0 silk. and a piece of adult feeding tubing (8-F) was
inserted into the artery. and tied securely in place.

The circumflex
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FIGUltE 7-1

REPRESENTATIVE TRACING OF MEASURED VARIABLES
DURING CONTROL CONDITIONS PRIOR TO CARDIAC
SYMPATHETIC NERVE STIMULATION
A representative tracing of hemodynamic recordings during a
control run. The heavy black line at the arrows, shows where the
actual measurements were taken for calculation of blood flow and
resistance. EKG: Lead II electrocardiogram; CX FLOW: circumflex blood
flow; ART P: arterial pressure; .MEAN CX FLOW: mean circumflex blood
flow; LV dP/dt: first derivative of left ventricular pressure; LAP:
left atrial pressure, LVP: left -ventricular pressure.
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artery was perfused with blood from the carotid artery which was cannulated with surgical grade Tygon tubing.

The blood from the carotid artery

flowed through an In Vivo extracorporeal flow probe and was measured on a
Carolina square wave electromagnetic analog flowmeter.

A T-tube was

connected to the extra-corporeal shunt and the side arm was used to
facilitate flushing of the shunt system with heparinized saline, which
was necessitated at frequent intervals to prevent the formation of clots.
Prior to insertion of the shunt, the dog was heparinized with 200 units
of heparin and the Tygon tubing was soaked in heparinized saline.

The

flowmeter was periodically calLbrated by running saline through the flow
probe at known rates via a Harvard perfusion pump.
adjusted accordingly.

The probe factor was

Flow was zeroed electrically and mechanically at

the beginning of each set of nerve stimulations by clamping the tubing
distal to extracorporeal flow probe.
Blood gases and pH were monitored throughout the experiment and
maintained within normal lLrnLts (pH 7.38-7.45, p02 80-120 mm Hg, pC02
30-40 mm Hg, HC03 23-28 mm Hg) by adjusting the rate and/or volume of the
Harvard respirator, with infusLons of sodium bicarbonate (20 meq/ml),
when necessary, to maintain pH normal.

Core temperature, measured in the

thoracic cavity by a YSl probe, vas kept between 37-39 C by means of a
0

heating pad beneath the dog, and an infrared heating lamp above the dog
when necessary.

Succinylcholine (10 mg, IV) and additional anesthetic

were administered as needed.

The heart was kept moist with sponge soaked

in saline, and plastic wrap vas kept over the open chest to retain
moisture and heat.

LidocaLne was adrnLnLstered intravenously if the heart

became arrhythmic, particularly durLng clamping of the circumflex artery
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and insertion of the shunt.

2. Adrenergic Receptor

~lockers

The adrenergic blockers used in this study are listed in Table 71.

Blockade by timolol (0.2 mg/kg, IV) was considered to be adequate

when stimulation of the left ansae subclavia produced no changes in the
Lead II electrocardiogram.

Maintenance doses of timolol (0.08 mg/kg/hr,

IV) were given to insure blockade of B-receptors throughout the experiment.

Alpha-1 blockade was achieved with prazosin hydrochloride (0.5

mg/kg, IV), a dose which was sufficient to attenuate the rise in arterial
pressure elicited by a 5 g/kg dose of phenylephrine (17).

Phenylephrine

was chosen to test the efficacy of alpha-1 blockade since it was considered to exert its agonist effects preferentially on post-junctional or
alpha-1 receptors.

Rauwolscine (0.3 mg/kg, IV) was considered to be a

reasonably pure alpha-2 blocking agent (14).
challenged by 5-10 g/kg dose of
challenged in each dog.

~HT-920.

Blockade by rauwolscine was

The adequacy of blockade was

Atropine was administered prior to recordings of

nerve stimulation, to prevent the stimulation of muscarinic receptors
during stimulation of the cardiac sympathetic nerves.

3. Experimental Protocol
Figure 7-2 shows in diagram form the protocols used in this study.
This study was comprised of four different protocols for investigation of
the role of alpha receptors during cardiac sympathetic nerve stimulation.
Stimulation of the cardiac nerYes was carried out under four separate
experimental conditions, all of which were done in the presence of
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TABLE 7-1
ADRENERGIC AND CHOLINERGIC AGONISTS AND
ANTAGONISTS USED DURING CARDIAC
SYMPATHETIC NERVE STIMULATION
SYMPATHETIC AGENT

SITE OF ACTION

DOSE USED

Timolol

B-l,B-2 Blockade

Prazosin

alpha-1 blockade

0.2 mg/kg,LD,
0.8mg/kg/h,MD
0.5 mg/kg

Rauwolscine

alpha-2 blockade

0.3 mg/kg

Phenylephrine

alpha-1 stimulant

5

BHT-920

alpba-2 stimulant

5-10

muscarinic blockade

0.2 mg/kg

g/kg
g/kg

PARASYMPATHETIC AGENT
Atropine
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FIGURE 7-2
PROTOCOLS US~D FOR GROUPS 1 AND 2 DURING
CARDIAC NERVE STIMULATION
GROUP 1 (N=7)

c
A

p

VL VM l

T
A

p

I
VL VM I

p
A

p

VL VM I
I

I

R
A

p

VL VM I

GROUP 2 (N=7)

c
A

p

I
VL VM l

T
A

I
p

I
I
\JL VM I

R
A

p

VL VM I

p

A

I
p

I

I

VL VM I

Protocols for Groups 1 and 2. C: Control conditions of no adrenergic
blockade; T: Stimulations done during £-blockade with timolol; P:
stimulations done during slpha-1 blockade with prazosin; R: stimulations
done during alpha-2 blockade with rauwolscine. A: Anterior ansa
subclavia stimulation; P: posterior ansa subclavia stimulation; VL:
ventrolateral cardiac nerve stimulation; VM: ventromedial cardiac nerve
stimulation; I: innominate card[ac nerve stimulation.
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atropine (0.3 mg/kg, I.V.) with hemodynamic responses recorded before,
during and after each nerve stimulation, at a paper speed of 100 mm/sec.
1) nerve stimulations were carried out under control conditions in which
there was no adrenergic blockade, 2) during &-blockade with timolol, 3)
during alpha-1 blockade with prazosin, and 4) during alpha-2 blockade
with rauwolscine.

The sequence of adrenergic blockade was randomized.

The adrenergic blocking agents used were not administered independently
of one another but were added in combination to the previous drug.
In Group 1 (n=7) the order of adrenergic blockade was 1) no
blockade (Control); 2) Iimolol, 3) Prazosin, 4) Rauwolscine.

In Group 2

(n-7) the order of the blockade was 1) no blockade, 2) Timolol, 3)
Rauwolscine, 4) Prazosin.

Ihe purpose of the first two groups was to

determine which of the five isolated cardiac nerves caused significant
vasoconstriction in the presence of beta blockade, and to determine
whether alpha-1 blockade or alpha-2 blockade would reverse the vasoconstriction thus elicited.
In Group 3 (n=S) the order of blockade was 1) Control, 2) Prazosin,
3) Rauwolscine and 4) Timolol.

In Group 4 (n=S) the order of the alpha

blocking agents was reversed: l) Control, 2) Rauwolscine 3) Prazosin and
4) Timolol.

The reason for these last two protocols was to determine

whether the order of alpha blockade resulted in any significant differences in blood flow and resistance, and whether either alpha-1 or alpha-2
receptor blockade caused a

lar~er

restricting influence on &-receptor

metabolically mediated increases in blood flow.
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4. Data Analysis

All measurements were read from a fast tracing (100 mm/sec).

Flow

was measured at end diastole which was taken at the point of the beginning of the positive slope of the dP/dt signal (Figure 7-1).

Resistance

was calculated as the difference between end diastolic arterial pressure
and end diastolic left ventricular pressure, divided by the end diastolic
circumflex flow.

The difference between prestimulation baseline flow

values and the flow response to nerve stimulation in each dog was used in
the analysis of data (delta).

The percent change in flow during nerve

stimulation for each dog was also used in the analysis of data, and was
also based on prestimulation flow and flow during nerve stimulation.

The

delta and percent change for each nerve (AAS, PAS, VLCN, VMCN, ICN) were
analyzed independently of one another.

Analysis of variance was used to

determine whether there vere significant differences between any of the
treatment groups (Control, Timolol, Prazosin, Rauwolscine), and Tukey's
test was used to isolate the differences at a p value of 0.05.
procedure was followed for Groups 1 through 4.

This

180
C.

RESULTS
1. Group One
In each group of dogs, all five of the major left side cardiac

nerves were stimulated and the responses to stimulation recorded and
subjected to statistical analysis.

The data for VMCN and ICN are not

included, as these nerves had no major vasoconstrictor action following
adminstration of timolol.
The blood flow values during control and during stimulation of the
AAS, PAS and VLCN are shovn in Table 7-2.

The changes from resting

levels are listed during each of the drug administrations.

Stimulation

of the AAS following timolol and prazosin resulted in a significantly
smaller change in blood flov compared to control stimulation of the AAS
(p<0.025).

Stimulation of the PAS following timolol, prazosin and

rauwolscine all

resulted in significantly smaller changes in blood flow

compared to control (p<0.01).

There were no significant differences

between different groups during stimulation of the VLCN in Group 1.
Figure 7·3 illustrates the percent change in blood flow during
stimulation of the AAS, FAS, and VLCN in each of the control conditions
and following the adrninstration of the adrenergic blocking agents.

In

Group 1 during stimulation of the AAS (top left panel), the change in
flow following timolol vas significantly lower than control (p<0.02).
The change in flow following prazosin remained significantly lower than
control (p<0.02).

Following adrn.LnLstration of rauwolscine, the percent

change in flow was no longer significantly different from control.
During stimulation of the PAS (middle left panel), the change in flow
following timolol and subsequent alpha blockade were significantly lower

181

TAl'>LE 7-2
Blood flow data in ml/min for Group l (n-7). Data are listed as
mean± SEM. Shown are the data for prestimulation baseline flow value,
response to stimulation of each of the three major nerves studied, and
the change in blood flow from prestimulation blood flow (delta).
Results are shown for nerve stimulation during each of the stimulation
protocols, 1) Control: during control (conditions of no adrenergic
blockade), 2) Timolol: following beta-blockade, 3) Prazosin: following
prazosin (alpha-1 blockade) and ~) Rauvolscine: following rauwolscine
(alpha-2 blockade). All significant changes shown are differences from
control response (no adrenergic blockade) to nerve stimulation.
indicates p<0.02, 'trindicates p<0.01.

*
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TABLE 7-2
CIRCUMFLEX ARTERY £LOOD FLOW DURING STIMUI.ATION OF
THE CARDIAC SYMPATHETIC NERVES IN GROUP 1

-------------------------------------------------------GROUP 1

llASELINE

AAS

DELTA

CONTROL

46. 66 ± 2.75

57.04

± 5.05 10.37 ± 5.89

TIMOLOL

42. 69 ± 3.47

39.06

± 3.94 -3.63 ± 0.61*

PRAZOSIN

3/a.. la.O ± 5.88

30.63

± 5.87

-3.78

RAUWOLS_CINE

37. 86 ± 6.09

39.52

± 5.66

1.67

± 1.23*
± 1. 51

--------------------------------------------------------llASELINE

PAS

DELTA

CONTROL

45. 3J ± 3.28

53.95 ± 4.9

12.87 ± 4. 72

TIMOLOL

41. 91 :!: 3.39

42. 90 ± 4.13

1.00 ± 1.84*

PRAZOSIN

33. 01 :!: 5.41

31.65 ± 5.49

0.07 ± 1.31*

RAUWOLSCINE

36.47

36. 36 ± 5.56

± 5.62

-0.11 ± 0.58

*

-------------------------------------------------------BASELINE

VLCN

DELTA

CONTROL

49. 91 ± 3 .62

TIMOLOL

40 ' 76

± 1 . 6 9 38.62 ± 2.67 -2.14 ± 2.03

PRAZOSIN

:n. s1

± 5.45

29.81 ± 5.55

-2.58 ± 1.19

RAUWOLSCINE

35. la.9 ± 5.80

35.53 ± 5.40

0. 04 ± 1.15

54.87 ± 5.15

4.96 ± 4.82
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FIGURE 7-3
PERCENT CHANGE IN BLOOD FLOW DURING CARDIAC NERVE
STIMULATION FOR GROUPS 1 AND 2
Percent change in blood fLov (mean ± SEM) from prestimulation
baseline flow for Groups 1 and l during stimulation of the AAS, PAS,
and VLCN.
All significant changes shown are significant differences
from the percent change during control conditions of no adrenergic
blockade. Group 1 (n-7) ( !locking order: Control, timolol, prazosin,
rauwolscine) is depicted on the left. Group 2 (n=7) (Blocking order:
Control, timolol, rauwolscine, prazosin) is depicted on the right.*
indicates p<0.05, *indicates p<~.02.
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than control (p<0.02).

No significant changes were evident during VLCN

stimulation in Group 1 (bottom left panel).
Table 7-3 lists the values of resistance before and during stimulation of the AAS, PAS, and VLCN and the change in resistance for Group 1.
During stimulation of the AAS resistance did not change significantly
following either 8- or alpha blockade.

During stimulation of the PAS

resistance was significantly lower following timolol and combined timolol
and prazosin compared to control (p<0.005).

There were no significant

differences between treatments during VLCN stimulation in Group 1.
Figure 7-4 illustrates the
levels.

~

change in resistance from resting

During AAS (top left panel), the change in resistance was

significantly higher during timolol and timolol and prazosin (p<0.01).
Following alpha-2 blockade with rauwolscine, the change in

resis~ance

was

no longer statistically different from control.
During stimulation of the PAS (middle left panel), the change in
resistance was significantly higher during beta blockade and combined
alpha-1 and beta blockade, from control (p<0.002).

Administration of

rauwolscine resulted in a change in resistance which was no longer
significantly different from control.
During VLCN stimulation (bottom left panel) with combined alpha and
beta blockade, the resistance vas significantly higher than control
(p<0.05).

Note that tirnalol ad.ministration did result in significant

increases in resistance during VLCN stimulation.
the response to VLCN toward control levels.

Rauwolscine returned
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TABLE 7-3

Calculated resistances (in llllD. Hg/ml/min) for Group 1 (n=7).
Shown are the data (mean ± SEM) for the prestimulation baseline
resistances, response to stimulation of each of the three major nerves,
and the change in resistance from prestlmulation values (delta).
Results are shown for response to nerve stimulation during each of the
stimulation protocols used. All signiflcant changes shown are
differences from control response (no adrenergic blockade) to nerve
stimulation.
*indicates p<0.005.
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TABLE 7-3
CALCULATED RESISTANCE OF THE CIRCUMFLEX ARTERY
DURING CARDIAC NERVE STIMULATION FOR GROUP 1
GROUP 1

BASELINE

CONTROL

2.57 ± 0.21

2.20

TIMOLOL

2.78 ± 0.28

3.23 ± 0.42

0.44 ± 0.18

PRAZOSIN

3.05 ± 0.84

3.92 ± 1.35

0.87

RAUWOLSCINE

2.06

±

1.95 ± 0.27

0.42

:BASELINE

±

DELTA

AAS

±

0.24

PAS

-0.37

±

0.16

± 0.53

-0.12 ± 0.17

DELTA

CONTROL

2.55

0.23

2.25

±

0.18

TIMOLOL

2.E6 ± 0.29

3.12

±

0.32

0.26

±

0.16*

PRAZOSIN

2.95

±

3.36

±

o.83

o.40

±

o.1s*

RAUWOLSCINE

2.27 ± 0.44

o.74

-0.31 ± 0.17

2.27 ± 0.42

0.00 ± 0.03

VLCN

DELTA
-0.18 ± 0.12

:BASELINE
CONTROL

2 .39

±

0.21

2. 20

±

0. 20

TIMOLOL

2. 96

±

0. 22

3.19

±

0.30

0.24

±

0.18

PRAZOSIN

2 .98

±

0. 63

3.48

±

0.80

0.50

±

0.18

RAUWOLSCINE

2. fi 5

± 0. 82

2.33

±

0.43

-0.32 ± 0.42

------------·----------------------------------------
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FIGURE 7-4
PERCENT CHANGE IN CALCUI.ATED RESISTANCE DURING CARDIAC
NERVE STIMULA.IION FOR GROUPS 1 AND 2
Depicted are the percent changes in resistance from prestimulation baseline resistance (mean ± SEK) during stimulation of the AAS
(top panel), PAS (Middle panel) and VLCN (bottom panel) for Group 1
(n-7) (left side of graph) and Group 2 (n-7) (right side of graph). *P
less than .05, *p less than .01. "ffp less than .002 and (jp less than
.005. All changes shown are in comparison to percent change during
control conditions of no adrenergic blockade.
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2. Group Two
The blood flow values for Group 2 during control and during
stimulation of the AAS, PAS and VLCN are shown in Table 7-4.

The changes

from baseline levels are listed during each of the drug administrations.
Stimulation of the AAS following timolol and combined timolol and
rauwolscine resulted in a significantly smaller change in blood flow
compared to control stimulation of the AAS (p<0.01).
changes between groups during stimulation of the PAS.

There were no
During stimulation

of the VLCN, flow changes were significantly reduced (p<0.005) following
timolol and after rauwolscine.

After prazosin, the changes during nerve

stimulation were not significantly different from control.

Figure 7-3

illustrates the percent change in blood flow during stimulation of the
AAS, PAS, and VLCN in each of the control conditions and following the
adminstration of the adrenergic blocking agents.

In Group 2 during

stimulation of the AAS (top right panel, Fig. 7-3), the change in flow
following timolol was significantly lower than control (p<0.05).

The

change in flow following rauwolscine was not significantly different from
control.

During PAS (middle right panel of Fig. 7-3), there were no

changes in flow following timolol and subsequent alpha blockade.

During

stimulation of the VLCN {bottom right panel, Fig 7-3), after timolol the
percent change in flow was significantly different from control (p<0.02).
After rauwolscine the percent change was no longer different from
control.

Thus, Figure 7-3 illustrates that stimulation of each of the

major cardiac nerves in the presence of &-blockade causes a significant
vasoconstriction compared to the change in flow when no &-blocking agent
was given.

Administration of alpha·l blockade in addition to &-blockade

f

r
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TARLE 7-4
Blood flows (m/min) for Group 2 (n-7) (Blocking order: control,
timolol, rauwolscine, prazosin). Shown are the values of blood flow
before and during stimulation of the AAS, PAS, and VLCN. Delta is the
change from prestimulation flow during each of the interventions.
Statistical comparisons were made between interventions. Data are
shown as mean± SEM. *Pless ~ban .01, compared to control response.
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TABLE 7-4
CIRCUMFLEX ARTERY BLOOD FLOW DURING STIMULATION OF
THE CARDIAC SYMPATHETIC NERVES IN GROUP 2
GROUP 2

BASELINE

CONTROL

36.16 ± 5.14

47.28 ± 5.65

11.11 ± 5.57

TIMOLOL

34.94 ± 4.01

29.85 ± 3.42

-5.20 ± 1.29

RAUWOLSCINE 39.57 ± 3.25

37.92 ± 2.61

-1.66 ± 1.29*

24.29 ± 2.90

25.89 ± 2.77

1.61 ± 2.33

BASELINE

PAS

PRAZOSIN

AAS

DELTA

*

DELTA

CONTROL

36.04 ± 6.23

38.82 ± 6.18

2.78 ± 1.66

TIMOLOL

33.54 ± 3.48

32.05 ± 3.18

-1.49 ± 1.21

RAUWOLSCINE 33.7S ± 2.51

38.24 ± 4.26

4.49 ± 3.09

25.21 ± 4.53

25.18 ± 3.88

-0.03 ± 0.94

PRAZOSIN

.RA SELINE
CONTROL

36.58 ± 4.77

TIMOLOL

34.04

VLCN

DELTA

40.83 ± 4.25

4.25 ± 2.12

± 4.39 29.12 ± 3.93

-4. 92 ± 1.13

*

RAUWOLSCINE l4.40 ± 2.29

32.42 ± 2.74

-1.97 ± 1.76*

22.05 ± 3.00

22.32 ± 2.86

0.27 ± 0.82

PRAZOSIN
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did not alter the vasoconstriction.

However, alpha-2 blockade in

addition to alpha-1 blockade or even prior to administration of alpha-1
blockade returned blood flow values toward control.
Table 7-5 lists the values of resistance before and during stimulation of the AAS, PAS, and VLCN and the change in resistance (delta).
During stimulation of the AAS resistance changed significantly following
timolol and remained lower even after both alpha-1 and alpha-2 blockade
(p<0.002).

During stimulation of the PAS resistance did not change

significantly.

During VLCN stimulation, the change in resistance was

significantly increased during timolol (p<0.01) but decreased after
alpha-2 blockade so that resistance was no longer significantly different
from control.
The right hand side of Figure 7-4 illustrates the percent change in
resistance for Group 2.

During AAS stimulation (Top right panel), the

change in resistance was significantly higher during tirnolol, rauwolscine
and prazosin (p<0.002).

There vere no changes in resistance during

stimulation of the PAS (m.iddle right panel).

Timolol produced increased

resistance from control during stimulation of the VLCN, p<.005, (bottom
right panel), but following rauvolscine, the resistance decreased back
toward control.
In summary, A-blockade during cardiac sympathetic stimulation
resulted in increases in coronary resistance which were not affected by
the addition of alpha-1 blockade.

Alpha-2 blockade resulted in reduc-

tions in resistance to levels comparable to control conditions of no
adrenergic blockade.

Resistance did not return to control levels

following alpha-1 blockade in combination with &-blockade.
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TA:&LE 7-5

Resistances (mm Hg/ml/min) for Group 2 (n-7) during stimulation
of the AAS, PAS, and VLCN. Delta is the change from baseline resistance during nerve stimulation. All statistical comparisons are based
on the control response to nerve stimulation. Data are listed as mean
1 indicates p<.01.
± SEM. *indicates p<.002,
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TABLE 7-5
CALCUI.ATED RESISTANCE OF THE CIRCUMFLEX ARTERY
DURING CARDIAC NERVE STIMUI.ATION FOR GROUP 2

------------------------------------------------------GROUP 2

:SASELINE

AAS

DELTA

-0.87 ± 0.35

CONTROL

3.21

± 0.31

2.35 ± 0.22

TIMOLOL

3.30

± 0.33

3.93 ± 0.34

0.63 ± 0.15 *

RAUWOLSCINE

3.14

± 0.27

3.42 ± 0.19

0.27 ± 0.16*

PRAZOSIN

z.ss ± 0.35

2.97 ± 0.53

0.12 ± 0.24*

-----------------------------------------------------.BASELINE

PAS

DELTA

± 0.33 2.97 ± 0.27

-0.22 ± 0.17

3.LtB ± 0.29

3.58 ± 0.21

0.10 ± 0.20

RAUWOLSCINE

3.78 ± 0.26

3.37 ± 0.19

-0.33 ± 0.20

PRAZOSIN

2.96

±

2.86 ± 0.49

-0.10 ± 0.13

CONTROL

3. 19

TIMOLOL

0.58

----------------------------------------------------BASELINE

VLCN

DELTA

CONTROL

3.09 ± 0.28

2.82 ± 0.31

-0.27 ± 0.14

TIMOLOL

3.4l ± 0.33

3.97

± 0.38

o. 54 ± o. nt

RAUWOLSCINE

3.56±0.17

3.74

± 0.12

0.18 ± 0.15

PRAZOSIN

3. ll ± 0.S6

3.14

± 0.47

0.02 ± 0.16
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In Groups 3 and 4, the sequence of adminstration of prazosin and
rauwolscine did not result in differences in the change in flow with and
of the major nerves.

Combined alpha-1 and alpha-2 blockade did not alter

the response to nerve stimulation significantly from the control response, regardless of which agent was administered first.
Comparison of the prestimulation flow values for Groups 1 through 4
with analysis of variance, determined that there were no significant
differences for prestimulation flow values between groups.
In summary in Groups 1 and 2, the nerves which have a significant
influence on circumflex blood flow are the AAS, PAS, and the VLCN.

These

nerves had not previously been shown to specifically cause vasoconstriction of the circumflex artery.

These nerves can cause significant

reductions in blood flow and increases in resistance during beta blockade.

The mechanism of this vasoconstrictor action appears to be alpha

mediated.

l'.I

I''\1.

I
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DISCUSSION
The aims in this study were to determine which of the major left

side cardiac nerves influence circumflex blood flow, whether they can
11

elicit significant vasoconstriction when stimulated separately in the

1

11

presence of beta blockade, and whether the vasoconstriction is alpha-1 or
alpha-2 mediated.
~

al. addressed the question of specific neural

innervation of the heart (22).

They stimulated cardiac nerves and

recorded the changes in contractile force measured by Walton-Brodie
In this way the patterns of sympathetic distribu-

tion to the heart were determined.

The ICN increased the contractile

force of the right ventricle and left ventricular apex.

The VMCN

increased the contractility of the right ventricular conus.

The VLCN

increased contractility in the dorsal lateral aspect of the left ventricle and slightly in the anterior wall.

Geis and Kaye extended these

findings by measuring the contractile changes of the posterior left
ventricle (7).

Both of these studies concurred that stimulation of the

left stellate ganglion produced profound increases in the contractile
function of all segments of the left ventricle.

Randall and Armour also

noted that stimulation of more distal branches caused more discrete areas
to be affected by the nerves (23).
Later studies investigated the influence of the sympathetics on
myocardial blood flow.

Rinkema et al. stimulated the left and right

stellate ganglia and injected microspheres to determine the changes in
regional blood flow.

11

I

Studies by Randall

strain gauge arches.

II
~

Stimulation of the left stellate ganglia produced

pronounced changes in posterior wall blood flow as well as anterior wall

198
blood flow (24).

Ross and Mulder placed electromagnetic flow probes on

the LAD, right coronary artery and left coronary artery, and stimulated
the ansae subclavia of the left stellate ganglion.

Their results were

similar to those of Rinkema et al., in that large increases in blood flow
were produced in both areas, with the circumflex artery responding to
stimulation of the left stellate with greater increases in flow than the
left anterior descending artery (25).
In the present study, there was an increase in blood flow during
stimulation of the AAS, PAS, and VLCN.

The response to stimulation of

these three nerves during timolol was significantly different from the
response to nerve stimulation under control conditions.
major nerves actually had this effect.

Only these three

The VMCN and ICN did not actually

increase flow during stimulation under control conditions.
plausible explanations for this.

There are two

First the distribution of these nerves

is not such as would cause major increases in left ventricular metabolism.

Second, both of these nerves contain proportionately more vagal

fibers than the other three cardiac nerves.

Hence it is not surprising

that following B-blockade neither nerve would effect significant vasoconstriction of the circumflex bed, since they usually have large parasympathetic influences, which vere not elicited in this study due to prior
muscarinic blockade with atropine.
A problem with this method of analysis is that nerves which do not
innervate a significant portion of the left ventricle and hence do not
cause significant metabolic vasodilation are excluded from the study.

It

is possible that such nerves may in fact contribute to reduction in blood
flow when stimulated, but the response would be significant only when
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compared to resting blood flow during beta blockade.

One possibility for

assessing the influence of all of the cardiac nerves on blood flow would
be to stimulate the nerves in an arrested or fibrillating heart preparation to avoid the confounding influence of neurally mediated metabolic
changes.

An additional disadvantage of this method is that it would

appear that the nerves supplying the myocardium also .supply the arteries
in the vicinity.

While it is possible that a large nerve such as the

VLCN has separate vasomotor and accelerator fibers, the separation of
vasomotor and inotropic effects during stimulation of this nerve would be
difficult.

Without a separation of myocardial influences from purely

vasomotor effects, the determination of a regional distribution and
pattern of innervation on coronary blood flow is hindered.
Only the AAS showed consistent vasoconstriction in Group 1 and
Group 2.

The reason for the non-uniformity of results between nerves is

most likely due to the amount of myocardium innervated.

Stimulation of

the left stellate ganglion causes large increases in contractile force
(7,22), and blood flow throughout the entire left ventricle (24).
Stimulation of the cardiac nerves more distally produces more discrete
changes in contraction and presumably blood flow.

If a large amount of

myocardium is innervated by one nerve, the response to nerve stimulation
will be more consistent between animals.

Smaller nerves which innervate

less myocardium will probably result in more variability of response
between animals, particularly if the site of stimulation is varied distal
to the stellate ganglion.
Following beta blockade with timolol the stimulation induced change
in flow decreased compared to control.

This indicates a vasoconstriction
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which is most likely due to the unmasking of alpha receptors, and is in
accord with previous studies which demonstrated a vasoconstriction
following beta blockade (5).

In a non-beating preparation, Gerova et al.

demonstrated coronary vasoconstriction of the LAD during stimulation of
the left stellate ganglia which was eliminated by adminstration of
phentolamine (8).

Many previous investigations have demonstrated

vasoconstriction which limits metabolic vasodilation (9), or is unmasked
by beta blockade (2), but most of those studies utilized phenoxybenzamine
or phentolamine which block both alpha-1 and alpha-2 receptors.

The

results from such studies would not clarify the separate influences of
both receptor subtypes.
Although alpha-2 receptors have been demonstrated to modulate
norepinephrine release (15,16,23), only recently have studies been done
to determine whether alpha-2 receptors also control coronary blood flow.
Investigations in recent years have proposed that it is actually alpha-2
receptors which mediate coronary vasoconstriction (10,12).
It is difficult to determine from the present studies whether
alpha-1 or alpha-2 receptors predominate in mediating coronary vasoconstriction.

Although timolol in Group 1 reduced flow and increased

resistance probably by unmasking alpha receptors, this reduction in flow
was not blocked by prazosin.

Subsequent adminstration of rauwolscine

eliminated the vasoconstriction.
In part, these effects of rauwolscine in Group 2 may be ascribed to
its presynaptic action.

~y

removing the negative feedback inhibition of

norepinephrine (NE), more NE might be expected to have stimulated the
unblocked alpha-1 receptors causing vasoconstriction following admini-
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stration of rauwolscine (See Figure 7-5).

In addition the peripheral

adminstration of rauwolscine may have resulted in a larger release of the
NE due to the open chest anesthetized preparation.

This higher back-

ground level of NE plus background levels of epinephrine which is taken
up by nerve terminals and released, may have caused a higher preexisting
level of vasoconstriction which would appear to cause of blunting of the
effect of NE during stimulation.

Thus changes in blood flow during

stimulation would not be as apparent due to a high existing level of
circulating catecholamines.

Separation of the pre and post synaptic

actions of alpha-2 receptors would clarify the results of this study and
also elucidate the respective roles of alpha-1 and alpha-2 receptors.
An unexpected result of this study was that blockade of alpha-1
receptors in Group 1 resulted in significantly higher resistance and
lower flows compared to control.
this.

There are several possibilities for

First, it may be that alpha-2 receptors are responsible for the

vasoconstriction.

This eonclusion would be supported by the fact that

subsequent alpha-2 blockade brought the change in resistance back toward
control.

Another possibility for this action of prazosin may be that

alpha-1 receptors on the myocardium mediate some form of metabolic
vasodilation and that olockade of these receptors unmasks alpha- 2
receptors located on the vasculature.

This conjecture has some basis in

recent studies on the importance of myocardial alpha-1 receptors by Corr
(3).

Corr has proposed that alpha-1 receptors can influence electrical

activity in the myocardium, and can also mediate the rise in blood
pressure elicited with stellate stimulation in the presence of beta
blockade.

Corr has also shown that myocardial alpha-1 receptors increase
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FIGURE 7-5
SCHEMATIC OF PRESYNAPTIC ADRENERGIC RECEPTOR MODULATION
OF NEURONALLY RELEASED NOREPINEPHRINE
Schematic of the modulation of norepinephrine release from a
sympathetic nerve terminal by adrenergic receptors and muscarinic
receptors and the effects of adrenergic nerve stimulation on a blood
vessel. (-) indicates a negative feedback effect on norepinephrine
release and (+) indicates positive feedback on release of
norepinephrine. (Modified from: Opie,L. The Heart. Ed. by L. Opie. New
York: Grune and Stratton, 1982, pp.234.)
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significantly in number during myocardial ischemia.
The time course of stimulation of the nerves might be important in
interpreting the results from this and previous studies.
the measurements were taken during a maximal response.

In our study
Other studies

which have demonstrated alpha-vasoconstriction have also measured either
maximal response, or stimulated for less than 2 minutes.

However, in the

study by Ross and Mulder (25), a maximum response to stimulation following beta blockade was reached at 10-15 seconds and slowly subsided
after 1-2 minutes of duration.

Williams and Most demonstrated that bolus

injections of phenylephrine caused vasoconstriction, but that with
prolonged administration of the alpha-1 agonist, the vasoconstriction
subsided (32).

The possibility of an overriding metabolic influence on

vasoconstriction during prolonged sympathetic stimulation cannot be ruled
out.
In conclusion, the major nerves which innervate the posterior wall
also influence coronary blood flow.

Furthermore, the traditional concept

of alpha-1 receptors innervating the vasculature needs to be reexamined.
It appears f.rom the results of this study that alpha-2 receptors play as
important, it not more so, a role in constricting the coronary vasculature.
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CHAPTER VIII

SUMMARY
1.

Stimulation of cardiac sympathetic nerves during beta blockade
increased infarct size following coronary artery occlusion,
compared to when the nerves were not stimulated, and compared to
when the sympathetic nerves were stimulated without prior beta
blockade.

2.

Blockade of alpha receptors in addition to beta receptor blockade
with sympathetic stimulation resulted in a smaller infarct size
compared to infarct size in the presence of sympathetic stimulation
and beta blockade alone.

3.

Blockade of alpha receptors did not increase blood flow to the
posterior wall following circumflex artery occlusion.

4.

Regional denervation of the posterior wall did not increase blood
flow to the occluded region.

5.

The left anterior ansa subclavia, left posterior ansa subclavia,
and ventrolateral cardiac nerve induce significant vasoconstriction
of the circumflex artery.

6.

Alpha-2 adrenergic receptor blockade effectively blocked the
vasoconstriction produced during stimulation of the left side
cardiac nerves, in the presence of beta-blockade.

Alpha-1 receptor

blockade did not eliminate the vasoconstriction induced under
similar conditions.
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CHAPTER IX
CONCLUSIONS

This dissertation began as an attempt to define the role of alpha
receptors in the evolution of a myocardial infarction and then broadened
to encompass an investigation into how alpha receptors altered blood flow
during coronary artery occlusion, how removal of the sympathetics
affected blood flow during coronary artery occlusion, and how specific
cardiac sympathetic nerves modulated blood flow to the posterior wall.
It was initially hypothesized that stimulation of the left stellate
ganglion in the presence of £-blockade would cause an increase in infarct
size due to alpha receptor stimulation (Chapter IV).

That study showed

that administration of timolol prior to a coronary artery occlusion did
not result in a smaller infarct size when compared to control.

The fact

that there was no difference in the mean size of the infarctions between
the control dogs, and dogs given timolol, suggested that circulating
catecholamines were not as important as neurally released catecholamines.
However, when the left stellate ganglion was stimulated in the presence
of beta blockade, the size of the infarcts were significantly larger than
control.

'When alpha-blockade was given in addition to &-blockade prior

to coronary artery occlusion, left stellate stimulation did not increase
the size of the infarcts compared to control.

Moreover, the size of the

infarcts were significantly smaller than when the left stellate was
stimulated in the presence of £-blockade alone.
209
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Thus, it was postulated that the deleterious effect on infarct size
of stellate stimulation in the presence of &-blockade, was due to a
reduction in blood flow to the ischemic zone via unopposed alpha receptor
stimulation.
In the next study (Chapter V), the possibility that alpha receptors
reduced blood flow to the ischemic zone during stellate stimulation was
tested as an explanation for the findings from the first study.

In the

second study, the administration of prazosin either before or after
coronary occlusion did not result in increased blood flow to the ischemic
region (Chapter V).

However, prazosin did increase blood flow to the

normal region when given prior to coronary artery occlusion.

Further-

more, not only did prazosin cause a vasodilation in the normal zone, it
actually increased blood flow above control levels, which was somewhat
surprising since blockade of alpha receptors would have been expected to
have merely removed the vasoconstrictor effects of left ansae subclavia
stimulation in the presence of &-blockade.

A possible explanation for

the large vasodilation elicited following prazosin, is that removal of
the influence of circulating catecholamines might account for the large
increase in blood flow following alpha blockade (See Chapter V).

In the

study in which infarct sizes were measured (Chapter IV) circulating
catecholamines may not have contributed as much to infarct size, due to
the limitation in blood flow to the posterior wall.

However, circulating

catecholamines were not measured in either study.
Even more surprising in the prazosin study than the increase in
flow to the normal zone during alpha-1 blockade, was the fact that left
ansae subclavia stimulation in the presence of g-blockade did not
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decrease blood flow from control.

Other investigators had reported a

potent vasoconstriction via alpha receptors when unopposed by &-blockade.
The posterior coronary artery occlusion in the prazosin study in all
probability confounded the results of anterior wall blood flow measurements.
Whereas blockade of alpha receptors was involved in the evolution
of a myocardial infarction in the infarct study, that effect did not
appear to be mediated by a reduction in blood flow to the ischemic zone
based on the results from the second study (Chapter V).

In light of the

fact that prazosin increased blood flow to the normal zone, the possibility exists that prazosin also increased border zone flow, and thus
retarded the extension of the infarction.

Alpha-blockade might have

accomplished this by blockade of peripheral alpha receptors resulting in
a reduction of total peripheral resistance, with a consequent drop in
afterload.

With a drop in afterload, the reduction in myocardial oxygen

conswnption would have allowed salvage of some marginally ischemic zones,
by returning the balance between oxygen supply and demand toward normal
levels.
The possible contribution of myocardial alpha receptors to the
development of ischemia should not be overlooked.

It is conceivable that

myocardial alpha-1 receptors alter cardiac metabolism and thus oxygen
conswnption.

Thus, in the infarct study, blockade of myocardial alpha-

receptors might have removed the detrimental influence of increased
myocardial metabolism.

During a coronary artery occlusion, the oxygen

supply/demand balance is upset.

Under such conditions alpha receptors

may not be expected to cause noticeable changes in metabolism, due to the
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overwhelming influence of &-receptors.

However, if &-receptors are

blocked, and the amount of coronary blood flow is decreased, a small
increment in oxygen consumption (via alpha-1 receptor stimulation) may
tip the balance on the side of increasing oxygen debt.

A vicious cycle

could result, with the increased demand outstripping the restricted blood
supply.

Blockade of alpha-1 receptors could then return the balance

toward normal.

It is likely that such a small change in blood flow could

not be detected in these studies in which microspheres were utilized.
Blood flows in the posterior wall following coronary occlusion dropped
down to the limit of the blood flow necessary to deposit the requisite
number of microspheres per tissue sample for accurate blood flow calculation.

Thus, the limited resolution of the microsphere technique at low

blood flows probably contributed to the lack of positive findings during
the treatment with prazosin.
Several possibilities exist for prazosin's beneficial effects on
the extent of myocardial infarction.

Prazosin may favorably alter

hemodynamics by reducing afterload via peripheral alpha blockade and it
may lower oxygen consumption by blocking myocardial alpha-1 receptors.
Furthermore, as was suggested in the study investigating the effects of
prazosin on blood flow, while it does not alter flow to the ischemic
zone, it may increase border zone flow and salvage tissue in that manner.
The results from the second study in which blood flow to the
myocardium was assessed following prazosin (Chapter V) indicated that
alpha receptors did not influence blood flow to the ischemic zone.

The

third study (Chapter VI) was included to determine whether regional denervation of the posterior wall might influence blood flow to the
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ischemic zone.

It was originally hypothesized that removal of the

sympathetic nerves to that region would entail removal of the 'tonic'
level of vasoconstriction previously reported, and thus increase blood
flow to the ischemic zone.

This study demonstrated that posterior wall

denervation did not result in increased blood flow to the ischemic zone
by removing sympathetic vasoconstriction.

However, posterior left

ventricular denervation did drop blood flow to both the anterior and
posterior wall and resulted in a reduction in mean arterial pressure.
During LSS, in the presence of &-blockade, blood pressure and blood
flow increased.

The fact that resistance did not change during LSS

suggests that the change in blood flow was not vasomotor in origin, but
was passive and reflected the rise in arterial pressure.

It was found

that increasing the dose of timolol did not eliminate the rise in
arterial pressure during stellate stimulation.

These effects indicate

the involvement of non-beta mediated effects, possibly via alpha-1
receptors on the myocardium.

However, alpha blockade was not admini-

stered in this study, to determine whether alpha-1 receptors would indeed
have blocked the increase in blood pressure elicited by stellate stimulation.
One of the intriguing findings in the phenol study, was that
regional denervation did not increase blood flow via removal of 'tonic'
vasoconstriction.

In fact, posterior wall denervation actually decreased

blood flow to both the posterior and anterior left ventricle.

In addi-

tion, regional denervation eliminated the response to left stellate
stimulation in the innervated region.

Prior to application of phenol to

the posterior wall, LSS had increased blood pressure and blood flow even

214
in the presence of beta blockade.

Following the regional denervation,

both responses to LSS were eliminated.

By removing the sympathetic

influences to both the anterior and posterior wall, cardiac metabolism
probably decreased as did cardiac function, with a consequent drop in
blood pressure and a passive drop in blood flow.

In addition, the

possibility exists that denervation of the posterior wall interrupted the
innervation of the anterior wall.

Previously it had been thought that

cardiac nerves travel in a base to apex fashion and follow the coronary
arteries to innervate the adjacent myocardium.

Finally, it cannot be

ruled out that acute application of phenol caused a stunning of the
myocardium, and decreased function possibly by a cardio-cardiac depressor
effect due to stimulation of posterior wall receptors.
In conclusion, the phenol study suggests that the previously
reported tonic level of alpha-vasoconstriction does not appear to be of
as much importance during coronary artery occlusion, as it might be
during normal physiologic conditions.

The results from the phenol study

(Chapter VI) indicate that an important pathway for nervous innervation
to the anterior wall is via fibers originating in the posterior region
which cross over the posterior epicardium to innervate the anterior wall.
Finally, there is possibility not tested in this study, that alpha
receptors have inotropic influences which can be eliminated by posterior
wall denervation.
The actual cardiac nerves mediating coronary vasoconstriction have
not been determined.

It was found in the last study, that the VLCN, AAS,

and PAS, all cause significant vasoconstriction of the circumflex artery
but only with prior £-blockade.

Many investigations have reported that
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alpha receptors mediate potent coronary vasoconstriction, but these
studies did not differentiate between alpha-1 and alpha-2 receptors.
Only recently have alpha-2 receptors been found to mediate vasoconstriction.

The vasoconstriction elicited by stimulation of the AAS, PAS, and

VLCN was eliminated more effectively by blockade of alpha-2 receptors
with rauwolscine, than by alpha-1 blockade with prazosin.

Thus, alpha-2

receptors appeared to play a slightly greater role in vasoconstriction of
the circumflex artery than did alpha-1 receptors.

However, as was

remarked upon, the pre- and post-junctional actions of alpha-2 receptors
could not be separated in this study (See Discussion, Chapter VI).
It would appear that alpha-mediated vasoconstriction does not play
a major role in altering blood flow to ischemic regions.

Alpha vasocon-

striction can be elicited by sympathetic stimulation, but only when the
overriding influence of B-mediated vasodilation is eliminated.

The time

course of stimulation used may have led to some conflicting results when
compared to earlier studies.

In Chapter VII, vasoconstriction in the

presence of B-blockade was readily elicited, but stimulations did not
last for more than 90 seconds.

This period of stimulation was comparable

to that used in other studies demonstrating alpha-mediated vasoconstriction.

However, in the first three studies presented, stellate stimula-

tion was continued for much longer durations, 3-5 minutes before beginning microsphere injections.

It is possible that alpha-vasoconstriction

is transient and of insignificant importance during longer periods of
sympathetic input.

If alpha receptors do mediate metabolic increases in

flow, however slight, then these effects may not be of apparent immediately.

This would be of particular importance during the course of
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ischemia, when regardless of whether alpha receptors mediate noticeable
vasomotor effects, the possibility of alpha-1 mediated increases in
metabolism may be enough to initiate significant myocardial damage.
It should not be disregarded that the open chest anesthetized preparation utilized in this dissertation does not facilitate the responses
of adrenergic receptors to stimulation.

Therefore the activity of alpha

receptors may be of more importance in studies done in conscious animals.
In conclusion, I would like to put into writing a few closing
comments on this area of research based on what I have found in my
studies.

I started this project with the concept that neural stimulation

of alpha receptors would cause vasoconstriction, which would worsen the
course of myocardial infarction.

However, this rather simple assumption

that alpha receptors vasoconstrict arteries during normal and abnormal
conditions has evolved into an appreciation of the complex interactions
between alpha-1 and alpha-2 receptors on blood flow and cardiac function.
I assumed that alpha receptor stimulation would decrease blood flow
to an ischemic bed and that this could be eliminated by alpha-1 blockade
or regional denervation.

Until recently alpha-1 receptors were thought

to be the primary mediator of vasoconstriction.

This was not seen in our

study, contrary to other studies, in part because the duration of
stimulation was longer than those used by other investigators.

Thus it

would appear that if alpha receptors induce coronary vasoconstriction it
is probably transient in nature.
However, if alpha receptors exert only transient influences on
blood flow, this does not mean that they are a receptor of only inconsequential importance or interest.

Our studies point toward the possible
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role of alpha receptors in other aspects of neural regulation of the
heart.

It is possible that alpha receptors have influences on function

and metabolism, but these effects have yet to be elucidated.

Thus the

concept of neural stimulation of alpha receptors causing coronary
vasoconstriction does not appear to be as important as has been written
in the literature.

Instead, I have come around full circle, to stress

the predominance of cardiac metabolism on blood flow.

In this picture of

blood flow regulation, the sympathetic nerves are even more important
because of their complex influence on myocardial and vascular beta and
alpha receptors.

APPENDIX A

RETROSPECTIVE ANALYSIS OF BLOOD FLOW
In order to check the accuracy of flows in the ischemic region,
endocardial and epicardial samples from the same slice were combined to
estimate flow retrospectively thus achieving sample weights of close to 1
gram.
Initial blood flow analysis:
Weight

FLows (ml/min/gm)

CAO- '
LSS-PRAZ

(gm)

CTRL

CAO

451
726
764

.495
.540
.587

.549
.819
.686

.636
.324
.408

Counts/min
Sample#
CTRL

CAO

CAOLSS

2685
4374
3981

1746
969
1328

710

CAO
CAO
LSS LSS-PRAZ

Endo
5

7
9

500
568

Blood Flow ........................................ 0.685
0.628

.507
.328
.342

0.456

.483
. 712

.690

0.392

Epi
6
8
10

5920
3545
4621

1818
2075
2154

779
1009
918

846
577
743

.689
.555
. 720

.869
.646
.649

.476
.674
.539

.400
.643
.451

.651
.551
.547

-------------------------Blood Flow ........................................ 0.721
0.583

*

0.546

0.498

Blood flows were initially calculated per sample as shown above. The
flows were separated into endocardial and epicardial flows, for each of
the four experimental conditions. The final value of blood flow used in
the analysis of data represents the average of all the samples in the
left ventricular ischemic zone.
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Flows estimated retrospectively:
'Weight

Counts/min
Sample#
CTRL

CAO

CAOLSS

CAOLSS-PRAZ

(gm)

Blood Flow (ml/min/gm)
CTRL

CAO

CAOCAOLSS LSSPRAZ

1.62

.732

.478

.412

1. 96

. 771

.590

.518

endo
5
7
9

2685
4374
3981

Totals
.674

1746
969
1328

500
568

451
726
764

0.50
0.54
0.59

11040

4043

1778

1941

1818
2075
2154

779
1009

846
577
743

0.69
0.56
0. 72

710

epi
6
8

10
Totals
.621

5920
3545
4621

918

-----------------------------------14086

6047

2706

2166

**The samples of tissue in each slice of the left ventricular ischemic
zone were first separated into endocardial and epicardial samples. The
counts/min and weight of each sample were summed. Blood flow was
calculated using the summed counts/min and weights for each slice. The
final blood flow value for the left ventricular ischemic zone represented
the average of the blood flow per slice of LV, not per sample of LV as
described in the first section of the table.
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